US20050288778A1 - Selectively adjustable cardiac valve implants - Google Patents

Selectively adjustable cardiac valve implants Download PDF

Info

Publication number
US20050288778A1
US20050288778A1 US11/123,891 US12389105A US2005288778A1 US 20050288778 A1 US20050288778 A1 US 20050288778A1 US 12389105 A US12389105 A US 12389105A US 2005288778 A1 US2005288778 A1 US 2005288778A1
Authority
US
United States
Prior art keywords
shape memory
annuloplasty ring
ring
size
configuration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/123,891
Inventor
Emanuel Shaoulian
Shahram Moaddeb
Samuel Shaolian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micardia Corp
Original Assignee
Micardia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micardia Corp filed Critical Micardia Corp
Priority to US11/123,891 priority Critical patent/US20050288778A1/en
Priority to JP2007519262A priority patent/JP2008504878A/en
Priority to PCT/US2005/021324 priority patent/WO2006012038A2/en
Priority to EP05784934A priority patent/EP1761213A4/en
Assigned to MICARDIA CORPORATION reassignment MICARDIA CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MOADDEB, SHAHRAM, SHAOULIAN, EMANUEL, SHAOLIAN, SAMUEL M.
Publication of US20050288778A1 publication Critical patent/US20050288778A1/en
Priority to US13/079,429 priority patent/US20110257740A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • A61F2/2448D-shaped rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0082Additional features; Implant or prostheses properties not otherwise provided for specially designed for children, e.g. having means for adjusting to their growth

Definitions

  • the present invention relates to methods and devices for reinforcing dysfunctional heart valves and other body structures. More specifically, the present invention relates to annuloplasty rings that can be adjusted within the body of a patient.
  • the circulatory system of mammals includes the heart and the interconnecting vessels throughout the body that include both veins and arteries.
  • the human heart includes four chambers, which are the left and right atrium and the left and right ventricles.
  • the mitral valve which allows blood flow in one direction, is positioned between the left ventricle and left atrium.
  • the tricuspid valve is positioned between the right ventricle and the right atrium.
  • the aortic valve is positioned between the left ventricle and the aorta, and the pulmonary valve is positioned between the right ventricle and pulmonary artery.
  • the heart valves function in concert to move blood throughout the circulatory system.
  • the right ventricle pumps oxygen-poor blood from the body to the lungs and then into the left atrium. From the left atrium, the blood is pumped into the left ventricle and then out the aortic valve into the aorta. The blood is then recirculated throughout the tissues and organs of the body and returns once again to the
  • valves of the heart do not function properly, due either to disease or congenital defects, the circulation of the blood may be compromised.
  • Diseased heart valves may be stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely. Incompetent heart valves cause regurgitation or excessive backward flow of blood through the valve when the valve is closed.
  • certain diseases of the heart valves can result in dilation of the heart and one or more heart valves.
  • the valve leaflet geometry deforms and causes ineffective closure of the valve leaflets. The ineffective closure of the valve can cause regurgitation of the blood, accumulation of blood in the heart, and other problems.
  • valve replacement surgery in which damaged leaflets are excised and the annulus is sculpted to receive a replacement valve.
  • annuloplasty Another repair technique that has been shown to be effective in treating incompetence is annuloplasty, in which the effective size of the valve annulus is contracted by attaching a prosthetic annuloplasty repair segment or ring to an interior wall of the heart around the valve annulus.
  • the annuloplasty ring reinforces the functional changes that occur during the cardiac cycle to improve coaptation and valve integrity.
  • annuloplasty rings help reduce reverse flow or regurgitation while permitting good hemodynamics during forward flow.
  • annuloplasty rings comprise an inner substrate of a metal such as stainless steel or titanium, or a flexible material such as silicon rubber or Dacron®.
  • the inner substrate is generally covered with a biocompatible fabric or cloth to allow the ring to be sutured to the heart tissue.
  • Annuloplasty rings may be stiff or flexible, may be open or closed, and may have a variety of shapes including circular, D-shaped, or C-shaped.
  • the configuration of the ring is generally based on the shape of the heart valve being repaired or on the particular application.
  • the tricuspid valve is generally circular and the mitral valve is generally D-shaped.
  • C-shaped rings may be used for tricuspid valve repairs, for example, because it allows a surgeon to position the break in the ring adjacent the atrioventricular node, thus avoiding the need for suturing at that location.
  • Annuloplasty rings support the heart valve annulus and restore the valve geometry and function.
  • the heart of a patient may change geometry over time after implantation. For example, the heart of a child will grow as the child ages.
  • dilation of the heart caused by accumulation of blood may cease and the heart may begin returning to its normal size. Whether the size of the heart grows or reduces after implantation of an annuloplasty ring, the ring may no longer be the appropriate size for the changed size of the valve annulus.
  • an adjustable annuloplasty device includes a body member configured to conform at least partially to a cardiac valve annulus.
  • the body member includes a shape memory material configured to transform from a first shape to a second shape in response to being heated.
  • the annuloplasty device further includes a thermally insulative material at least partially covering said body member and a thermally conductive material extending into said thermally insulative material.
  • the thermally conductive material is configured to communicate thermal energy to the body member.
  • the thermally conductive material can be configured as an imaging marker and can include a radiopaque material.
  • the annuloplasty device further includes a suturable material at least partially covering said thermally insulative material.
  • the thermally conductive material can be disposed at least partially over said suturable material and can provide indicia of one or more valve commissure locations after said annuloplasty device is implanted on or near a heart valve annulus.
  • the thermally conductive material can include at least one of a metallic wire or a metallic ribbon and the body member can be selected from a variety of shapes including, for example, ring shaped, C-shaped and D-shaped.
  • an adjustable annuloplasty device in another embodiment, includes a body member configured to conform at least partially to a cardiac valve annulus.
  • the body member includes a shape memory material configured to transform from a first shape to a second shape in response to being heated.
  • the annuloplasty device further includes a thermally conductive member adjacent said body member, said thermally conductive material configured to communicate thermal energy to said body member.
  • the thermally conductive member can be further configured as an imaging marker and may include a radiopaque material.
  • the annuloplasty device may further include a suturable material at least partially covering said body member.
  • the thermally conductive member can be disposed at least partially over said suturable material and the thermally conductive member can provide indicia of one or more valve commissure locations after said adjustable annuloplasty device is implanted on or near a heart valve annulus.
  • the thermally conductive member can include at least one of a metallic wire or a metallic ribbon, and the body member may be selected from a variety of shapes including, for example, ring shaped, C-shaped and D-shaped.
  • an adjustable annuloplasty device in another embodiment, includes a body member having a material that exhibits a ferromagnetic shape memory effect.
  • the body member has a first size of a dimension of said device in a first configuration and a second size of said dimension of said device in a second configuration.
  • the body member is configured to be implanted into a heart so as to reinforce a cardiac valve annulus in said first configuration.
  • the body member is configured to transform from said first configuration to said second configuration in vivo in response to a magnetic field inducing said ferromagnetic shape memory effect.
  • the body member in said second configuration is configured to reduce a size of said cardiac valve annulus.
  • the shape memory material may include at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni 2 MnGa, and Co—Ni—Al.
  • the body member can be configured to transform from said first configuration to said second configuration without substantially changing the temperature of said ferromagnetic shape memory material.
  • the device can have a ring shape, a C-shape, a D-shape, or other shape.
  • an adjustable annuloplasty device in another embodiment, includes a body member including a shape memory material and an energy absorption enhancement material configured to absorb energy in response to a first activation energy.
  • the energy absorption enhancement material is in thermal communication with said shape memory material.
  • the body member has a first size of a body dimension in a first configuration and a second size of said body dimension in a second configuration.
  • the body member is configured to be implanted in said first configuration into a heart.
  • the body member is configured to transform from said first configuration to said second configuration in response to said first activation energy.
  • the second configuration is configured to reduce a dimension of a cardiac valve annulus in said heart.
  • the energy absorption enhancement material may be further configured to heat in response to said first activation energy and may be configured to transfer heat to said shape memory material.
  • the shape memory material can include at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid.
  • the annuloplasty device may further include an electrically conductive material configured to conduct a current in response to said first activation energy and to transfer thermal energy to said shape memory material.
  • the annuloplasty device may further include a suturable material configured to facilitate attachment of said body member to said cardiac valve annulus.
  • the body member can have a third size of said body dimension in a third configuration, wherein said third size is larger than said second size, and wherein said body member is configured to transform to said third configuration in response to a second activation energy to increase said dimension of said cardiac valve annulus.
  • the body member can have a third size of said body dimension in a third configuration, wherein said third size is smaller than said second size, and wherein said body member is configured to transform to said third configuration in response to a second activation energy to decrease said dimension of said cardiac valve annulus.
  • the energy absorption enhancement material can include a nanoparticle that may include, for example, at least one of a nanoshell and a nanosphere.
  • the energy absorption enhancement material can be radiopaque.
  • an adjustable annuloplasty ring in another embodiment, includes a tubular member configured to be attached to or near a cardiac valve annulus.
  • the tubular member includes a receptacle end and an insert end configured to couple with said receptacle end of said tubular member such that said tubular member substantially forms a shape of a ring.
  • the insert end is configured to move with respect to said receptacle end to change a circumference of said ring.
  • the tubular member can further include a shape memory material configured to change, after implantation in a patient's body, from a first shape to a second shape in response to an activation energy, wherein said shape change causes said change in the circumference of said ring.
  • the tubular member can further include an energy absorption enhancement material disposed within said tubular member.
  • the energy absorption enhancement material facilitates transfer of heat to said shape memory material.
  • the energy absorption enhancement material can be further disposed on an outer surface of said tubular member.
  • the tubular member can further include a ratchet member configured to allow said insert end to move predominantly in a first direction with respect to said receptacle end, and to resist movement in a second, opposite direction.
  • the annuloplasty ring can be ring shaped, C-shaped, D-shaped, or another shape.
  • an adjustable annuloplasty ring in another embodiment, includes a body member configured to be attached to or near a cardiac valve annulus.
  • the body member includes a first end and a second end configured to couple with said first end of said body member such that said body member substantially forms a shape of a ring.
  • the second end is configured to move with respect to said first end to change a circumference of said ring.
  • the body member can further include a shape memory material configured to change, after implantation in a patient's body, from a first shape to a second shape in response to an activation energy, wherein said shape change causes said change in the circumference of said ring.
  • the body member can further include an energy absorption enhancement material that facilitates transfer of heat to said shape memory material.
  • the body member can further include a ratchet member configured to allow said second end to move predominantly in a first direction with respect to said first end, and to resist movement in a second, opposite direction.
  • the annuloplasty ring can be ring shaped, C-shaped, D-shaped, or another shape.
  • an adjustable annuloplasty ring in another embodiment, includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension. The second size is less than said first size.
  • the ring also includes a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension. The second size is less than said third size.
  • the first shape memory member can be configured to change shape in response to being heated to a first temperature and the second shape memory member can be configured to change shape in response to being heated to a second temperature. The first temperature can be lower than said second temperature or the second temperature can be lower than said first temperature.
  • At least one of said first shape memory member and said second shape memory member can include at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid. At least one of said first shape memory member and said second shape memory member can be configured to change shape in response to a magnetic field. At least one of said first shape memory member and said second shape memory member can include at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni 2 MnGa, and Co—Ni—Al.
  • the ring dimension can be a septolateral dimension.
  • an adjustable annuloplasty ring in another embodiment, includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said second size is less than said first size, and a second shape memory member configured to transform said annuloplasty ring from said second size to a third size of the ring dimension, wherein said third size is less than said second size.
  • an adjustable annuloplasty ring in another embodiment, includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size, and a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said third size is less than said second size.
  • an adjustable annuloplasty ring in another embodiment, includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size, and a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said second size is less than said third size.
  • the annuloplasty device has a first shape in a first configuration and a second shape in a second configuration.
  • the annuloplasty device is configured to transform from said first configuration to said second configuration in response to a first activation energy applied thereto.
  • the transformation is configured to reduce a distance between said anterior portion and said posterior portion without substantially decreasing a distance between said two lateral portions.
  • the annuloplasty device can also include one or more imaging markers that can include, for example, radiopaque markers.
  • the transformation can be further configured to increase said distance between said two lateral portions.
  • the annuloplasty device further includes a wire that extends at least partially along said anterior and posterior portions, and a first shape memory member at least partially covering or contacting said wire.
  • the wire can be selected from the group consisting of a round wire, a flat wire, a mesh wire, a rod-shaped wire, and a band-shaped wire.
  • the first shape memory member can include a tubular structure, wherein at least a portion of said wire passes through said tubular structure.
  • the tubular structure can include a first shape memory body configured to respond to said first activation energy by bending said wire such that said annuloplasty device transforms from said first shape to said second shape.
  • the tubular structure can further include a second shape memory body configured to respond to a second activation energy by bending said wire such that said annuloplasty device transforms from said second shape to a third shape.
  • the annuloplasty device in said third shape can have a reduced distance between said anterior portion and said posterior portion as compared to said second shape.
  • the annuloplasty device in said third shape can have an increased distance between said anterior portion and said posterior portion as compared to said second shape.
  • At least one of said first activation energy and said second activation energy can include a magnetic field, acoustic energy, radio frequency energy.
  • the first shape memory body can change to a first activation temperature in response to said first activation energy, wherein said second shape memory body changes to a second activation temperature in response to said second activation energy.
  • the first activation temperature can be lower than said second activation temperature.
  • the annuloplasty device further includes a first shape memory band that extends at least partially along said anterior and posterior portions.
  • the first shape memory band loops back on itself in a curvilinear configuration such that portions of said first shape memory band overlap one another.
  • the first shape memory band can be configured to change its length in response to said first activation energy such that said overlapping portions slide with respect to one another to change said annuloplasty device from said first configuration to said second configuration.
  • the annuloplasty device can further include a second shape memory band at least partially disposed between or adjacent to said overlapping portions of said first shape memory band.
  • the second shape memory band can be configured to respond to a second activation energy to transform said annuloplasty device from said second configuration to a third configuration.
  • the annuloplasty device in said third configuration can have a reduced distance between said anterior portion and said posterior portion as compared to said second shape.
  • the annuloplasty device in said third configuration can have an increased distance between said anterior portion and said posterior portion as compared to said second shape.
  • At least one of said first activation energy and said second activation energy can include a magnetic field, acoustic energy, radio frequency energy, or another form of energy.
  • the first shape memory band can change to a first activation temperature in response to said first activation energy, wherein said second shape memory band changes to a second activation temperature in response to said second activation energy.
  • an annuloplasty device changes a patient's cardiac valve annulus size in an anteroposterior dimension without substantially changing said annulus in a lateral dimension.
  • the changing occurs in response to a transmission of energy from a non-invasive source external to the patient's heart to said annuloplasty device.
  • FIG. 1A is a top view in partial section of an adjustable annuloplasty ring according to certain embodiments of the invention.
  • FIG. 1B is a side view of the annuloplasty ring of FIG. 1A ;
  • FIG. 1C is a transverse cross-sectional view of the annuloplasty ring of FIG. 1A ;
  • FIG. 2 is a graphical representation of the diameter of an annuloplasty ring in relation to the temperature of the annuloplasty ring according to certain embodiments of the invention
  • FIG. 3A is a top view in partial section of an adjustable annuloplasty ring having a D-shaped configuration according to certain embodiments of the invention
  • FIG. 3B is a side view of the annuloplasty ring of FIG. 3A ;
  • FIG. 3C is a transverse cross-sectional view of the annuloplasty ring of FIG. 3A ;
  • FIG. 4A is a top view of an annuloplasty ring having a substantially circular configuration according to certain embodiments of the invention.
  • FIG. 4B is a side view of the annuloplasty ring of FIG. 4A ;
  • FIG. 4C is a transverse cross-sectional view of the annuloplasty ring of FIG. 4A ;
  • FIG. 5 is a top view of an annuloplasty ring having a substantially D-shaped configuration according to certain embodiments of the invention.
  • FIG. 6A is a schematic diagram of a top view of a shape memory wire having a substantially D-shaped configuration according to certain embodiments of the invention.
  • FIGS. 6B-6E are schematic diagrams of side views of the shape memory wire of FIG. 6A according to certain embodiments of the invention.
  • FIG. 7A is a perspective view in partial section of an annuloplasty ring comprising the shape memory wire of FIG. 6A according to certain embodiments of the invention.
  • FIG. 7B is a perspective view in partial section of a portion of the annuloplasty ring of FIG. 7A ;
  • FIG. 8 is a schematic diagram of a shape memory wire having a substantially C-shaped configuration according to certain embodiments of the invention.
  • FIG. 9A is a perspective view in partial section of an annuloplasty ring comprising the shape memory wire of FIG. 8 according to certain embodiments of the invention.
  • FIG. 9B is a perspective view in partial section of a portion of the annuloplasty ring of FIG. 9A ;
  • FIG. 10A is a perspective view in partial section an annuloplasty ring comprising a first shape memory wire and a second shape memory wire according to certain embodiments of the invention
  • FIG. 10B is a top cross-sectional view of the annuloplasty ring of FIG. 10A ;
  • FIG. 11A is a perspective view in partial section of an annuloplasty ring comprising a first shape memory wire and a second shape memory wire according to certain embodiments of the invention
  • FIG. 11B is a top cross-sectional view of the annuloplasty ring of FIG. 11A ;
  • FIG. 12 is a perspective view of a shape memory wire wrapped in a coil according to certain embodiments of the invention.
  • FIGS. 13A and 13B are schematic diagrams illustrating an annuloplasty ring according to certain embodiments of the invention.
  • FIG. 14 is a schematic diagram illustrating an annuloplasty ring according to certain embodiments of the invention.
  • FIG. 15 is a schematic diagram illustrating an annuloplasty ring according to certain embodiments of the invention.
  • FIGS. 16A and 16B are schematic diagrams illustrating an annuloplasty ring having a plurality of temperature response zones or sections according to certain embodiments of the invention.
  • FIGS. 17A and 17B are schematic diagrams illustrating an annuloplasty ring having a plurality of temperature response zones or sections according to certain embodiments of the invention.
  • FIG. 18 is a sectional view of a mitral valve with respect to an exemplary annuloplasty ring according to certain embodiments of the invention.
  • FIG. 19 is a schematic diagram of a substantially C-shaped wire comprising a shape memory material configured to contract in a first direction and expand in a second direction according to certain embodiments of the invention.
  • FIGS. 20A and 20B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention.
  • FIGS. 21A and 21B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention.
  • FIGS. 22A and 22B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention.
  • FIG. 23 is a transverse cross-sectional view of the body member of FIGS. 21A and 21B ;
  • FIG. 24 is a perspective view of a body member usable by an annuloplasty ring according to certain embodiments comprising a first shape memory band and a second shape memory band;
  • FIG. 25A is a schematic diagram illustrating the body member of FIG. 24 in a first configuration or shape according to certain embodiments of the invention.
  • FIG. 25B is a schematic diagram illustrating the body member of FIG. 24 in a second configuration or shape according to certain embodiments of the invention.
  • FIG. 25C is a schematic diagram illustrating the body member of FIG. 24 in a third configuration or shape according to certain embodiments of the invention.
  • FIG. 26 is a perspective view illustrating an annuloplasty ring comprising one or more thermal conductors according to certain embodiments of the invention.
  • FIGS. 27A-27C are transverse cross-sectional views of the annuloplasty ring of FIG. 26 schematically illustrating exemplary embodiments of the invention for conducting thermal energy to an internal shape memory wire;
  • FIG. 28 is a schematic diagram of an annuloplasty ring comprising one or more thermal conductors according to certain embodiments of the invention.
  • an adjustable annuloplasty ring is implanted into the body of a patient such as a human or other animal.
  • the adjustable annuloplasty ring is implanted through an incision or body opening either thoracically (e.g., open-heart surgery) or percutaneously (e.g., via a femoral artery or vein, or other arteries or veins) as is known to someone skilled in the art.
  • the adjustable annuloplasty ring is attached to the annulus of a heart valve to improve leaflet coaptation and to reduce regurgitation.
  • the annuloplasty ring may be selected from one or more shapes comprising a round or circular shape, an oval shape, a C-shape, a D-shape, a U-shape, an open circle shape, an open oval shape, and other curvilinear shapes.
  • the size of the annuloplasty ring can be adjusted postoperatively to compensate for changes in the size of the heart.
  • postoperatively refers to a time after implanting the adjustable annuloplasty ring and closing the body opening through which the adjustable annuloplasty ring was introduced into the patient's body.
  • the annuloplasty ring may be implanted in a child whose heart grows as the child gets older.
  • the size of the annuloplasty ring may need to be increased.
  • the size of an enlarged heart may start to return to its normal size after an annuloplasty ring is implanted.
  • the size of the annuloplasty ring may need to be decreased postoperatively to continue to reinforce the heart valve annulus.
  • the annuloplasty ring comprises a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field.
  • Shape memory is the ability of a material to regain its shape after deformation.
  • Shape memory materials include polymers, metals, metal alloys and ferromagnetic alloys.
  • the annuloplasty ring is adjusted in vivo by applying an energy source to activate the shape memory material and cause it to change to a memorized shape.
  • the energy source may include, for example, radio frequency (RF) energy, x-ray energy, microwave energy, ultrasonic energy such as focused ultrasound, high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like.
  • electromagnetic radiation that is useful is infrared energy having a wavelength in a range between approximately 750 nanometers and approximately 1600 nanometers.
  • This type of infrared radiation may be produced efficiently by a solid state diode laser.
  • the annuloplasty ring implant is selectively heated using short pulses of energy having an on and off period between each cycle. The energy pulses provide segmental heating which allows segmental adjustment of portions of the annuloplasty ring without adjusting the entire implant.
  • the annuloplasty ring includes an energy absorbing material to increase heating efficiency and localize heating in the area of the shape memory material.
  • Energy absorbing materials for light or laser activation energy may include nanoshells, nanospheres and the like, particularly where infrared laser energy is used to energize the material.
  • Such nanoparticles may be made from a dielectric, such as silica, coated with an ultra thin layer of a conductor, such as gold, and be selectively tuned to absorb a particular frequency of electromagnetic radiation.
  • the nanoparticles range in size between about 5 nanometers and about 20 nanometers and can be suspended in a suitable material or solution, such as saline solution. Coatings comprising nanotubes or nanoparticles can also be used to absorb energy from, for example, HIFU, MRI, inductive heating, or the like.
  • thin film deposition or other coating techniques such as sputtering, reactive sputtering, metal ion implantation, physical vapor deposition, and chemical deposition can be used to cover portions or all of the annuloplasty ring.
  • Such coatings can be either solid or microporous.
  • HIFU energy for example, a microporous structure traps and directs the HIFU energy toward the shape memory material.
  • the coating improves thermal conduction and heat removal.
  • the coating also enhances radio-opacity of the annuloplasty ring implant.
  • Coating materials can be selected from various groups of biocompatible organic or non-organic, metallic or non-metallic materials such as Titanium Nitride (TiN), Iridium Oxide (Irox), Carbon, Platinum black, Titanium Carbide (TiC) and other materials used for pacemaker electrodes or implantable pacemaker leads. Other materials discussed herein or known in the art can also be used to absorb energy.
  • TiN Titanium Nitride
  • Iridium Oxide Irox
  • Carbon Platinum black
  • TiC Titanium Carbide
  • Other materials discussed herein or known in the art can also be used to absorb energy.
  • fine conductive wires such as platinum coated copper, titanium, tantalum, stainless steel, gold, or the like, are wrapped around the shape memory material to allow focused and rapid heating of the shape memory material while reducing undesired heating of surrounding tissues.
  • the energy source is applied surgically either during implantation or at a later time.
  • the shape memory material can be heated during implantation of the annuloplasty ring by touching the annuloplasty ring with warm object.
  • the energy source can be surgically applied after the annuloplasty ring has been implanted by percutaneously inserting a catheter into the patient's body and applying the energy through the catheter.
  • RF energy, light energy or thermal energy e.g., from a heating element using resistance heating
  • thermal energy can be provided to the shape memory material by injecting a heated fluid through a catheter or circulating the heated fluid in a balloon through the catheter placed in close proximity to the shape memory material.
  • the shape memory material can be coated with a photodynamic absorbing material which is activated to heat the shape memory material when illuminated by light from a laser diode or directed to the coating through fiber optic elements in a catheter.
  • the photodynamic absorbing material includes one or more drugs that are released when illuminated by the laser light.
  • a removable subcutaneous electrode or coil couples energy from a dedicated activation unit.
  • the removable subcutaneous electrode provides telemetry and power transmission between the system and the annuloplasty ring.
  • the subcutaneous removable electrode allows more efficient coupling of energy to the implant with minimum or reduced power loss.
  • the subcutaneous energy is delivered via inductive coupling.
  • the energy source is applied in a non-invasive manner from outside the patient's body.
  • the external energy source is focused to provide directional heating to the shape memory material so as to reduce or minimize damage to the surrounding tissue.
  • a handheld or portable device comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the annuloplasty ring. The current heats the annuloplasty ring and causes the shape memory material to transform to a memorized shape.
  • the annuloplasty ring also comprises. an electrically conductive coil wrapped around or embedded in. the memory shape material. The externally generated electromagnetic field induces a current in the annuloplasty ring's coil, causing it to heat and transfer thermal energy to the shape memory material.
  • an external HIFU transducer focuses ultrasound energy onto the implanted annuloplasty ring to heat the shape memory material.
  • the external HIFU transducer is a handheld or portable device.
  • the terms “HIFU,” “high intensity focused ultrasound” or “focused ultrasound” as used herein are broad terms and are used at least in their ordinary sense and include, without limitation, acoustic energy within a wide range of intensities and/or frequencies.
  • HIFU includes acoustic energy focused in a region, or focal zone, having an intensity and/or frequency that is considerably less than what is currently used for ablation in medical procedures.
  • the focused ultrasound is not destructive to the patient's cardiac tissue.
  • HIFU includes acoustic energy within a frequency range of approximately 0.5 MHz and approximately 30 MHz and a power density within a range of approximately 1 W/cm 2 and approximately 500 W/cm 2 .
  • the annuloplasty ring comprises an ultrasound absorbing material or hydro-gel material that allows focused and rapid heating when exposed to the ultrasound energy and transfers thermal energy to the shape memory material.
  • a HIFU probe is used with an adaptive lens to compensate for heart and respiration movement. The adaptive lens has multiple focal point adjustments.
  • a HIFU probe with adaptive capabilities comprises a phased array or linear configuration.
  • an external HIFU probe comprises a lens configured to be placed between a patient's ribs to improve acoustic window penetration and reduce or minimize issues and challenges regarding passing through bones.
  • HIFU energy is synchronized with an ultrasound imaging device to allow visualization of the annuloplasty ring implant during HIFU activation.
  • ultrasound imaging is used to non-invasively monitor the temperature of tissue surrounding the annuloplasty ring by using principles of speed of sound shift and changes to tissue thermal expansion.
  • non-invasive energy is applied to the implanted annuloplasty ring using a Magnetic Resonance Imaging (MRI) device.
  • the shape memory material is activated by a constant magnetic field generated by the MRI device.
  • the MRI device generates RF pulses that induce current in the annuloplasty ring and heat the shape memory material.
  • the annuloplasty ring can include one or more coils and/or MRI energy absorbing material to increase the efficiency and directionality of the heating.
  • Suitable energy absorbing materials for magnetic activation energy include particulates of ferromagnetic material.
  • Suitable energy absorbing materials for RF energy include ferrite materials as well as other materials configured to absorb RF energy at resonant frequencies thereof.
  • the MRI device is used to determine the size of the implanted annuloplasty ring before, during and/or after the shape memory material is activated.
  • the MRI device generates RF pulses at a first frequency to heat the shape memory material and at a second frequency to image the implanted annuloplasty ring.
  • the size of the annuloplasty ring can be measured without heating the ring.
  • an MRI energy absorbing material heats sufficiently to activate the shape memory material when exposed to the first frequency and does not substantially heat when exposed to the second frequency.
  • Other imaging techniques known in the art can also be used to determine the size of the implanted ring including, for example, ultrasound imaging, computed tomography (CT) scanning, X-ray imaging, or the like. In certain embodiments, such imaging techniques also provide sufficient energy to activate the shape memory material.
  • CT computed tomography
  • imaging and resizing of the annuloplasty ring is performed as a separate procedure at some point after the annuloplasty ring as been surgically implanted into the patient's heart and the patient's heart, pericardium and chest have been surgically closed.
  • the success of the surgery can be checked and corrections can be made, if necessary, before closing the patient's chest.
  • activation of the shape memory material is synchronized with the heart beat during an imaging procedure.
  • an imaging technique can be used to focus HIFU energy onto an annuloplasty ring in a patient's body during a portion of the cardiac cycle.
  • the annuloplasty ring may move in and out of this area of focused energy.
  • the patient's body is exposed to the HIFU energy only during portions of the cardiac cycle that focus the HIFU energy onto the cardiac ring.
  • the energy is gated with a signal that represents the cardiac cycle such as an electrocardiogram signal.
  • the synchronization and gating is configured to allow delivery of energy to the shape memory materials at specific times during the cardiac cycle to avoid or reduce the likelihood of causing arrhythmia or fibrillation during vulnerable periods.
  • the energy can be gated so as to only expose the patient's heart to the energy during the T wave of the electrocardiogram signal.
  • shape memory materials include, for example, polymers, metals, and metal alloys including ferromagnetic alloys.
  • Exemplary shape memory polymers that are usable for certain embodiments of the present invention are disclosed by Langer, et al. in U.S. Pat. No. 6,720,402, issued Apr. 13, 2004, U.S. Pat. No. 6,388,043, issued May 14, 2002, and U.S. Pat. No. 6,160,084, issued Dec. 12, 2000, each of which are hereby incorporated by reference herein.
  • Shape memory polymers respond to changes in temperature by changing to one or more permanent or memorized shapes. In certain embodiments, the shape memory polymer is heated to a temperature between approximately 38 degrees Celsius and approximately 60 degrees Celsius.
  • the shape memory polymer is heated to a temperature in a range between approximately 40 degrees Celsius and approximately 55 degrees Celsius. In certain embodiments, the shape memory polymer has a two-way shape memory effect wherein the shape memory polymer is heated to change it to a first memorized shape and cooled to change it to a second memorized shape.
  • the shape memory polymer can be cooled, for example, by inserting or circulating a cooled fluid through a catheter.
  • Shape memory polymers implanted in a patient's body can be heated non-invasively using, for example, external light energy sources such as infrared, near-infrared, ultraviolet, microwave and/or visible light sources.
  • the light energy is selected to increase absorption by the shape memory polymer and reduce absorption by the surrounding tissue.
  • damage to the tissue surrounding the shape memory polymer is reduced when the shape memory polymer is heated to change its shape.
  • the shape memory polymer comprises gas bubbles or bubble containing liquids such as fluorocarbons and is heated by inducing a cavitation effect in the gas/liquid when exposed to HIFU energy.
  • the shape memory polymer may be heated using electromagnetic fields and may be coated with a material that absorbs electromagnetic fields.
  • Certain metal alloys have shape memory qualities and respond to changes in temperature and/or exposure to magnetic fields.
  • Exemplary shape memory alloys that respond to changes in temperature include titanium-nickel, copper-zinc-aluminum, copper-aluminum-nickel, iron-manganese-silicon, iron-nickel-aluminum, gold-cadmium, combinations of the foregoing, and the like.
  • the shape memory alloy comprises a biocompatible material such as a titanium-nickel alloy.
  • Shape memory alloys exist in two distinct solid phases called martensite and austenite.
  • the martensite phase is relatively soft and easily deformed, whereas the austenite phase is relatively stronger and less easily deformed.
  • shape memory alloys enter the austenite phase at a relatively high temperature and the martensite phase at a relatively low temperature.
  • Shape memory alloys begin transforming to the martensite phase at a start temperature (M s ) and finish transforming to the martensite phase at a finish temperature (M f ).
  • M s start temperature
  • M f finish temperature
  • Such shape memory alloys begin transforming to the austenite phase at a start temperature (A s ) and finish transforming to the austenite phase at a finish temperature (A f ). Both transformations have a hysteresis.
  • the M s temperature and the A f temperature are not coincident with each other, and the M f temperature and the A s temperature are not coincident with each other.
  • the shape memory alloy is processed to form a memorized shape in the austenite phase in the form of a ring or partial ring.
  • the shape memory alloy is then cooled below the M f temperature to enter the martensite phase and deformed into a larger or smaller ring.
  • the shape memory alloy is formed into a ring or partial ring that is larger than the memorized shape but still small enough to improve leaflet coaptation and reduce regurgitation in a heart valve upon being attached to the heart valve annulus.
  • the shape memory alloy is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumference of the ring in the martensite phase by hand to achieve a desired fit for a particular heart valve annulus.
  • the circumference of the ring can be adjusted non-invasively by heating the shape memory alloy to an activation temperature (e.g., temperatures ranging from the A s temperature to the A f temperature).
  • Activation temperatures at which the shape memory alloy causes the shape of the annuloplasty ring to change shape can be selected and built into the annuloplasty ring such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring during the activation process.
  • Exemplary A f temperatures for suitable shape memory alloys range between approximately 45 degrees Celsius and approximately 70 degrees Celsius.
  • exemplary M s temperatures range between approximately 10 degrees Celsius and approximately 20 degrees Celsius, and exemplary M f temperatures range between approximately ⁇ 1 degrees Celsius and approximately 15 degrees Celsius.
  • the size of the annuloplasty ring can be changed all at once or incrementally in small steps at different times in order to achieve the adjustment necessary to produce the desired clinical result.
  • Certain shape memory alloys may further include a rhombohedral phase, having a rhombohedral start temperature (R s ) and a rhombohedral finish temperature (R f ), that exists between the austenite and martensite phases.
  • R s rhombohedral start temperature
  • R f rhombohedral finish temperature
  • An example of such a shape memory alloy is a NiTi alloy, which is commercially available from Memry Corporation (Bethel, Connecticut).
  • an exemplary R s temperature range is between approximately 30 degrees Celsius and approximately 50 degrees Celsius
  • an exemplary R f temperature range is between approximately 20 degrees Celsius and approximately 35 degrees Celsius.
  • shape memory material having a rhombohedral phase may experience a partial physical distortion, as compared to the generally rigid structure of the austenite phase and the generally deformable structure of the martensite phase.
  • Certain shape memory alloys exhibit a ferromagnetic shape memory effect wherein the shape memory alloy transforms from the martensite phase to the austenite phase when exposed to an external magnetic field.
  • the term “ferromagnetic” as used herein is a broad term and is used in its ordinary sense and includes, without limitation, any material that easily magnetizes, such as a material having atoms that orient their electron spins to conform to an external magnetic field.
  • Ferromagnetic materials include permanent magnets, which can be magnetized through a variety of modes, and materials, such as metals, that are attracted to permanent magnets.
  • Ferromagnetic materials also include electromagnetic materials that are capable of being activated by an electromagnetic transmitter, such as one located outside the heart 100 .
  • ferromagnetic materials may include one or more polymer-bonded magnets, wherein magnetic particles are bound within a polymer matrix, such as a biocompatible polymer.
  • the magnetic materials can comprise isotropic and/or anisotropic materials, such as for example NdFeB (Neodynium Iron Boron), SmCo (Samarium Cobalt), ferrite and/or AlNiCo (Aluminum Nickel Cobalt) particles.
  • annuloplasty ring comprising a ferromagnetic shape memory alloy can be implanted in a first configuration having a first shape and later changed to a second configuration having a second (e.g., memorized) shape without heating the shape memory material above the A s temperature.
  • a second configuration having a second (e.g., memorized) shape without heating the shape memory material above the A s temperature.
  • nearby healthy tissue is not exposed to high temperatures that could damage the tissue.
  • the size of the annuloplasty ring can be adjusted more quickly and more uniformly than by heat activation.
  • Exemplary ferromagnetic shape memory alloys include Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni 2 MnGa, Co—Ni—Al, and the like. Certain of these shape memory materials may also change shape in response to changes in temperature. Thus, the shape of such materials can be adjusted by exposure to a magnetic field, by changing the temperature of the material, or both.
  • annuloplasty rings comprise a combination of shape memory polymer and shape memory alloy (e.g., NiTi).
  • shape memory alloy e.g., NiTi
  • an annuloplasty ring comprises a shape memory polymer tube and a shape memory alloy (e.g., NiTi) disposed within the tube.
  • shape memory polymers are used with shape memory alloys to create a bi-directional (e.g., capable of expanding and contracting) annuloplasty ring. Bi-directional annuloplasty rings can be created with a wide variety of shape memory material combinations having different characteristics.
  • FIGS. 1A-1C illustrate an adjustable annuloplasty ring 100 according to certain embodiments that can be adjusted in vivo after implantation into a patient's body.
  • the annuloplasty ring 100 has a substantially annular configuration and comprises a tubular body member 112 that folds back upon itself in a substantial circle having a nominal diameter as indicated by arrow 123 .
  • the tubular body member 112 comprises a receptacle end 114 and an insert end 116 .
  • the insert end 116 of the tubular member 112 is reduced in outer diameter or transverse dimension as compared to the receptacle end 114 .
  • dimension is a broad term having its ordinary and customary meaning and includes a size or distance from a first point to a second point along a line or arc.
  • a dimension may be a circumference, diameter, radius, arc length, or the like.
  • a dimension may be a distance between an anterior portion and a posterior portion of an annulus.
  • the receptacle end accepts the insert end 116 of the tubular member 112 to complete the ring-like structure of the annuloplasty ring 100 .
  • the insert end 116 slides freely within the receptacle end 114 of the annuloplasty ring 100 which allows contraction of the overall circumference of the ring 100 as the insert end 116 enters the receptacle end 114 as shown by arrows 118 in FIG. 1A .
  • the nominal diameter or transverse dimension 123 of the annuloplasty ring 100 can be adjusted from approximately 25 mm to approximately 38 mm.
  • the diameter or transverse dimension 123 of the annuloplasty ring 100 can be adjusted to other sizes depending on the particular application. Indeed, the diameter or transverse dimension 123 of the annuloplasty ring 100 can be configured to reinforce body structures substantially smaller than 25 mm and substantially larger than 38 mm.
  • the insert end 116 can couple with the receptacle end 114 without being inserted in the receptacle end 114 .
  • the insert end 116 can overlap the receptacle end 114 such that it slides adjacent thereto.
  • the ends 114 , 116 may grooved to guide the movement of the adjacent ends 114 , 116 relative to one another.
  • Other embodiments within the scope of the invention will occur to those skilled in the art.
  • the annuloplasty ring 100 also comprises a suturable material 128 , shown partially cut away in FIG. 1A , and not shown in FIGS. 1B and 1C for clarity.
  • the suturable material 128 is disposed about the tubular member 112 to facilitate surgical implantation of the annuloplasty ring 100 in a body structure, such as about a heart valve annulus.
  • the suturable material 128 comprises a suitable biocompatible material such. as Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or the like.
  • the suturable material 128 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue.
  • the suturable material 128 may be disposed about the entire circumference of the tubular member 112 , or selected portions thereof.
  • the suturable material 128 is disposed so as to enclose substantially the entire tubular member 112 except at the narrowed insert end 116 that slides into the receptacle end 118 of the tubular member 112 .
  • the annuloplasty ring 100 also comprises a ratchet member 120 secured to the receptacle end 114 of the tubular member 112 .
  • the ratchet member 120 comprises a pawl 122 configured to engage transverse slots 124 (shown in FIG. 1B ) on the insert end 116 of the tubular member 112 .
  • the pawl 122 of the ratchet member 120 engages the slots 124 in such a way as to allow contraction of the circumference of the annuloplasty ring 100 and prevent or reduce circumferential expansion of the annuloplasty ring 100 .
  • the ratchet reduces unwanted circumferential expansion of the annuloplasty ring 100 after implantation due, for example, to dynamic forces on the annuloplasty ring 100 from the heart tissue during systolic contraction of the heart.
  • the tubular member 112 comprises a rigid material such as stainless steel, titanium, or the like, or a flexible material such as silicon rubber, Dacron®, or the like.
  • the circumference of the annuloplasty ring 100 is adjusted in vivo by inserting a catheter (not shown) into the body and pulling a wire (not shown) attached to the tubular member 112 through the catheter to manually slide the insert end 116 of the tubular member 112 into the receptacle end 114 of the tubular member 112 .
  • the pawl 122 of the ratchet member 120 engages the slots 124 on the insert end 116 to hold the insert end 116 in the receptacle end 114 .
  • the size of the annuloplasty ring 100 can also be reduced to provide an appropriate amount of reinforcement to the heart valve.
  • the tubular member 112 comprises a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field.
  • the shape memory material may include shape memory polymers (e.g., polylactic acid (PLA), polyglycolic acid (PGA)) and/or shape memory alloys (e.g., nickel-titanium) including ferromagnetic shape memory alloys (e.g., Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni 2 MnGa, Co—Ni—Al).
  • shape memory polymers e.g., polylactic acid (PLA), polyglycolic acid (PGA)
  • shape memory alloys e.g., nickel-titanium
  • ferromagnetic shape memory alloys e.g., Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn
  • the annuloplasty ring 100 is adjusted in vivo by applying an energy source such as radio frequency energy, X-ray energy, microwave energy, ultrasonic energy such as high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like.
  • an energy source such as radio frequency energy, X-ray energy, microwave energy, ultrasonic energy such as high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like.
  • the energy source is applied in a non-invasive manner from outside the body.
  • a magnetic field and/or RF pulses can be applied to the annuloplasty ring 100 within a patient's body with an apparatus external to the patient's body such as is commonly used for magnetic resonance imaging (MRI).
  • MRI magnetic resonance imaging
  • the energy source may be applied surgically such as by inserting a catheter into the body and applying the energy through the catheter.
  • the tubular body member 112 comprises a shape memory material that responds to the application of temperature that differs from a nominal ambient temperature, such as the nominal body temperature of 37 degrees Celsius for humans.
  • the tubular member 112 is configured to respond by starting to contract upon heating the tubular member 112 above the A s temperature of the shape memory material.
  • the annuloplasty ring 100 has an initial diameter or transverse dimension 123 of approximately 30 mm, and contracts or shrinks to a transverse dimension 123 of approximately 23 mm to approximately 28 mm, or any increment between those values. This produces a contraction percentage in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter.
  • the activation temperatures (e.g., temperatures ranging from the A s temperature to the A f temperature) at which the tubular member 112 contracts to a reduced circumference may be selected and built into the annuloplasty ring 100 such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring 100 during the activation process.
  • Exemplary A f temperatures for the shape memory material of the tubular member 112 at which substantially maximum contraction occurs are in a range between approximately 38 degrees Celsius and approximately 1310 degrees Celsius. In certain embodiments, the A f temperature is in a range between approximately 39 degrees Celsius and approximately 75 degrees Celsius.
  • activation temperatures at which the glass transition of the material or substantially maximum contraction occur range between approximately 38 degrees Celsius and approximately 60 degrees Celsius. In other such embodiments, the activation temperature is in a range between approximately 40 degrees Celsius and approximately 59 degrees Celsius.
  • the tubular member 112 is shape set in the austenite phase to a remembered configuration during the manufacturing of the tubular member 112 such that the remembered configuration is that of a relatively small circumferential value with the insert end 116 fully inserted into the receptacle end 114 .
  • the tubular member 112 is manually deformed to a larger circumferential value with the insert end 116 only partially inserted into the receptacle end 114 to achieve a desired starting nominal circumference for the annuloplasty ring 100 .
  • the tubular member 112 is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumferential value by hand to achieve a desired fit with the heart valve annulus.
  • the starting nominal circumference for the annuloplasty ring 100 is configured to improve leaflet coaptation and reduce regurgitation in a heart valve.
  • the annuloplasty ring 100 is preferably activated non-invasively by the application of energy to the patient's body to heat the tubular member 112 .
  • an MRI device is used as discussed above to heat the tubular member 112 , which then causes the shape memory material of the tubular member 112 to transform to the austenite phase and remember its contracted configuration.
  • the circumference of the annuloplasty ring 100 is reduced in vivo without the need for surgical intervention.
  • Standard techniques for focusing the magnetic field from the MRI device onto the annuloplasty ring 100 may be used.
  • a conductive coil can be wrapped around the patient in an area corresponding to the annuloplasty ring 100 .
  • the shape memory material is activated by exposing it other sources of energy, as discussed above.
  • FIG. 2 graphically illustrates the relationship between the temperature of the tubular member 112 and the diameter or transverse dimension 123 of the annuloplasty ring 100 according to certain embodiments.
  • the diameter of the tubular member 112 has a first diameter do.
  • the shape memory material is then increased to a first raised temperature T 1 .
  • the diameter of the tubular member 112 reduces to a second diameter d n .
  • the diameter of the tubular member 112 can then be reduced to a third diameter d nm by raising the temperature to a second temperature T 2 .
  • the change in diameter from d 0 to d nm is substantially continuous as the temperature is increased from body temperature to T 2 .
  • a magnetic field of about 2.5 Tesla to about 3.0 Tesla is used to raise the temperature of the tubular member 112 above the A f temperature to complete the austenite phase and return the tubular member 112 to the remembered configuration with the insert end 116 fully inserted into the receptacle end 114 .
  • a lower magnetic field e.g., 0.5 Tesla
  • the tubular member 112 comprises a plurality of shape memory materials with different activation temperatures and the diameter of the tubular member 112 is reduced in steps as the temperature increases.
  • the diameter or transverse dimension 123 of the ring 100 can be assessed or monitored during the contraction process to determine the amount of contraction by use of MRI imaging, ultrasound imaging, computed tomography (CT), X-ray or the like. If magnetic energy is being used to activate contraction of the ring 100 , for example, MRI imaging techniques can be used that produce a field strength that is lower than that required for activation of the annuloplasty ring 100 .
  • the tubular member 112 comprises an energy absorption enhancement material 126 .
  • the energy absorption enhancement material 126 may be disposed within an inner chamber of the tubular member 112 .
  • the energy absorption enhancement material 126 may also be coated on the outside of the tubular member 112 to enhance energy absorption by the tubular member 112 .
  • thermal energy from the energy absorption enhancement material 126 is efficiently transferred to the shape memory material of the annuloplasty ring 100 , such as the tubular member 112 .
  • the energy absorption enhancement material 126 may include a material or compound that selectively absorbs a desired heating energy and efficiently converts the non-invasive heating energy to heat which is then transferred by thermal conduction to the tubular member 112 .
  • the energy absorption enhancement material 126 allows the tubular member 112 to be actuated and adjusted by the non-invasive application of lower levels of energy and also allows for the use of non-conducting materials, such as shape memory polymers, for the tubular member 112 .
  • magnetic flux ranging between about 2.5 Tesla and about 3.0 Tesla may be used for activation.
  • the energy absorption enhancement material 126 also reduces thermal damage to nearby tissue. Suitable energy absorption enhancement materials 126 are discussed above.
  • a circumferential contraction cycle can be reversed to induce an expansion of the annuloplasty ring 100 .
  • Some shape memory alloys such as NiTi or the like, respond to the application of a temperature below the nominal ambient temperature.
  • the tubular member 112 is cooled below the M s temperature to start expanding the annuloplasty ring 100 .
  • the tubular member 112 can also be cooled below the M f temperature to finish the transformation to the martensite phase and reverse the contraction cycle.
  • certain polymers also exhibit a two-way shape memory effect and can be used to both expand and contract the annuloplasty ring 100 through heating and cooling processes.
  • Cooling can be achieved, for example, by inserting a cool liquid onto or into the annuloplasty ring 100 through a catheter, or by cycling a cool liquid or gas through a catheter placed near the annuloplasty ring 100 .
  • Exemplary temperatures for a NiTi embodiment for cooling and reversing a contraction cycle range between approximately 20 degrees Celsius and approximately 30 degrees Celsius.
  • one or more biasing elements are operatively coupled to the tubular member 112 so as to exert a circumferentially expanding force thereon.
  • a biasing element such as a spring (not shown) is disposed in the receptacle end 114 of the tubular member 112 so as to push the insert end 16 at least partially out of the receptacle end 114 during cooling.
  • the tubular member 112 does not include the ratchet member 120 such that the insert end 116 can slide freely into or out of the receptacle end 114 .
  • the tubular member comprises ferromagnetic shape memory material, as discussed above.
  • the diameter of the tubular member 112 can be changed by exposing the tubular member 112 to a magnetic field.
  • nearby healthy tissue is not exposed to high temperatures that could damage the tissue.
  • the shape memory material does not need to be heated, the size of the tubular member 112 can be adjusted more quickly and more uniformly than by heat activation.
  • FIGS. 3A-3C illustrate an embodiment of an adjustable annuloplasty ring 300 that is similar to the annuloplasty ring 100 discussed above, but having a D-shaped configuration instead of a circular configuration.
  • the annuloplasty ring 300 comprises a tubular body member 311 having a receptacle end 312 and an insert end 314 sized and configured to slide freely in the hollow receptacle end 312 in an axial direction which allows the annuloplasty ring 300 to constrict upon activation to a lesser circumference or transverse dimension as indicated by arrows 316 .
  • the annuloplasty ring 300 has a major transverse dimension indicated by arrow 318 that is reduced upon activation of the annuloplasty ring 300 .
  • the major transverse dimension indicated by arrow 318 can be the same as or similar to the transverse dimension indicated by arrow 123 discussed above.
  • the features, dimensions and materials of the annuloplasty ring 300 are the same as or similar to the features, dimensions and materials of annuloplasty ring 100 discussed above.
  • the D-shaped configuration of ring 32 allows a proper fit of the ring 32 with the morphology of some particular heart valves.
  • FIGS. 4A-4C show an embodiment of an annuloplasty ring 400 that includes a continuous tubular member 410 surrounded by a suturable material 128 .
  • the tubular member 410 has a substantially circular transverse cross section, as shown in FIG. 4C , and has an absorption enhancing material 126 disposed within an inner chamber of the tubular member 410 .
  • the absorption enhancing material 126 is also disposed on the outer surface of the tubular member 410 .
  • the tubular member 410 may be made from a shape memory material such as a shape memory polymer or a shape memory alloy including a ferromagnetic shape memory alloy, as discussed above.
  • the annuloplasty ring 400 can be activated by the surgical and/or non-invasive application of heating energy by the methods discussed above with regard to other embodiments.
  • the annuloplasty ring 400 can be activated by the non-invasive application of a suitable magnetic field.
  • the annuloplasty ring 400 has a nominal inner diameter or transverse dimension indicated by arrow 412 in FIG. 4A that is set during manufacture of the ring 400 .
  • the annuloplasty ring 400 is sufficiently malleable when it is implanted into a patient's body that it can be adjusted by hand to be fitted to a particular heart valve annulus.
  • the tubular member 410 upon activating the tubular member 410 by the application of energy, the tubular member 410 remembers and assumes a configuration wherein the transverse dimension is less than the nominal transverse dimension 412 .
  • a contraction in a range between approximately 6 percent to approximately 23 percent may be desirable in some embodiments which have continuous hoops of shape memory tubular members 410 .
  • the tubular member 410 comprises a shape memory NiTi alloy having an inner transverse dimension in a range between approximately 25 mm and approximately 38 mm.
  • the tubular member 410 can contract or shrink in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter.
  • the annuloplasty ring 400 has a nominal inner transverse dimension 412 of approximately 30 mm and an inner transverse dimension in a range between approximately 23 mm and approximately 128 mm in a fully contracted state.
  • the inner transverse dimension 412 of certain embodiments can be altered as a function of the temperature of the tubular member 410 .
  • the progress of the size change can be measured or monitored in real-time conventional imaging techniques. Energy from conventional imaging devices can also be used to activate the shape memory material and change the inner transverse dimension 412 of the tubular member 410 .
  • the features, dimensions and materials of the annuloplasty ring 400 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above.
  • the tubular member 410 comprises a shape memory material that exhibits a two-way shape memory effect when heated and cooled.
  • the annuloplasty ring 400 in certain such embodiments, can be contracted and expanded.
  • FIG. 5 illustrates a top view of an annuloplasty ring 500 having a D-shaped configuration according to certain embodiments.
  • the annuloplasty ring 500 includes a continuous tubular member 510 comprising a shape memory material that has a nominal inner transverse dimension indicated by arrow 512 that may contract or shrink upon the activation of the shape memory material by surgically or non-invasive applying energy thereto, as discussed above.
  • the tubular member 510 may comprise a homogeneous shape memory material, such as a shape memory polymer or a shape memory alloy including, for example, a ferromagnetic shape memory alloy.
  • the tubular member 510 may comprise two or more sections or zones of shape memory material having different temperature response curves.
  • the shape memory response zones may be configured in order to achieve a desired configuration of the annuloplasty ring 500 as a whole when in a contracted state, either fully contracted or partially contracted.
  • the tubular member 510 may have a first zone or section 514 that includes the arched portion of the tubular member that terminates at or near the corners 516 and a second zone or section 518 that includes the substantially straight portion of the tubular member 510 disposed directly between the corners 516 .
  • the annuloplasty ring 500 is shown in a contracted state in FIG. 5 as indicated by the dashed lines 520 , 522 , which represent contracted states of certain embodiments wherein both the first section 514 and second section 518 of the tubular member 510 have contracted axially.
  • a suturable material (not shown), such as the suturable material 128 shown in FIG. 1 , may be disposed about the tubular member 510 and the tubular member 510 may comprise or be coated with an energy absorption enhancement material 126 , as discussed above.
  • the features, dimensions and materials of the annuloplasty ring 500 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above.
  • FIG. 6A is a schematic diagram of a top view of a substantially D-shaped wire 600 comprising a shape memory material according to certain embodiments of the invention.
  • the term “wire” is a broad term having its normal and customary meaning and includes, for example, mesh, flat, round, rod-shaped, or band-shaped members. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above.
  • the wire 600 comprises a substantially linear portion 608 , two corner portions 610 , and a substantially semi-circular portion 612 .
  • the wire 600 is shown relative to a first reference point 614 , a second reference point 616 and a third reference point 618 .
  • the radius of the substantially semi-circular portion 612 is defined with respect to the first reference point 614 and the corner portions 610 are respectively defined with respect to the second reference point 616 and the third reference point 618 .
  • FIG. 6A shows a first transverse dimension A, a second transverse dimension B.
  • the first transverse dimension A is in a range between approximately 20.0 mm and approximately 40.0 mm
  • the second transverse dimension B is in a range between approximately 10.0 mm and approximately 25.0 mm
  • the wire 600 comprises a rod having a diameter in a range between approximately 0.45 mm and approximately 0.55 mm
  • the radius of each corner portion 610 is in a range between approximately 5.8 mm and 7.2 mm
  • the radius of the substantially semi-circular portion 612 is in a range between approximately 11.5 mm and approximately 14.0 mm.
  • the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.1 mm and 7.4 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 11.7 mm and approximately 14.3 mm.
  • the first transverse dimension A is in a range between approximately 26.1 mm and approximately 31.9 mm
  • the second transverse dimension B is in a range between approximately 20.3 mm and approximately 24.9 mm
  • the wire 600 comprises a rod having a diameter in a range between approximately 0.4 mm and approximately 0.6 mm
  • the radius of each corner portion 610 is in a range between approximately 6.7 mm and 8.3 mm
  • the radius of the substantially semi-circular portion 612 is in a range between approximately 13.3 mm and approximately 16.2 mm.
  • the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.9 mm and 8.5 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 13.5 mm and approximately 16.5 mm.
  • the wire 600 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above.
  • the first transverse dimension A of the wire 600 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase.
  • the austenite start temperature A s is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius
  • the austenite finish temperature A f is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius
  • the martensite start temperature M s is less than approximately 30 degrees Celsius
  • the martensite finish temperature M f is greater than approximately 20 degrees Celsius.
  • the austenite finish temperature A f is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
  • Other embodiments can include other start and finish temperatures for martensite, rhombohedral and austenite phases as described herein.
  • FIGS. 6B-6E are schematic diagrams of side views of the shape memory wire 600 of FIG. 6A according to certain embodiments.
  • the shape memory wire 600 is configured to change shape in a third dimension perpendicular to the first transverse dimension A and the second transverse dimension B.
  • the shape memory wire 600 is substantially planar or flat in the third dimension, as shown in FIG. 6B , when implanted into a patient's body.
  • the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and flexes or bows in the third dimension such that it is no longer planar, as shown in FIG. 6C .
  • Such bowing may be symmetrical as shown in FIG. 6C or asymmetrical as shown in FIG. 6D to accommodate the natural shape of the annulus.
  • the shape memory wire 600 is configured to bow in the third dimension a distance in a range between approximately 2 millimeters and approximately 10 millimeters. In certain embodiments, the shape memory wire 600 is implanted so as to bow towards the atrium when implanted around a cardiac valve annulus to accommodate the natural shape of the annulus. In other embodiments, the shape memory wire 600 is configured to bow towards the ventricle when implanted around a cardiac valve to accommodate the natural shape of the annulus.
  • the shape memory wire 600 is bowed in the third dimension, as shown in FIG. 6C , when implanted into the patient's body. Then, after implantation, the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and further flexes or bows in the third dimension, as shown in FIG. 6E . In certain other embodiments, the shape memory wire 600 is bowed in the third dimension, as shown in FIG. 6C , when implanted into the patient's body.
  • the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and changes shape in the third dimension so as to become substantially flat, as shown in FIG. 6B .
  • annuloplasty rings disclosed herein can also be configured to bow or change shape in a third dimension so as to accommodate or further reinforce a valve annulus.
  • FIG. 7A is a perspective view illustrating portions of an annuloplasty ring 700 comprising the wire 600 shown in FIG. 6A according to certain embodiments of the invention.
  • the wire 600 is covered by a flexible material 712 such as silicone rubber and a suturable material 714 such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material.
  • the suturable material 714 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue.
  • portions of the flexible material 712 and the suturable material 714 are not shown in FIG.
  • the flexible material 712 and the suturable material 714 are continuous and cover substantially the entire wire 600 .
  • the wire 600 is coated with an energy absorption enhancement material, as discussed above.
  • FIG. 7B is an enlarged perspective view of a portion of the annuloplasty ring 700 shown in FIG. 7A .
  • portions of the flexible material 712 are not shown to expose the wire 600 and portions of the suturable material 714 are shown peeled back to expose the flexible material 712 .
  • the diameter of the flexible material 712 is in a range between approximately 0.10 inches and approximately 0.15 inches.
  • FIG. 7B shows the wire 600 substantially centered within the circumference of the flexible material 712 . However, in certain embodiments, the wire 600 is offset within the circumference of the flexible material 712 to allow more space for sutures.
  • FIG. 8 is a schematic diagram of a substantially C-shaped wire 800 comprising a shape memory material according to certain embodiments of the invention.
  • Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above.
  • the wire 800 comprises two corner portions 810 , and a substantially semi-circular portion 812 .
  • the wire 800 is shown relative to a first reference point 814 , a second reference point 816 and a third reference point 818 .
  • the radius of the substantially semi-circular portion 812 is defined with respect to the first reference point 814 and the corner portions 810 are respectively defined with respect to the second reference point 816 and the third reference point 818 .
  • FIG. 8 shows a first transverse dimension A and a second transverse dimension B.
  • the wire 800 comprises a rod having a diameter and dimensions A and B as discussed above in relation to FIG. 6A .
  • the wire 800 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above.
  • the first transverse dimension A of the wire 800 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase.
  • the austenite start temperature A s is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius
  • the austenite finish temperature A f is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius
  • the martensite start temperature M s is less than approximately 30 degrees Celsius
  • the martensite finish temperature M f is greater than approximately 20 degrees Celsius.
  • the austenite finish temperature A f is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
  • FIG. 9A is a perspective view illustrating portions of an annuloplasty ring 900 comprising the wire 800 shown in FIG. 8 according to certain embodiments of the invention.
  • the wire 800 is covered by a flexible material 912 such as silicone rubber and a suturable material 914 such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material.
  • the suturable material 914 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue.
  • portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 9A to show the wire 800 .
  • the flexible material 912 and the suturable material 914 cover substantially the entire wire 800 .
  • the wire 800 is coated with an energy absorption enhancement material, as discussed above.
  • FIG. 9B is an enlarged perspective view of a portion of the annuloplasty ring 900 shown in FIG. 9A .
  • portions of the flexible material 912 are not shown to expose the wire 800 and portions of the suturable material 914 are shown peeled back to expose the flexible material 912 .
  • the diameter of the flexible material 912 is in a range between approximately 0.10 inches and approximately 0.15 inches.
  • FIG. 9B shows the wire 800 substantially centered within the circumference of the flexible material 912 .
  • the wire 800 is offset within the circumference of the flexible material 912 to allow more space for sutures.
  • FIG. 10A is a perspective view illustrating portions of an annuloplasty ring 1000 configured to contract and expand according to certain embodiments of the invention.
  • FIG. 10B is a top cross-sectional view of the annuloplasty ring 1000 .
  • the annuloplasty ring 1000 may be implanted in a child with an enlarged heart. When the size of the heart begins to recover to its natural size, the annuloplasty ring 1000 can be contracted. Then, as the child gets older and the heart begins to grow, the annuloplasty ring 1000 can be enlarged as needed.
  • the annuloplasty ring 1000 comprises a first shape memory wire 1010 for contracting the annuloplasty ring 1000 and a second shape memory wire 1012 for expanding the annuloplasty ring 1000 .
  • the first and second shape memory wires, 1010 , 1012 are covered by the flexible material 912 and the suturable material 914 shown in FIGS. 9A-9B .
  • portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 10A to show the shape memory wires 1010 , 1012 .
  • the flexible material 912 and the suturable material 914 substantially cover the first and second shape memory wires 1010 , 1012 .
  • the flexible material 912 operatively couples the first shape memory wire 1010 and the second shape memory wire 1012 such that a shape change in one will mechanically effect the shape of the other.
  • the first and second shape memory wires 1010 , 1012 each comprise a shape memory material, such as the shape memory materials discussed above. However, the first and second shape memory wires 1010 , 1012 are activated at different temperatures.
  • the annuloplasty ring 1000 is heated to a first temperature that causes the first shape memory wire 1010 to transition to its austenite phase and contract to its memorized shape.
  • the second shape memory wire 1012 is in its martensite phase and is substantially flexible as compared the contracted first shape memory wire 1010 .
  • the first shape memory wire 1010 transitions to its austenite phase, it exerts a sufficient force on the second shape memory wire 1012 through the flexible material 912 to deform the second shape memory wire 1012 and cause the annuloplasty ring 1000 to contract.
  • the annuloplasty ring 1000 can be expanded by heating the annuloplasty ring to a second temperature that causes the second shape memory wire 1012 to transition to its austenite phase and expand to its memorized shape.
  • the second temperature is higher than the first temperature.
  • both the first and second shape memory wires 1010 , 1012 are in their respective austenite phases.
  • the diameter of the second shape memory wire 1012 is sufficiently larger than the diameter of the first shape memory wire 1010 such that the second memory shape wire 1012 exerts a greater force to maintain its memorized shape in the austenite phase than the first shape memory wire 1010 .
  • the first shape memory wire 1010 is mechanically deformed by the force of the second memory shape wire 1012 and the annuloplasty ring 1000 expands.
  • the first memory shape wire 1010 is configured to contract by approximately 10% to 25% when transitioning to its austenite phase.
  • the first memory shape wire 1010 has an austenite start temperature A s in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, an austenite finish temperature A f in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, a martensite start temperature M s less than approximately 30 degrees Celsius, and a martensite finish temperature M f greater than approximately 20 degrees Celsius.
  • the austenite finish temperature A f of the first memory shape wire 1010 is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
  • the second memory shape wire 1012 is configured to expand by approximately 10% to 25% when transitioning to its austenite phase.
  • the second memory shape wire 1010 has an austenite start temperature A s in a range between approximately 60 degrees Celsius and approximately 70 degrees Celsius, an austenite finish temperature A f in a range between approximately 65 degrees Celsius and approximately 75 degrees Celsius, a martensite start temperature M s less than approximately 30 degrees Celsius, and a martensite finish temperature M f greater than approximately 20 degrees Celsius.
  • the austenite finish temperature A f of the first memory shape wire 1010 is in a range between approximately 68.75 degrees Celsius and approximately 71.25 degrees Celsius.
  • FIG. 11A is a perspective view illustrating portions of an annuloplasty ring 1100 according to certain embodiments comprising the first shape memory wire 1010 for contraction, the second shape memory wire 1012 for expansion, the flexible material 912 and the suturable material 914 shown in FIGS. 10A-10B .
  • portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 11A to show the shape memory wires 1010 , 1012 .
  • the flexible material 912 and the suturable material 914 substantially cover the first and second shape memory wires 1010 , 1012 .
  • FIG. 11B is an enlarged perspective view of a portion of the annuloplasty ring 1100 shown in FIG. 1A .
  • portions of the flexible material 912 are not shown to expose the first and second shape memory wires 1010 , 1012 and portions of the suturable material 914 are shown peeled back to expose the flexible material 912 .
  • the first shape memory wire 1010 comprises a first coating 1120 and the second shape memory wire 1012 comprises a second coating 1122 .
  • the first coating 1120 and the second coating 1122 each comprise silicone tubing configured to provide suture attachment to a heart valve annulus.
  • the first coating 1120 and the second coating 1122 each comprise an energy absorption material, such as the energy absorption materials discussed above.
  • the first coating 1120 heats when exposed to a first form of energy and the second coating 1122 heats when exposed to a second form of energy.
  • the first coating 1120 may heat when exposed to MRI energy and the second coating 1122 may heat when exposed to HIFU energy.
  • first coating 1120 may heat when exposed to RF energy at a first frequency and the second coating 1122 may heat when exposed to RF energy at a second frequency.
  • first shape memory wire 1010 and the second shape memory wire 1012 can be activated independently such that one transitions to its austenite phase while the other remains in its martensite phase, resulting in contraction or expansion of the annuloplasty ring 1100 .
  • FIG. 12 is a perspective view of a shape memory wire 800 , such as the wire 800 shown in FIG. 8 , wrapped in an electrically conductive coil 1210 according to certain embodiments of the invention.
  • the coil 1210 is wrapped around a portion of the wire 800 where it is desired to focus energy and heat the wire 800 .
  • the coil 1210 is wrapped around approximately 5% to approximately 15% of the wire 800 .
  • the coil 1210 is wrapped around approximately 15% to approximately 70% of the wire 800 .
  • the coil 1210 is wrapped around substantially the entire wire 800 .
  • the wire 800 also comprises a coating comprising an energy absorption material, such as the energy absorption materials discussed above. The coating may or may not be covered by the coil 1210 .
  • an electrical current can be non-invasively induced in the coil 1210 using electromagnetic energy.
  • a handheld or portable device comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the coil 1210 .
  • the electrical current causes the coil 1210 to heat.
  • the coil 1210 , the wire 800 and the coating are thermally conductive so as to transfer the heat or thermal energy from the coil 1210 to the wire 800 .
  • thermal energy can be directed to the wire 800 , or portions thereof, while reducing thermal damage to surrounding tissue.
  • FIGS. 13A and 13B show an embodiment of an annuloplasty ring 1310 having a nominal inner diameter or transverse dimension indicated by arrow 1312 and a nominal outer diameter or transverse dimension indicated by arrows 1314 .
  • the ring 1310 includes a tubular member 1316 having a substantially round transverse cross section with an internal shape memory member 1318 disposed within an inner chamber 1319 of the tubular member 1316 .
  • the internal shape memory member 1318 is a ribbon or wire bent into a series of interconnected segments 1320 .
  • the inner transverse dimension 1312 becomes smaller due to axial shortening of the tubular member 1316 and an inward radial force applied to an inner chamber surface 1322 of the tubular member 1316 by the internal shape memory member 1318 .
  • the internal shape memory member 1318 is expanded upon heating such that the ends of segments 1320 push against the inner chamber surface 1322 and outer chamber surface 1324 , as shown by arrow 1326 in FIG. 13B , and facilitate radial contraction of the inner transverse dimension 1312 .
  • activation of the internal shape memory member 1318 changes the relative distance between the against the inner chamber surface 1322 and outer chamber surface 1324 .
  • the inner shape memory member 1318 may also have a heating energy absorption enhancement material, such as one or more of the energy absorption enhancement materials discussed above, disposed about it within the inner chamber 1319 .
  • the energy absorption material may also be coated on an outer surface and/or an inner surface of the tubular member 1316 .
  • the inner transverse dimension 1312 of the ring 1310 in FIG. 13B is less than the inner transverse dimension 1312 of the ring 1310 shown in FIG. 13A .
  • the outer transverse dimension 1314 is substantially constant in both FIGS. 13A and 13B .
  • an adjustable annuloplasty ring may have some compliance in order to allow for expansion and contraction of the ring in concert with the expansion and contraction of the heart during the beating cycle or with the hydrodynamics of the pulsatile flow through the valve during the cycle.
  • an entire annuloplasty ring, or a section or sections thereof may be desirable for an entire annuloplasty ring, or a section or sections thereof, to have some axial flexibility to allow for some limited and controlled expansion and contraction under clinical conditions.
  • FIGS. 14 and 15 illustrate embodiments of adjustable annuloplasty rings that allow some expansion and contraction in a deployed state.
  • FIG. 14 shows an annuloplasty ring 1400 that is constructed in such a way that it allows mechanical expansion and compression of the ring 1400 under clinical conditions.
  • the ring 1400 includes a coil 1412 made of a shape memory material, such as one or more of the shape memory materials discussed above.
  • the shape memory material or other portion of the ring 1400 may be coated with an energy absorption material, such as the energy absorption materials discussed above.
  • the coil 1412 may have a typical helical structure of a normal spring wire coil, or alternatively, may have another structure such as a ribbon coil.
  • the coil 1412 is surrounded by a suturable material 128 , such as Dacron® or the other suturable materials discussed herein.
  • the coiled structure or configuration of the coil 1412 allows the ring 1400 to expand and contract slightly when under physiological pressures and forces from heart dynamics or hydrodynamics of blood flow through a host heart valve.
  • the ring 1400 is responsive to temperature changes which may be induced by the application of heating energy on the coil 1412 .
  • the coil 1412 will contract axially or circumferentially such that an inner transverse dimension of the ring 1400 decreases, as shown by the dashed lines in FIG. 14 .
  • reference 1412 ′ represents the coil 1412 in its contracted state
  • reference 128 ′ represents the suturable material 128 in its contracted state around the contracted coil 1412 ′.
  • the coil 1412 expands axially or circumferentially such that the inner transverse dimension of the ring 1400 increases.
  • the ring 1400 can be expanded and contracted by applying invasive or non-invasive energy thereto.
  • FIG. 15 illustrates another embodiment of an adjustable annuloplasty ring 1500 that has dynamic compliance with dimensions, features and materials that may be the same as or similar to those of ring 1400 .
  • the ring 1500 has a zig-zag ribbon member 1510 in place of the coil 1412 in the embodiment of FIG. 14 .
  • the ribbon member 1510 will contract axially or circumferentially such that an inner transverse dimension of the ring 1500 decreases, as shown by the dashed lines in FIG. 15 .
  • reference 1510 ′ represents the ribbon member 1510 in its contracted state
  • reference 128 ′ represents the suturable material 128 in its contracted state around the contracted ribbon member 1510 ′.
  • the ribbon member 1510 expands axially or circumferentially such that the inner transverse dimension of the ring 1500 increases.
  • the ring 1500 can be expanded and contracted by applying invasive or non-invasive energy thereto.
  • FIGS. 14 and 15 may have a substantially circular configuration as shown in the figures, or may have D-shaped or C-shaped configurations as shown with regard to other embodiments discussed above.
  • the features, dimensions and materials of rings 1400 and 1500 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 400 discussed above.
  • FIGS. 16A and 16B illustrate an annuloplasty ring 1600 according to certain embodiments that has a substantially circular shape or configuration when in the non-activated state shown in FIG. 16A .
  • the ring 1600 comprises shape memory material or materials which are separated into a first temperature response zone 1602 , a second temperature response zone 1604 , a third temperature response zone 1606 and a fourth temperature response zone 1608 .
  • the zones are axially separated by boundaries 1610 .
  • the ring 1600 is shown with four zones 1602 , 1604 , 1606 , 1608 , an artisan will recognize from the disclosure herein that other embodiments may include two or more zones of the same or differing lengths.
  • one embodiment of an annuloplasty ring 1600 includes approximately three to approximately eight temperature response zones.
  • the shape memory materials of the various temperature response zones 1602 , 1604 , 1606 , 1608 are selected to have temperature responses and reaction characteristics such that a desired shape and configuration can be achieved in vivo by the application of invasive or non-invasive energy, as discussed above. In addition to general contraction and expansion changes, more subtle changes in shape and configuration for improvement or optimization of valve function or hemodynamics may be achieved with such embodiments.
  • the first zone 1602 and second zone 1604 of the ring 1600 are made from a shape memory material having a first shape memory temperature response.
  • the third zone 1606 and fourth zone 1608 are made from a shape memory material having a second shape memory temperature response.
  • the four zones comprise the same shape memory material, such as NiTi alloy or other shape memory material as discussed above, processed to produce the varied temperature response in the respective zones.
  • two or more of the zones may comprise different shape memory materials.
  • Certain embodiments include a combination of shape memory alloys and shape memory polymers in order to achieve the desired results.
  • FIG. 16B shows the ring 1600 after heat activation such that it comprises expanded zones 1606 ′, 1608 ′ corresponding to the zones 1606 , 1608 shown in FIG. 16A .
  • activation has expanded the zones 1606 ′, 1608 ′ so as to increase the axial lengths of the segments of the ring 1600 corresponding to those zones.
  • the zones 1606 and 1608 are configured to contract by a similar percentage instead of expand.
  • the zones 1602 , 1604 , 1606 , 1608 are configured to each have a different shape memory temperature response such that each segment corresponding to each zone 1602 , 1604 , 1606 , 1608 could be activated sequentially.
  • FIG. 16B schematically illustrates that the zones 1606 ′, 1608 ′ have expanded axially (i.e., from their initial configuration as shown by the zones 1606 , 1608 in FIG. 16A ).
  • the zones 1602 , 1604 are configured to be thermally activated to remember a shape memory dimension or size upon reaching a temperature in a range between approximately 51 degrees Celsius and approximately 60 degrees Celsius.
  • the zones 1606 and 1608 are configured to respond at temperatures in a range between approximately 41 degrees Celsius and approximately 48 degrees Celsius.
  • the zones 1606 , 1608 will respond by expanding or contracting by virtue of the shape memory mechanism, and the zones 1602 , 1604 will not.
  • the zones 1602 , 1604 are configured to expand or contract by virtue of the shape memory mechanism at a temperature in a range between approximately 50 degrees Celsius and approximately 60 degrees Celsius.
  • the zones 1606 , 1608 are configured to respond at a temperature in a range between approximately 39 degrees Celsius and approximately 45 degrees Celsius.
  • the materials, dimensions and features of the annuloplasty ring 1600 and the corresponding zones 1602 , 1604 , 1606 , 1608 have the same or similar features, dimensions or materials as those of the other ring embodiments discussed above. In certain embodiments, the features of the annuloplasty ring 1600 are added to the embodiments discussed above.
  • FIGS. 17A and 17B illustrate an annuloplasty ring 1700 according to certain embodiments that is similar to the annuloplasty ring 1600 discussed above, but having a “D-shaped” configuration.
  • the ring 1700 comprises shape memory material or materials which are separated into a first temperature response zone 1714 , a second temperature response zone 1716 , a third temperature response zone 1718 and a fourth temperature response zone 1720 .
  • the segments defined by the zones 1714 , 1716 , 1718 , 1720 are separated by boundaries 1722 .
  • the ring 1700 according to certain embodiments has the same or similar features, dimensions and materials as the features, dimension and materials of the ring 1600 discussed above.
  • FIG. 17B shows the ring 1700 after heat activation such that it comprises expanded zones 1718 ′, 1720 ′ corresponding to the zones 1718 , 1720 shown in FIG. 17A .
  • activation has expanded the zones 1718 ′, 1720 ′ by virtue of the shape memory mechanism.
  • the zones 1718 , 1720 could also be selectively shrunk or contracted axially by virtue of the same shape memory mechanism for an embodiment having a remembered shape smaller than the nominal shape shown in FIG. 17A .
  • the transverse cross sections of the rings 1600 and 1700 are substantially round, but can also have any other suitable transverse cross sectional configuration, such as oval, square, rectangular or the like.
  • FIG. 18 is a sectional view of a mitral valve 1810 having an anterior (aortic) leaflet 1812 , a posterior leaflet 1814 and an annulus 1816 .
  • the anterior leaflet 1812 and the posterior leaflet 1814 meet at a first commissure 1818 and a second commissure 1820 .
  • the annulus 1816 encircles the leaflets 1812 , 1814 and maintains their spacing to provide closure of a gap 1822 during left ventricular contraction.
  • the leaflets 1812 , 1814 do not achieve sufficient coaptation to close the gap 1822 , resulting in regurgitation.
  • the annulus 1816 is reinforced so as to push the anterior leaflet 1812 and the posterior leaflet 1814 closer together without substantially pushing the first commissure 1818 and the second commissure 1820 toward one another.
  • FIG. 18 schematically illustrates an exemplary annuloplasty ring 1826 comprising shape memory material configured to reinforce the annulus 1816 according to certain embodiments of the invention.
  • the annuloplasty ring 1826 is shown in an activated state wherein it has transformed to a memorized configuration upon application of invasive or non-invasive energy, as described herein. While the annuloplasty ring 1826 is substantially C-shaped, an artisan will recognize from the disclosure herein that other shapes are possible including, for example, a continuous circular, oval or D-shaped ring.
  • the annuloplasty ring 1826 comprises a first marker 1830 and a second marker 1832 that are aligned with the first commissure 1818 and the second commissure 1820 , respectively, when the annuloplasty ring 1826 is implanted around the mitral valve 1810 .
  • the first marker 1830 and the second marker 1832 comprise materials that can be imaged in-vivo using standard imaging techniques.
  • the markers 1830 comprise radiopaque markers or other imaging materials, as is known in the art.
  • the markers 1830 , 1832 can be used for subsequent procedures for alignment with the annuloplasty ring 1826 and/or the commissures 1818 , 1820 .
  • the markers 1830 , 1832 can be used to align a percutaneous energy source, such as a heated balloon inserted through a catheter, with the annuloplasty ring 1826 .
  • the annuloplasty ring 1826 contracts in the direction of the arrow 1824 to push the anterior leaflet 1812 toward the posterior leaflet 1814 .
  • Such anterior/posterior contraction improves the coaptation of the leaflets 1812 , 1814 such that the gap 1824 between the leaflets 1812 , 1814 sufficiently closes during left ventricular contraction.
  • the annuloplasty ring 1826 also expands in the direction of arrows 1834 .
  • the first commissure 1818 and the second commissure 1820 are pulled away from each other, which draws the leaflets 1812 , 1814 closer together and further improves their coaptation.
  • the annuloplasty ring does not expand in the direction of the arrows 1834 .
  • the distance between the lateral portions of the annuloplasty ring 1826 between the anterior portion and the posterior portion e.g., the lateral portions approximately correspond to the locations of the markers 1830 , 1832 in the embodiment shown in FIG. 18 ) remains substantially the same after the shape memory material is activated.
  • FIG. 19 is a schematic diagram of a substantially C-shaped wire comprising a shape memory material configured to contract in a first direction and expand in a second direction according to certain embodiments of the invention.
  • Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above.
  • FIG. 19 schematically illustrates the wire 800 in its activated configuration or memorized shape. For illustrative purposes, the wire 800 is shown relative to dashed lines representing its deformed shape or configuration when implanted into a body before activation.
  • the wire 800 When the shape memory material is activated, the wire 800 is configured to respond by contracting in a first direction as indicated by arrow 1824 . In certain embodiments, the wire 800 also expands in a second direction as indicated by arrows 1834 . Thus, the wire 800 is usable by the annuloplasty ring 1826 shown in FIG. 18 to improve the coaptation of the leaflets 1812 , 1814 by contracting the annulus 1816 in the anterior/posterior direction. In certain embodiments, the anterior/posterior contraction is in a range between approximately 10% and approximately 20%. In certain embodiments, only a first portion 1910 and a second portion 1912 of the wire 800 comprise the shape memory material. When the shape memory material is activated, the first portion 1910 and the second portion 1912 of the wire 800 are configured to respond by transforming to their memorized configurations and reshaping the wire 800 as shown.
  • FIGS. 20A and 20B are schematic diagrams of a body member 2000 according to certain embodiments usable by an annuloplasty ring, such as the annuloplasty ring 1826 shown in FIG. 18 .
  • the body member 2000 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • PTFE polytetrafluoroethylene
  • the body member 2000 comprises a wire 2010 and a shape memory tube 2012 .
  • the terms “tube,” “tubular member” and “tubular structure” are broad terms having at least their ordinary and customary meaning and include, for example, hollow elongated structures that may in cross-section be cylindrical, elliptical, polygonal, or any other shape. Further, the hollow portion of the elongated structure may be filled with one or more materials that may be the same as and/or different than the material of the elongated structure.
  • the wire 2010 comprises a metal or metal alloy such as stainless steel, titanium, platinum, combinations of the foregoing, or the like.
  • the shape memory tube 2012 comprises shape memory materials formed in a tubular structure through which the wire 2010 is inserted. In certain other embodiments, the shape memory tube 2012 comprises a shape memory material coated over the wire 2010 . Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. Although not shown, in certain embodiments, the body member 2000 comprises an energy absorption enhancement material, as discussed above.
  • FIG. 20A schematically illustrates the body member 2000 in a first configuration or shape
  • FIG. 20B schematically illustrates the body member 2000 in a second configuration or shape after the shape memory tube has been activated.
  • dashed lines in FIG. 20B also show the first configuration of the body member 2000 .
  • the shape memory tube 2012 is configured to respond by contracting in a first direction as indicated by arrow 1824 .
  • the shape memory tube 2012 is also configured to expand in a second direction as indicated by arrows 1834 .
  • the transformation of the shape memory tube 2012 exerts a force on the wire 2010 so as to change its shape.
  • the body member 2000 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818 , 1820 further apart and push the leaflets 1812 , 1814 closer together to improve coaptation.
  • FIGS. 21A and 21B are schematic diagrams of a body member 2100 according to certain embodiments usable by an annuloplasty ring, such as the annuloplasty ring 1826 shown in FIG. 18 .
  • the body member 2100 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • PTFE polytetrafluoroethylene
  • the body member 2100 comprises a wire 2010 , such as the wire 2010 shown in FIGS. 20A and 20B and a shape memory tube 2112 .
  • the shape memory tube 2112 is sized and configured to cover a certain percentage of the wire 2010 .
  • an artisan will recognize from the disclosure herein that in other embodiments the shape memory tube 2112 may cover other percentages of the wire 2010 .
  • FIGS. 22A and 22B schematically illustrate another embodiment of a body member 2200 comprising a shape memory tube 2112 covering a substantial portion of a wire 2010 .
  • the amount of coverage depends on such factors as the particular application, the desired shape change, the shape memory materials used, the amount of force to be exerted by the shape memory tube 2112 when changing shape, combinations of the foregoing, and the like. For example, in certain embodiments where, as in FIGS. 22A and 22B , portions of the shape memory tube 2112 are selectively heated to reshape the wire 2010 at a particular location.
  • HIFU energy is directed towards, for example, the left side of the shape memory tube 2112 , the right side of the shape memory tube 2112 , the bottom side of the shape memory tube 2112 , or a combination of the foregoing to activate only a portion of the shape memory tube 2112 .
  • the body member 2200 can be reshaped one or more portions at a time to allow selective adjustments.
  • the shape memory tube 2112 comprises a first shape memory material 2114 and a second shape memory material 2116 formed in a tubular structure through which the wire 2010 is inserted.
  • the first shape memory material 2114 and the second shape memory material 2116 are each configured as a semi-circular portion of the tubular structure.
  • FIG. 23 is a transverse cross-sectional view of the body member 2100 . As schematically illustrated in FIG. 23 , the first shape memory material 2114 and the second shape memory material 2116 are joined at a first boundary 2310 and a second boundary 2312 .
  • silicone tubing (not shown) holds the first shape memory material 2114 and the second shape memory material 2116 together.
  • the first shape memory material 2114 and the second shape memory material 2116 each comprise a shape memory coating covering opposite sides of the wire 2010 .
  • Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above.
  • the body member 2100 comprises an energy absorption enhancement material, as discussed above.
  • FIG. 21A schematically illustrates the body member 2100 in a first configuration or shape before the first shape memory material 2114 and the second shape memory material 2116 are activated.
  • the first shape memory material 2114 and the second shape memory material 2116 are configured to be activated or return to their respective memorized shapes at different temperatures.
  • the first shape memory material 2114 and the second shape memory material 2116 can be activated at different times to selectively expand and/or contract the body member 2100 .
  • the second shape memory material 2116 is configured to be activated at a lower temperature than the first shape memory material 2114 .
  • FIG. 21B schematically illustrates the body member 2100 in a second configuration or shape after the second shape memory material 2116 has been activated.
  • dashed lines in FIG. 21B also show the first configuration of the body member 2100 .
  • the second shape memory material 2116 When the second shape memory material 2116 is activated, it responds by bending the body member 2100 in a first direction as indicated by arrow 1824 . In certain embodiments, activation also expands the body member 2100 in a second direction as indicated by arrows 1834 .
  • the body member 2100 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818 , 1820 further apart and push the leaflets 1812 , 1814 closer together to improve coaptation.
  • the first shape memory material 2114 can then be activated to bend the body member 2100 opposite to the first direction as indicated by arrow 2118 .
  • the body member 2100 is reshaped to the first configuration as shown in FIG. 21A (or the dashed lines in FIG. 21B ).
  • the body member 2100 can be enlarged to accommodate the growth.
  • activation of the first shape memory material 2114 further contracts the body member 2100 in the direction of the arrow 1824 .
  • the first shape memory material 2114 has an austenite start temperature As in a range between approximately 42 degrees Celsius and approximately 50 degrees Celsius and the second shape memory material 2116 has an austenite start temperature A s in a range between approximately 38 degrees Celsius and 41 degrees Celsius.
  • FIG. 24 is a perspective view of a body member 2400 usable by an annuloplasty ring according to certain embodiments comprising a first shape memory band 2410 and a second shape memory band 2412 .
  • Suitable shape memory materials for the bands 2410 , 2412 include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above.
  • the body member 2100 comprises an energy absorption enhancement material, as discussed above.
  • the body member 2100 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • the first shape memory band 2410 is configured to loop back on itself to form a substantially C-shaped configuration.
  • the first shape memory band 2410 can be configured to loop back on itself in other configurations including, for example, circular, D-shaped, or other curvilinear configurations.
  • the first shape memory band 2410 expands or contracts such that overlapping portions of the band 2410 slide with respect to one another, changing the overall shape of the body member 2400 .
  • the second shape memory band 2412 is disposed along a surface of the first shape memory band 2410 such that the second shape memory band 2412 is physically deformed when the first shape memory band 2410 is activated, and the first shape memory band 2410 is physically deformed when the second shape memory band 2412 is activated.
  • the second shape memory band 2412 is disposed between overlapping portions of the first shape memory band 2410 .
  • the second shape memory band 2412 may be disposed adjacent to an outer surface or an inner surface of the first shape memory band 2410 rather than between overlapping portions of the first shape memory band 2410 .
  • the second shape memory band 2412 When the second shape memory band 2412 is activated, it expands or contracts so as to slide with respect to the first shape memory band 2410 .
  • the first shape memory band 2410 and the second shape memory band 2412 are held in relative position to one another by the flexible material and/or suturable material discussed above.
  • first shape memory band 2410 and the second shape memory band 2412 shown in FIG. 24 are substantially flat, an artisan will recognize from the disclosure herein that other shapes are possible including, for example, rod-shaped wire.
  • first shape memory band 2410 and the second shape memory band 2412 advantageously comprise substantially flat surfaces configured to guide one another during expansion and/or contraction.
  • the surface area of overlapping portions of the first shape memory band 2410 and/or the second shape memory band 2412 guide the movement of the body member 2400 in a single plane and reduce misalignment (e.g., twisting or moving in a vertical plane) during shape changes.
  • the surface area of overlapping portions also advantageously increases support to a heart valve by reducing misalignment during beating of the heart.
  • the body member 2400 may not comprise either the first shape memory band 2410 or the second shape memory band 2412 .
  • the body member 2400 does not include the second shape memory band 2412 and is configured to expand and/or contract by only activating the first shape memory band 2410 .
  • either the first band 2410 or the second band 2412 may not comprise a shape memory material.
  • the first band 2410 may titanium, platinum, stainless steel, combinations of the foregoing, or the like and may be used with or without the second band 2412 to support a coronary valve annulus.
  • the body member 2400 is configured to change shape at least twice by activating both the first shape memory band 2410 and the second shape memory band 2412 .
  • FIG. 25A schematically illustrates the body member 2400 in a first configuration or shape before the first shape memory band 2410 or the second shape memory band 2412 are activated.
  • the first shape memory band 2410 and the second shape memory band 2412 are configured to be activated or return to their respective memorized shapes at different temperatures.
  • the first shape memory band 2410 and the second shape memory band 2412 can be activated at different times to selectively expand and/or contract the body member 2400 .
  • FIGS. 25C schematically illustrates the body member 2400 in a first configuration or shape before the first shape memory band 2410 or the second shape memory band 2412 are activated.
  • the first shape memory band 2410 and the second shape memory band 2412 are configured to be activated or return to their respective memorized shapes at different temperatures.
  • the first shape memory band 2410 and the second shape memory band 2412 can be activated at different times
  • the first shape memory band 2410 is configured to be activated at a lower temperature than the second shape memory band 2412 .
  • the second shape memory band 2412 may be configured to be activated at a lower temperature than the first shape memory band 2410 .
  • FIG. 25B schematically illustrates the body member 2400 in a second configuration or shape after the first shape memory band 2410 has been activated.
  • the first shape memory band 2410 When the first shape memory band 2410 is activated, it responds by bending the body member 2400 in a first direction as indicated by arrow 1824 . In certain embodiments, the activation also expands the body member 2400 in a second direction as indicated by arrows 1834 .
  • the body member 2400 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818 , 1820 further apart and push the leaflets 1812 , 1814 closer together to improve coaptation.
  • the second shape memory band 2412 can then be activated to further contract the body member 2400 in the direction of the arrow 1824 and, in certain embodiments, further expand the body member 2400 in the direction of arrows 1834 .
  • activating the second shape memory band 2412 reshapes the body member 2400 to a third configuration as shown in FIG. 25C .
  • the body member 2400 can be re-sized to provide continued support and improved leaflet coaptation.
  • activation of the second shape memory band 2412 bends the body member 2400 opposite to the first direction as indicated by arrow 2118 .
  • activating the second shape memory band 2412 reshapes the body member 2400 to the first configuration as shown in FIG. 25A .
  • the body member 2400 can be re-sized to accommodate the growth.
  • flexible materials and/or suturable materials used to cover shape memory materials also thermally insulate the shape memory materials so as to increase the time required to activate the shape memory materials through application of thermal energy.
  • thermally conductive materials are configured to penetrate the flexible materials and/or suturable materials so as to deliver thermal energy to the shape memory materials such that the time required to activate the shape memory materials is decreased.
  • FIG. 26 is a perspective view illustrating an annuloplasty ring 2600 comprising one or more thermal conductors 2610 , 2612 , 2614 according to certain embodiments of the invention.
  • the annuloplasty ring 2600 further comprises a shape memory wire 800 covered by a flexible material 912 and a suturable material 914 , such as the wire 800 , the flexible material 912 and the suturable material 914 shown in FIG. 9A .
  • the shape memory wire 800 is offset from the center of the flexible material 912 to allow more room for sutures to pass through the flexible material 912 and suturable material 914 to attach the annuloplasty ring 2600 to a cardiac valve.
  • the flexible material 912 and/or the suturable material 914 are thermally insulative.
  • the flexible material 912 comprises a thermally insulative material.
  • the annuloplasty ring 2600 is shown in FIG. 26 as substantially C-shaped, an artisan will recognize from the disclosure herein that the one or more thermal conductors 2610 , 2612 , 2614 can also be used with other configurations including, for example, circular, D-shaped, or other curvilinear configurations.
  • the thermal conductors 2610 , 2612 , 2614 comprise a thin (e.g., having a thickness in a range between approximately 0.002 inches and approximately 0.015 inches) wire wrapped around the outside of the suturable material 914 and penetrating the suturable material 914 and the flexible material 912 at one or more locations 2618 so as to transfer externally applied heat energy to the shape memory wire 800 .
  • FIGS. 27A-27C are transverse cross-sectional views of the annuloplasty ring 2600 schematically illustrating exemplary embodiments for conducting thermal energy to the shape memory wire 800 . In the exemplary embodiment shown in FIG.
  • the thermal conductor 2614 wraps around the suturable material 914 one or more times, penetrates the suturable material 914 and the flexible material 912 , passes around the shape memory wire 800 , and exits the flexible material 912 and the suturable material 914 .
  • the thermal conductor 2614 physically contacts the shape memory wire 800 .
  • the thermal conductor 2614 does not physically contact the shape memory wire 800 but passes sufficiently close to the shape memory wire 800 so as to decrease the time required to activate the shape memory wire 800 . Thus, the potential for thermal damage to surrounding tissue is reduced.
  • the thermal conductor 2614 wraps around the suturable material 914 one or more times, penetrates the suturable material 914 and the flexible material 912 , passes around the shape memory wire 800 two or more times, and exits the flexible material 912 and the suturable material 914 .
  • the thermal conductor 2614 concentrates more energy in the area of the shape memory wire 800 as compared to the exemplary embodiment shown in FIG. 27A .
  • the thermal conductor 2614 may or may not physically contact. the shape memory wire 800 .
  • the thermal conductor 2614 wraps around the suturable material 914 one or more times and passes through the suturable material 914 and the flexible material 912 two or more times. Thus, portions of the thermal conductor 2614 are disposed proximate the shape memory wire 800 so as to transfer heat energy thereto. Again, the thermal conductor 2614 may or may not physically contact the shape memory wire 800 .
  • An artisan will recognize from the disclosure herein that one or more of the exemplary embodiments shown in FIGS. 27A-27C can be combined and that the thermal conductor 2614 can be configured to penetrate the suturable material 914 and the flexible material 912 in other ways in accordance with the invention so as to transfer heat to the shape memory wire 800 .
  • the locations of the thermal conductors 2610 , 2612 , 2614 are selected based at least in part on areas where energy will be applied to activate the shape memory wire 800 .
  • heat energy is applied percutaneously through a balloon catheter and the thermal conductors 2610 , 2612 , 2614 are disposed on the surface of the suturable material 914 in locations likely to make contact with the inflated balloon.
  • the thermal conductors 2610 , 2612 , 2614 are located so as to mark desired positions on the annuloplasty ring 2600 .
  • the thermal conductors 2610 , 2612 , 2614 may be disposed at locations on the annuloplasty ring 2600 corresponding to commissures of heart valve leaflets, as discussed above with respect to FIG. 18 .
  • the thermal conductors 2610 , 2612 , 2614 can be used to align a percutaneous energy source, such as a heated balloon inserted through a catheter, with the annuloplasty ring 2600 .
  • the thermal conductors 2610 , 2612 , 2614 comprise radiopaque materials such as gold, copper or other imaging materials, as is known in the art.
  • FIG. 28 is a schematic diagram of an annuloplasty ring 2800 according to certain embodiments of the invention comprising one or more thermal conductors 2810 , 2812 , 2814 , 2816 , 2818 , such as the thermal conductors 2610 , 2612 , 2614 shown in FIG. 26 .
  • the annuloplasty ring 2800 further comprises a shape memory wire 800 covered by a flexible material 912 and a suturable material 914 , such as the wire 800 , the flexible material 912 and the suturable material 914 shown in FIG. 9A .
  • the shape memory wire 800 is not sufficiently thermally conductive so as to quickly transfer heat applied in the areas of the thermal conductors 2810 , 2812 , 2814 , 2816 , 2818 .
  • the annuloplasty ring 2800 comprises a thermal conductor 2820 that runs along the length of the shape memory wire 800 so as to transfer heat to points of the shape memory wire 800 extending beyond or between the thermal conductors 2810 , 2812 , 2814 , 2816 , 2818 .
  • each of the thermal conductors 2810 , 2812 , 2814 , 2816 , 2818 comprise a separate thermally conductive wire configured to transfer heat to the thermal conductive wire 2820 .
  • at least two of the thermal conductors 2810 , 2812 , 2814 , 2816 , 2818 and the thermal conductor 2820 comprise one continuous thermally conductive wire.
  • thermal energy can be quickly transferred to the annuloplasty ring 2600 or the annuloplasty ring 2800 to reduce the amount of energy required to activate the shape memory wire 800 and to reduce thermal damage to the patient's surrounding tissue.

Abstract

Methods and devices are provided for support of a body structure. The devices can be adjusted within the body of a patient in a minimally invasive or non-invasive manner such as by applying energy percutaneously or external to the patient's body. The energy may include, for example, acoustic energy, radio frequency energy, light energy and magnetic energy. Thus, as the body structure changes size and/or shape, the size and/or shape of the annuloplasty rings can be adjusted to provide continued reinforcement. In certain embodiments, the devices include a first body member including a first shape memory material configured to transform the annuloplasty ring from a first configuration having a first size of a dimension to a second configuration having a second size of the dimension. The second size is less than said first size in septal lateral distance. The devices also include a second body member including a second shape memory material configured to transform the annuloplasty ring from the second configuration to a third configuration having a third size of the dimension, wherein the second size is less than the third size in septal lateral distance.

Description

    RELATED APPLICATIONS
  • This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 60/584,432, filed Jun. 29, 2004, the entirety of which is hereby incorporated by reference herein.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to methods and devices for reinforcing dysfunctional heart valves and other body structures. More specifically, the present invention relates to annuloplasty rings that can be adjusted within the body of a patient.
  • 2. Description of the Related Art
  • The circulatory system of mammals includes the heart and the interconnecting vessels throughout the body that include both veins and arteries. The human heart includes four chambers, which are the left and right atrium and the left and right ventricles. The mitral valve, which allows blood flow in one direction, is positioned between the left ventricle and left atrium. The tricuspid valve is positioned between the right ventricle and the right atrium. The aortic valve is positioned between the left ventricle and the aorta, and the pulmonary valve is positioned between the right ventricle and pulmonary artery. The heart valves function in concert to move blood throughout the circulatory system. The right ventricle pumps oxygen-poor blood from the body to the lungs and then into the left atrium. From the left atrium, the blood is pumped into the left ventricle and then out the aortic valve into the aorta. The blood is then recirculated throughout the tissues and organs of the body and returns once again to the right atrium.
  • If the valves of the heart do not function properly, due either to disease or congenital defects, the circulation of the blood may be compromised. Diseased heart valves may be stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely. Incompetent heart valves cause regurgitation or excessive backward flow of blood through the valve when the valve is closed. For example, certain diseases of the heart valves can result in dilation of the heart and one or more heart valves. When a heart valve annulus dilates, the valve leaflet geometry deforms and causes ineffective closure of the valve leaflets. The ineffective closure of the valve can cause regurgitation of the blood, accumulation of blood in the heart, and other problems.
  • Diseased or damaged heart valves can be treated by valve replacement surgery, in which damaged leaflets are excised and the annulus is sculpted to receive a replacement valve. Another repair technique that has been shown to be effective in treating incompetence is annuloplasty, in which the effective size of the valve annulus is contracted by attaching a prosthetic annuloplasty repair segment or ring to an interior wall of the heart around the valve annulus. The annuloplasty ring reinforces the functional changes that occur during the cardiac cycle to improve coaptation and valve integrity. Thus, annuloplasty rings help reduce reverse flow or regurgitation while permitting good hemodynamics during forward flow.
  • Generally, annuloplasty rings comprise an inner substrate of a metal such as stainless steel or titanium, or a flexible material such as silicon rubber or Dacron®. The inner substrate is generally covered with a biocompatible fabric or cloth to allow the ring to be sutured to the heart tissue. Annuloplasty rings may be stiff or flexible, may be open or closed, and may have a variety of shapes including circular, D-shaped, or C-shaped. The configuration of the ring is generally based on the shape of the heart valve being repaired or on the particular application. For example, the tricuspid valve is generally circular and the mitral valve is generally D-shaped. Further, C-shaped rings may be used for tricuspid valve repairs, for example, because it allows a surgeon to position the break in the ring adjacent the atrioventricular node, thus avoiding the need for suturing at that location.
  • Annuloplasty rings support the heart valve annulus and restore the valve geometry and function. Although the implantation of an annuloplasty ring can be effective, the heart of a patient may change geometry over time after implantation. For example, the heart of a child will grow as the child ages. As another example, after implantation of an annuloplasty ring, dilation of the heart caused by accumulation of blood may cease and the heart may begin returning to its normal size. Whether the size of the heart grows or reduces after implantation of an annuloplasty ring, the ring may no longer be the appropriate size for the changed size of the valve annulus.
  • SUMMARY OF THE INVENTION
  • Thus, it would be advantageous to develop systems and methods for reinforcing a heart valve annulus or other body structure using an annuloplasty device that can be adjusted within the body of a patient in a minimally invasive or non-invasive manner. In an embodiment, an adjustable annuloplasty device includes a body member configured to conform at least partially to a cardiac valve annulus. The body member includes a shape memory material configured to transform from a first shape to a second shape in response to being heated. The annuloplasty device further includes a thermally insulative material at least partially covering said body member and a thermally conductive material extending into said thermally insulative material. The thermally conductive material is configured to communicate thermal energy to the body member. The thermally conductive material can be configured as an imaging marker and can include a radiopaque material. The annuloplasty device further includes a suturable material at least partially covering said thermally insulative material. The thermally conductive material can be disposed at least partially over said suturable material and can provide indicia of one or more valve commissure locations after said annuloplasty device is implanted on or near a heart valve annulus. The thermally conductive material can include at least one of a metallic wire or a metallic ribbon and the body member can be selected from a variety of shapes including, for example, ring shaped, C-shaped and D-shaped.
  • In another embodiment, an adjustable annuloplasty device includes a body member configured to conform at least partially to a cardiac valve annulus. The body member includes a shape memory material configured to transform from a first shape to a second shape in response to being heated. The annuloplasty device further includes a thermally conductive member adjacent said body member, said thermally conductive material configured to communicate thermal energy to said body member. The thermally conductive member can be further configured as an imaging marker and may include a radiopaque material. The annuloplasty device may further include a suturable material at least partially covering said body member. The thermally conductive member can be disposed at least partially over said suturable material and the thermally conductive member can provide indicia of one or more valve commissure locations after said adjustable annuloplasty device is implanted on or near a heart valve annulus. The thermally conductive member can include at least one of a metallic wire or a metallic ribbon, and the body member may be selected from a variety of shapes including, for example, ring shaped, C-shaped and D-shaped.
  • In another embodiment, an adjustable annuloplasty device includes a body member having a material that exhibits a ferromagnetic shape memory effect. The body member has a first size of a dimension of said device in a first configuration and a second size of said dimension of said device in a second configuration. The body member is configured to be implanted into a heart so as to reinforce a cardiac valve annulus in said first configuration. The body member is configured to transform from said first configuration to said second configuration in vivo in response to a magnetic field inducing said ferromagnetic shape memory effect. The body member in said second configuration is configured to reduce a size of said cardiac valve annulus. The shape memory material may include at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al. The body member can be configured to transform from said first configuration to said second configuration without substantially changing the temperature of said ferromagnetic shape memory material. The device can have a ring shape, a C-shape, a D-shape, or other shape.
  • In another embodiment, an adjustable annuloplasty device includes a body member including a shape memory material and an energy absorption enhancement material configured to absorb energy in response to a first activation energy. The energy absorption enhancement material is in thermal communication with said shape memory material. The body member has a first size of a body dimension in a first configuration and a second size of said body dimension in a second configuration. The body member is configured to be implanted in said first configuration into a heart. The body member is configured to transform from said first configuration to said second configuration in response to said first activation energy. The second configuration is configured to reduce a dimension of a cardiac valve annulus in said heart. The energy absorption enhancement material may be further configured to heat in response to said first activation energy and may be configured to transfer heat to said shape memory material.
  • The shape memory material can include at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid. The annuloplasty device may further include an electrically conductive material configured to conduct a current in response to said first activation energy and to transfer thermal energy to said shape memory material. The annuloplasty device may further include a suturable material configured to facilitate attachment of said body member to said cardiac valve annulus. The body member can have a third size of said body dimension in a third configuration, wherein said third size is larger than said second size, and wherein said body member is configured to transform to said third configuration in response to a second activation energy to increase said dimension of said cardiac valve annulus. The body member can have a third size of said body dimension in a third configuration, wherein said third size is smaller than said second size, and wherein said body member is configured to transform to said third configuration in response to a second activation energy to decrease said dimension of said cardiac valve annulus. The energy absorption enhancement material can include a nanoparticle that may include, for example, at least one of a nanoshell and a nanosphere. The energy absorption enhancement material can be radiopaque.
  • In another embodiment, an adjustable annuloplasty ring includes a tubular member configured to be attached to or near a cardiac valve annulus. The tubular member includes a receptacle end and an insert end configured to couple with said receptacle end of said tubular member such that said tubular member substantially forms a shape of a ring. The insert end is configured to move with respect to said receptacle end to change a circumference of said ring. The tubular member can further include a shape memory material configured to change, after implantation in a patient's body, from a first shape to a second shape in response to an activation energy, wherein said shape change causes said change in the circumference of said ring. The tubular member can further include an energy absorption enhancement material disposed within said tubular member. The energy absorption enhancement material facilitates transfer of heat to said shape memory material. The energy absorption enhancement material can be further disposed on an outer surface of said tubular member. The tubular member can further include a ratchet member configured to allow said insert end to move predominantly in a first direction with respect to said receptacle end, and to resist movement in a second, opposite direction. The annuloplasty ring can be ring shaped, C-shaped, D-shaped, or another shape.
  • In another embodiment, an adjustable annuloplasty ring includes a body member configured to be attached to or near a cardiac valve annulus. The body member includes a first end and a second end configured to couple with said first end of said body member such that said body member substantially forms a shape of a ring. The second end is configured to move with respect to said first end to change a circumference of said ring. The body member can further include a shape memory material configured to change, after implantation in a patient's body, from a first shape to a second shape in response to an activation energy, wherein said shape change causes said change in the circumference of said ring. The body member can further include an energy absorption enhancement material that facilitates transfer of heat to said shape memory material. The body member can further include a ratchet member configured to allow said second end to move predominantly in a first direction with respect to said first end, and to resist movement in a second, opposite direction. The annuloplasty ring can be ring shaped, C-shaped, D-shaped, or another shape.
  • In another embodiment, an adjustable annuloplasty ring includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension. The second size is less than said first size. The ring also includes a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension. The second size is less than said third size. The first shape memory member can be configured to change shape in response to being heated to a first temperature and the second shape memory member can be configured to change shape in response to being heated to a second temperature. The first temperature can be lower than said second temperature or the second temperature can be lower than said first temperature. At least one of said first shape memory member and said second shape memory member can include at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid. At least one of said first shape memory member and said second shape memory member can be configured to change shape in response to a magnetic field. At least one of said first shape memory member and said second shape memory member can include at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al. The ring dimension can be a septolateral dimension.
  • In another embodiment, an adjustable annuloplasty ring includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said second size is less than said first size, and a second shape memory member configured to transform said annuloplasty ring from said second size to a third size of the ring dimension, wherein said third size is less than said second size.
  • In another embodiment, an adjustable annuloplasty ring includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size, and a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said third size is less than said second size.
  • In another embodiment, an adjustable annuloplasty ring includes a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size, and a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said second size is less than said third size.
  • In another embodiment, an annuloplasty device configured to support a heart valve includes an anterior portion, a posterior portion, and two lateral portions corresponding to intersections of said anterior portion and said posterior portion. The annuloplasty device has a first shape in a first configuration and a second shape in a second configuration. The annuloplasty device is configured to transform from said first configuration to said second configuration in response to a first activation energy applied thereto. The transformation is configured to reduce a distance between said anterior portion and said posterior portion without substantially decreasing a distance between said two lateral portions. The annuloplasty device can also include one or more imaging markers that can include, for example, radiopaque markers. The transformation can be further configured to increase said distance between said two lateral portions.
  • In another embodiment, the annuloplasty device further includes a wire that extends at least partially along said anterior and posterior portions, and a first shape memory member at least partially covering or contacting said wire. The wire can be selected from the group consisting of a round wire, a flat wire, a mesh wire, a rod-shaped wire, and a band-shaped wire. The first shape memory member can include a tubular structure, wherein at least a portion of said wire passes through said tubular structure. The tubular structure can include a first shape memory body configured to respond to said first activation energy by bending said wire such that said annuloplasty device transforms from said first shape to said second shape.
  • The tubular structure can further include a second shape memory body configured to respond to a second activation energy by bending said wire such that said annuloplasty device transforms from said second shape to a third shape. The annuloplasty device in said third shape can have a reduced distance between said anterior portion and said posterior portion as compared to said second shape. Alternatively, the annuloplasty device in said third shape can have an increased distance between said anterior portion and said posterior portion as compared to said second shape. At least one of said first activation energy and said second activation energy can include a magnetic field, acoustic energy, radio frequency energy. In certain embodiments, the first shape memory body can change to a first activation temperature in response to said first activation energy, wherein said second shape memory body changes to a second activation temperature in response to said second activation energy. The first activation temperature can be lower than said second activation temperature.
  • In certain embodiments, the annuloplasty device further includes a first shape memory band that extends at least partially along said anterior and posterior portions. The first shape memory band loops back on itself in a curvilinear configuration such that portions of said first shape memory band overlap one another. The first shape memory band can be configured to change its length in response to said first activation energy such that said overlapping portions slide with respect to one another to change said annuloplasty device from said first configuration to said second configuration. The annuloplasty device can further include a second shape memory band at least partially disposed between or adjacent to said overlapping portions of said first shape memory band. The second shape memory band can be configured to respond to a second activation energy to transform said annuloplasty device from said second configuration to a third configuration. The annuloplasty device in said third configuration can have a reduced distance between said anterior portion and said posterior portion as compared to said second shape. Alternatively, the annuloplasty device in said third configuration can have an increased distance between said anterior portion and said posterior portion as compared to said second shape. At least one of said first activation energy and said second activation energy can include a magnetic field, acoustic energy, radio frequency energy, or another form of energy. The first shape memory band can change to a first activation temperature in response to said first activation energy, wherein said second shape memory band changes to a second activation temperature in response to said second activation energy.
  • In another embodiment, an annuloplasty device changes a patient's cardiac valve annulus size in an anteroposterior dimension without substantially changing said annulus in a lateral dimension. The changing occurs in response to a transmission of energy from a non-invasive source external to the patient's heart to said annuloplasty device.
  • For purposes of summarizing the invention, certain aspects, advantages and novel features of the invention have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment of the invention. Thus, the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Systems and methods which embody the various features of the invention will now be described with reference to the following drawings:
  • FIG. 1A is a top view in partial section of an adjustable annuloplasty ring according to certain embodiments of the invention;
  • FIG. 1B is a side view of the annuloplasty ring of FIG. 1A;
  • FIG. 1C is a transverse cross-sectional view of the annuloplasty ring of FIG. 1A;
  • FIG. 2 is a graphical representation of the diameter of an annuloplasty ring in relation to the temperature of the annuloplasty ring according to certain embodiments of the invention;
  • FIG. 3A is a top view in partial section of an adjustable annuloplasty ring having a D-shaped configuration according to certain embodiments of the invention;
  • FIG. 3B is a side view of the annuloplasty ring of FIG. 3A;
  • FIG. 3C is a transverse cross-sectional view of the annuloplasty ring of FIG. 3A;
  • FIG. 4A is a top view of an annuloplasty ring having a substantially circular configuration according to certain embodiments of the invention;
  • FIG. 4B is a side view of the annuloplasty ring of FIG. 4A;
  • FIG. 4C is a transverse cross-sectional view of the annuloplasty ring of FIG. 4A;
  • FIG. 5 is a top view of an annuloplasty ring having a substantially D-shaped configuration according to certain embodiments of the invention;
  • FIG. 6A is a schematic diagram of a top view of a shape memory wire having a substantially D-shaped configuration according to certain embodiments of the invention;
  • FIGS. 6B-6E are schematic diagrams of side views of the shape memory wire of FIG. 6A according to certain embodiments of the invention;
  • FIG. 7A is a perspective view in partial section of an annuloplasty ring comprising the shape memory wire of FIG. 6A according to certain embodiments of the invention;
  • FIG. 7B is a perspective view in partial section of a portion of the annuloplasty ring of FIG. 7A;
  • FIG. 8 is a schematic diagram of a shape memory wire having a substantially C-shaped configuration according to certain embodiments of the invention;
  • FIG. 9A is a perspective view in partial section of an annuloplasty ring comprising the shape memory wire of FIG. 8 according to certain embodiments of the invention;
  • FIG. 9B is a perspective view in partial section of a portion of the annuloplasty ring of FIG. 9A;
  • FIG. 10A is a perspective view in partial section an annuloplasty ring comprising a first shape memory wire and a second shape memory wire according to certain embodiments of the invention;
  • FIG. 10B is a top cross-sectional view of the annuloplasty ring of FIG. 10A;
  • FIG. 11A is a perspective view in partial section of an annuloplasty ring comprising a first shape memory wire and a second shape memory wire according to certain embodiments of the invention;
  • FIG. 11B is a top cross-sectional view of the annuloplasty ring of FIG. 11A;
  • FIG. 12 is a perspective view of a shape memory wire wrapped in a coil according to certain embodiments of the invention;
  • FIGS. 13A and 13B are schematic diagrams illustrating an annuloplasty ring according to certain embodiments of the invention;
  • FIG. 14 is a schematic diagram illustrating an annuloplasty ring according to certain embodiments of the invention;
  • FIG. 15 is a schematic diagram illustrating an annuloplasty ring according to certain embodiments of the invention;
  • FIGS. 16A and 16B are schematic diagrams illustrating an annuloplasty ring having a plurality of temperature response zones or sections according to certain embodiments of the invention;
  • FIGS. 17A and 17B are schematic diagrams illustrating an annuloplasty ring having a plurality of temperature response zones or sections according to certain embodiments of the invention;
  • FIG. 18 is a sectional view of a mitral valve with respect to an exemplary annuloplasty ring according to certain embodiments of the invention;
  • FIG. 19 is a schematic diagram of a substantially C-shaped wire comprising a shape memory material configured to contract in a first direction and expand in a second direction according to certain embodiments of the invention;
  • FIGS. 20A and 20B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention;
  • FIGS. 21A and 21B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention;
  • FIGS. 22A and 22B are schematic diagrams of a body member usable by an annuloplasty ring according to certain embodiments of the invention;
  • FIG. 23 is a transverse cross-sectional view of the body member of FIGS. 21A and 21B;
  • FIG. 24 is a perspective view of a body member usable by an annuloplasty ring according to certain embodiments comprising a first shape memory band and a second shape memory band;
  • FIG. 25A is a schematic diagram illustrating the body member of FIG. 24 in a first configuration or shape according to certain embodiments of the invention;
  • FIG. 25B is a schematic diagram illustrating the body member of FIG. 24 in a second configuration or shape according to certain embodiments of the invention;
  • FIG. 25C is a schematic diagram illustrating the body member of FIG. 24 in a third configuration or shape according to certain embodiments of the invention;
  • FIG. 26 is a perspective view illustrating an annuloplasty ring comprising one or more thermal conductors according to certain embodiments of the invention;
  • FIGS. 27A-27C are transverse cross-sectional views of the annuloplasty ring of FIG. 26 schematically illustrating exemplary embodiments of the invention for conducting thermal energy to an internal shape memory wire; and
  • FIG. 28 is a schematic diagram of an annuloplasty ring comprising one or more thermal conductors according to certain embodiments of the invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The present invention involves systems and methods for reinforcing dysfunctional heart valves and other body structures with adjustable rings. In certain embodiments, an adjustable annuloplasty ring is implanted into the body of a patient such as a human or other animal. The adjustable annuloplasty ring is implanted through an incision or body opening either thoracically (e.g., open-heart surgery) or percutaneously (e.g., via a femoral artery or vein, or other arteries or veins) as is known to someone skilled in the art. The adjustable annuloplasty ring is attached to the annulus of a heart valve to improve leaflet coaptation and to reduce regurgitation. The annuloplasty ring may be selected from one or more shapes comprising a round or circular shape, an oval shape, a C-shape, a D-shape, a U-shape, an open circle shape, an open oval shape, and other curvilinear shapes.
  • The size of the annuloplasty ring can be adjusted postoperatively to compensate for changes in the size of the heart. As used herein, “postoperatively” refers to a time after implanting the adjustable annuloplasty ring and closing the body opening through which the adjustable annuloplasty ring was introduced into the patient's body. For example, the annuloplasty ring may be implanted in a child whose heart grows as the child gets older. Thus, the size of the annuloplasty ring may need to be increased. As another example, the size of an enlarged heart may start to return to its normal size after an annuloplasty ring is implanted. Thus, the size of the annuloplasty ring may need to be decreased postoperatively to continue to reinforce the heart valve annulus.
  • In certain embodiments, the annuloplasty ring comprises a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field. Shape memory is the ability of a material to regain its shape after deformation. Shape memory materials include polymers, metals, metal alloys and ferromagnetic alloys. The annuloplasty ring is adjusted in vivo by applying an energy source to activate the shape memory material and cause it to change to a memorized shape. The energy source may include, for example, radio frequency (RF) energy, x-ray energy, microwave energy, ultrasonic energy such as focused ultrasound, high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like. For example, one embodiment of electromagnetic radiation that is useful is infrared energy having a wavelength in a range between approximately 750 nanometers and approximately 1600 nanometers. This type of infrared radiation may be produced efficiently by a solid state diode laser. In certain embodiments, the annuloplasty ring implant is selectively heated using short pulses of energy having an on and off period between each cycle. The energy pulses provide segmental heating which allows segmental adjustment of portions of the annuloplasty ring without adjusting the entire implant.
  • In certain embodiments, the annuloplasty ring includes an energy absorbing material to increase heating efficiency and localize heating in the area of the shape memory material. Thus, damage to the surrounding tissue is reduced or minimized. Energy absorbing materials for light or laser activation energy may include nanoshells, nanospheres and the like, particularly where infrared laser energy is used to energize the material. Such nanoparticles may be made from a dielectric, such as silica, coated with an ultra thin layer of a conductor, such as gold, and be selectively tuned to absorb a particular frequency of electromagnetic radiation. In certain such embodiments, the nanoparticles range in size between about 5 nanometers and about 20 nanometers and can be suspended in a suitable material or solution, such as saline solution. Coatings comprising nanotubes or nanoparticles can also be used to absorb energy from, for example, HIFU, MRI, inductive heating, or the like.
  • In other embodiments, thin film deposition or other coating techniques such as sputtering, reactive sputtering, metal ion implantation, physical vapor deposition, and chemical deposition can be used to cover portions or all of the annuloplasty ring. Such coatings can be either solid or microporous. When HIFU energy is used, for example, a microporous structure traps and directs the HIFU energy toward the shape memory material. The coating improves thermal conduction and heat removal. In certain embodiments, the coating also enhances radio-opacity of the annuloplasty ring implant. Coating materials can be selected from various groups of biocompatible organic or non-organic, metallic or non-metallic materials such as Titanium Nitride (TiN), Iridium Oxide (Irox), Carbon, Platinum black, Titanium Carbide (TiC) and other materials used for pacemaker electrodes or implantable pacemaker leads. Other materials discussed herein or known in the art can also be used to absorb energy.
  • In addition, or in other embodiments, fine conductive wires such as platinum coated copper, titanium, tantalum, stainless steel, gold, or the like, are wrapped around the shape memory material to allow focused and rapid heating of the shape memory material while reducing undesired heating of surrounding tissues.
  • In certain embodiments, the energy source is applied surgically either during implantation or at a later time. For example, the shape memory material can be heated during implantation of the annuloplasty ring by touching the annuloplasty ring with warm object. As another example, the energy source can be surgically applied after the annuloplasty ring has been implanted by percutaneously inserting a catheter into the patient's body and applying the energy through the catheter. For example, RF energy, light energy or thermal energy (e.g., from a heating element using resistance heating) can be transferred to the shape memory material through a catheter positioned on or near the shape memory material. Alternatively, thermal energy can be provided to the shape memory material by injecting a heated fluid through a catheter or circulating the heated fluid in a balloon through the catheter placed in close proximity to the shape memory material. As another example, the shape memory material can be coated with a photodynamic absorbing material which is activated to heat the shape memory material when illuminated by light from a laser diode or directed to the coating through fiber optic elements in a catheter. In certain such embodiments, the photodynamic absorbing material includes one or more drugs that are released when illuminated by the laser light.
  • In certain embodiments, a removable subcutaneous electrode or coil couples energy from a dedicated activation unit. In certain such embodiments, the removable subcutaneous electrode provides telemetry and power transmission between the system and the annuloplasty ring. The subcutaneous removable electrode allows more efficient coupling of energy to the implant with minimum or reduced power loss. In certain embodiments, the subcutaneous energy is delivered via inductive coupling.
  • In other embodiments, the energy source is applied in a non-invasive manner from outside the patient's body. In certain such embodiments, the external energy source is focused to provide directional heating to the shape memory material so as to reduce or minimize damage to the surrounding tissue. For example, in certain embodiments, a handheld or portable device comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the annuloplasty ring. The current heats the annuloplasty ring and causes the shape memory material to transform to a memorized shape. In certain such embodiments, the annuloplasty ring also comprises. an electrically conductive coil wrapped around or embedded in. the memory shape material. The externally generated electromagnetic field induces a current in the annuloplasty ring's coil, causing it to heat and transfer thermal energy to the shape memory material.
  • In certain other embodiments, an external HIFU transducer focuses ultrasound energy onto the implanted annuloplasty ring to heat the shape memory material. In certain such embodiments, the external HIFU transducer is a handheld or portable device. The terms “HIFU,” “high intensity focused ultrasound” or “focused ultrasound” as used herein are broad terms and are used at least in their ordinary sense and include, without limitation, acoustic energy within a wide range of intensities and/or frequencies. For example, HIFU includes acoustic energy focused in a region, or focal zone, having an intensity and/or frequency that is considerably less than what is currently used for ablation in medical procedures. Thus, in certain such embodiments, the focused ultrasound is not destructive to the patient's cardiac tissue. In certain embodiments, HIFU includes acoustic energy within a frequency range of approximately 0.5 MHz and approximately 30 MHz and a power density within a range of approximately 1 W/cm2 and approximately 500 W/cm2.
  • In certain embodiments, the annuloplasty ring comprises an ultrasound absorbing material or hydro-gel material that allows focused and rapid heating when exposed to the ultrasound energy and transfers thermal energy to the shape memory material. In certain embodiments, a HIFU probe is used with an adaptive lens to compensate for heart and respiration movement. The adaptive lens has multiple focal point adjustments. In certain embodiments, a HIFU probe with adaptive capabilities comprises a phased array or linear configuration. In certain embodiments, an external HIFU probe comprises a lens configured to be placed between a patient's ribs to improve acoustic window penetration and reduce or minimize issues and challenges regarding passing through bones. In certain embodiments, HIFU energy is synchronized with an ultrasound imaging device to allow visualization of the annuloplasty ring implant during HIFU activation. In addition, or in other embodiments, ultrasound imaging is used to non-invasively monitor the temperature of tissue surrounding the annuloplasty ring by using principles of speed of sound shift and changes to tissue thermal expansion.
  • In certain embodiments, non-invasive energy is applied to the implanted annuloplasty ring using a Magnetic Resonance Imaging (MRI) device. In certain such embodiments, the shape memory material is activated by a constant magnetic field generated by the MRI device. In addition, or in other embodiments, the MRI device generates RF pulses that induce current in the annuloplasty ring and heat the shape memory material. The annuloplasty ring can include one or more coils and/or MRI energy absorbing material to increase the efficiency and directionality of the heating. Suitable energy absorbing materials for magnetic activation energy include particulates of ferromagnetic material. Suitable energy absorbing materials for RF energy include ferrite materials as well as other materials configured to absorb RF energy at resonant frequencies thereof.
  • In certain embodiments, the MRI device is used to determine the size of the implanted annuloplasty ring before, during and/or after the shape memory material is activated. In certain such embodiments, the MRI device generates RF pulses at a first frequency to heat the shape memory material and at a second frequency to image the implanted annuloplasty ring. Thus, the size of the annuloplasty ring can be measured without heating the ring. In certain such embodiments, an MRI energy absorbing material heats sufficiently to activate the shape memory material when exposed to the first frequency and does not substantially heat when exposed to the second frequency. Other imaging techniques known in the art can also be used to determine the size of the implanted ring including, for example, ultrasound imaging, computed tomography (CT) scanning, X-ray imaging, or the like. In certain embodiments, such imaging techniques also provide sufficient energy to activate the shape memory material.
  • In certain embodiments, imaging and resizing of the annuloplasty ring is performed as a separate procedure at some point after the annuloplasty ring as been surgically implanted into the patient's heart and the patient's heart, pericardium and chest have been surgically closed. However, in certain other embodiments, it is advantageous to perform the imaging after the heart and/or pericardium have been closed, but before closing the patient's chest, to check for leakage or the amount of regurgitation. If the amount of regurgitation remains excessive after the annuloplasty ring has been implanted, energy from the imaging device (or from another source as discussed herein) can be applied to the shape memory material so as to at least partially contract the annuloplasty ring and reduce regurgitation to an acceptable level. Thus, the success of the surgery can be checked and corrections can be made, if necessary, before closing the patient's chest.
  • In certain embodiments, activation of the shape memory material is synchronized with the heart beat during an imaging procedure. For example, an imaging technique can be used to focus HIFU energy onto an annuloplasty ring in a patient's body during a portion of the cardiac cycle. As the heart beats, the annuloplasty ring may move in and out of this area of focused energy. To reduce damage to the surrounding tissue, the patient's body is exposed to the HIFU energy only during portions of the cardiac cycle that focus the HIFU energy onto the cardiac ring. In certain embodiments, the energy is gated with a signal that represents the cardiac cycle such as an electrocardiogram signal. In certain such embodiments, the synchronization and gating is configured to allow delivery of energy to the shape memory materials at specific times during the cardiac cycle to avoid or reduce the likelihood of causing arrhythmia or fibrillation during vulnerable periods. For example, the energy can be gated so as to only expose the patient's heart to the energy during the T wave of the electrocardiogram signal.
  • As discussed above, shape memory materials include, for example, polymers, metals, and metal alloys including ferromagnetic alloys. Exemplary shape memory polymers that are usable for certain embodiments of the present invention are disclosed by Langer, et al. in U.S. Pat. No. 6,720,402, issued Apr. 13, 2004, U.S. Pat. No. 6,388,043, issued May 14, 2002, and U.S. Pat. No. 6,160,084, issued Dec. 12, 2000, each of which are hereby incorporated by reference herein. Shape memory polymers respond to changes in temperature by changing to one or more permanent or memorized shapes. In certain embodiments, the shape memory polymer is heated to a temperature between approximately 38 degrees Celsius and approximately 60 degrees Celsius. In certain other embodiments, the shape memory polymer is heated to a temperature in a range between approximately 40 degrees Celsius and approximately 55 degrees Celsius. In certain embodiments, the shape memory polymer has a two-way shape memory effect wherein the shape memory polymer is heated to change it to a first memorized shape and cooled to change it to a second memorized shape. The shape memory polymer can be cooled, for example, by inserting or circulating a cooled fluid through a catheter.
  • Shape memory polymers implanted in a patient's body can be heated non-invasively using, for example, external light energy sources such as infrared, near-infrared, ultraviolet, microwave and/or visible light sources. Preferably, the light energy is selected to increase absorption by the shape memory polymer and reduce absorption by the surrounding tissue. Thus, damage to the tissue surrounding the shape memory polymer is reduced when the shape memory polymer is heated to change its shape. In other embodiments, the shape memory polymer comprises gas bubbles or bubble containing liquids such as fluorocarbons and is heated by inducing a cavitation effect in the gas/liquid when exposed to HIFU energy. In other embodiments, the shape memory polymer may be heated using electromagnetic fields and may be coated with a material that absorbs electromagnetic fields.
  • Certain metal alloys have shape memory qualities and respond to changes in temperature and/or exposure to magnetic fields. Exemplary shape memory alloys that respond to changes in temperature include titanium-nickel, copper-zinc-aluminum, copper-aluminum-nickel, iron-manganese-silicon, iron-nickel-aluminum, gold-cadmium, combinations of the foregoing, and the like. In certain embodiments, the shape memory alloy comprises a biocompatible material such as a titanium-nickel alloy.
  • Shape memory alloys exist in two distinct solid phases called martensite and austenite. The martensite phase is relatively soft and easily deformed, whereas the austenite phase is relatively stronger and less easily deformed. For example, shape memory alloys enter the austenite phase at a relatively high temperature and the martensite phase at a relatively low temperature. Shape memory alloys begin transforming to the martensite phase at a start temperature (Ms) and finish transforming to the martensite phase at a finish temperature (Mf). Similarly, such shape memory alloys begin transforming to the austenite phase at a start temperature (As) and finish transforming to the austenite phase at a finish temperature (Af). Both transformations have a hysteresis. Thus, the Ms temperature and the Af temperature are not coincident with each other, and the Mf temperature and the As temperature are not coincident with each other.
  • In certain embodiments, the shape memory alloy is processed to form a memorized shape in the austenite phase in the form of a ring or partial ring. The shape memory alloy is then cooled below the Mf temperature to enter the martensite phase and deformed into a larger or smaller ring. For example, in certain embodiments, the shape memory alloy is formed into a ring or partial ring that is larger than the memorized shape but still small enough to improve leaflet coaptation and reduce regurgitation in a heart valve upon being attached to the heart valve annulus. In certain such embodiments, the shape memory alloy is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumference of the ring in the martensite phase by hand to achieve a desired fit for a particular heart valve annulus. After the ring is attached to the heart valve annulus, the circumference of the ring can be adjusted non-invasively by heating the shape memory alloy to an activation temperature (e.g., temperatures ranging from the As temperature to the Af temperature).
  • Thereafter, when the shape memory alloy is exposed to a temperature elevation and transformed to the austenite phase, the alloy changes in shape from the deformed shape to the memorized shape. Activation temperatures at which the shape memory alloy causes the shape of the annuloplasty ring to change shape can be selected and built into the annuloplasty ring such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring during the activation process. Exemplary Af temperatures for suitable shape memory alloys range between approximately 45 degrees Celsius and approximately 70 degrees Celsius. Furthermore, exemplary Ms temperatures range between approximately 10 degrees Celsius and approximately 20 degrees Celsius, and exemplary Mf temperatures range between approximately −1 degrees Celsius and approximately 15 degrees Celsius. The size of the annuloplasty ring can be changed all at once or incrementally in small steps at different times in order to achieve the adjustment necessary to produce the desired clinical result.
  • Certain shape memory alloys may further include a rhombohedral phase, having a rhombohedral start temperature (Rs) and a rhombohedral finish temperature (Rf), that exists between the austenite and martensite phases. An example of such a shape memory alloy is a NiTi alloy, which is commercially available from Memry Corporation (Bethel, Connecticut). In certain embodiments, an exemplary Rs temperature range is between approximately 30 degrees Celsius and approximately 50 degrees Celsius, and an exemplary Rf temperature range is between approximately 20 degrees Celsius and approximately 35 degrees Celsius. One benefit of using a shape memory material having a rhombohedral phase is that in the rhomobohedral phase the shape memory material may experience a partial physical distortion, as compared to the generally rigid structure of the austenite phase and the generally deformable structure of the martensite phase.
  • Certain shape memory alloys exhibit a ferromagnetic shape memory effect wherein the shape memory alloy transforms from the martensite phase to the austenite phase when exposed to an external magnetic field. The term “ferromagnetic” as used herein is a broad term and is used in its ordinary sense and includes, without limitation, any material that easily magnetizes, such as a material having atoms that orient their electron spins to conform to an external magnetic field. Ferromagnetic materials include permanent magnets, which can be magnetized through a variety of modes, and materials, such as metals, that are attracted to permanent magnets. Ferromagnetic materials also include electromagnetic materials that are capable of being activated by an electromagnetic transmitter, such as one located outside the heart 100. Furthermore, ferromagnetic materials may include one or more polymer-bonded magnets, wherein magnetic particles are bound within a polymer matrix, such as a biocompatible polymer. The magnetic materials can comprise isotropic and/or anisotropic materials, such as for example NdFeB (Neodynium Iron Boron), SmCo (Samarium Cobalt), ferrite and/or AlNiCo (Aluminum Nickel Cobalt) particles.
  • Thus, an annuloplasty ring comprising a ferromagnetic shape memory alloy can be implanted in a first configuration having a first shape and later changed to a second configuration having a second (e.g., memorized) shape without heating the shape memory material above the As temperature. Advantageously, nearby healthy tissue is not exposed to high temperatures that could damage the tissue. Further, since the ferromagnetic shape memory alloy does not need to be heated, the size of the annuloplasty ring can be adjusted more quickly and more uniformly than by heat activation.
  • Exemplary ferromagnetic shape memory alloys include Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, Co—Ni—Al, and the like. Certain of these shape memory materials may also change shape in response to changes in temperature. Thus, the shape of such materials can be adjusted by exposure to a magnetic field, by changing the temperature of the material, or both.
  • In certain embodiments, combinations of different shape memory materials are used. For example, annuloplasty rings according to certain embodiments comprise a combination of shape memory polymer and shape memory alloy (e.g., NiTi). In certain such embodiments, an annuloplasty ring comprises a shape memory polymer tube and a shape memory alloy (e.g., NiTi) disposed within the tube. Such embodiments are flexible and allow the size and shape of the shape memory to be further reduced without impacting fatigue properties. In addition, or in other embodiments, shape memory polymers are used with shape memory alloys to create a bi-directional (e.g., capable of expanding and contracting) annuloplasty ring. Bi-directional annuloplasty rings can be created with a wide variety of shape memory material combinations having different characteristics.
  • In the following description, reference is made to the accompanying drawings, which form a part hereof, and which show, by way of illustration, specific embodiments or processes in which the invention may be practiced. Where possible, the same reference numbers are used throughout the drawings to refer to the same or like components. In some instances, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. The present disclosure, however, may be practiced without the specific details or with certain alternative equivalent components and methods to those described herein. In other instances, well-known components and methods have not been described in detail so as not to unnecessarily obscure aspects of the present disclosure.
  • FIGS. 1A-1C illustrate an adjustable annuloplasty ring 100 according to certain embodiments that can be adjusted in vivo after implantation into a patient's body. The annuloplasty ring 100 has a substantially annular configuration and comprises a tubular body member 112 that folds back upon itself in a substantial circle having a nominal diameter as indicated by arrow 123. The tubular body member 112 comprises a receptacle end 114 and an insert end 116. The insert end 116 of the tubular member 112 is reduced in outer diameter or transverse dimension as compared to the receptacle end 114. As used herein, “dimension” is a broad term having its ordinary and customary meaning and includes a size or distance from a first point to a second point along a line or arc. For example, a dimension may be a circumference, diameter, radius, arc length, or the like. As another example, a dimension may be a distance between an anterior portion and a posterior portion of an annulus.
  • The receptacle end accepts the insert end 116 of the tubular member 112 to complete the ring-like structure of the annuloplasty ring 100. The insert end 116 slides freely within the receptacle end 114 of the annuloplasty ring 100 which allows contraction of the overall circumference of the ring 100 as the insert end 116 enters the receptacle end 114 as shown by arrows 118 in FIG. 1A. In certain embodiments, the nominal diameter or transverse dimension 123 of the annuloplasty ring 100 can be adjusted from approximately 25 mm to approximately 38 mm. However, an artisan will recognize from the disclosure herein that the diameter or transverse dimension 123 of the annuloplasty ring 100 can be adjusted to other sizes depending on the particular application. Indeed, the diameter or transverse dimension 123 of the annuloplasty ring 100 can be configured to reinforce body structures substantially smaller than 25 mm and substantially larger than 38 mm.
  • An artisan will recognize from the disclosure herein that in other embodiments the insert end 116 can couple with the receptacle end 114 without being inserted in the receptacle end 114. For example, the insert end 116 can overlap the receptacle end 114 such that it slides adjacent thereto. In other embodiments, for example, the ends 114, 116 may grooved to guide the movement of the adjacent ends 114, 116 relative to one another. Other embodiments within the scope of the invention will occur to those skilled in the art.
  • The annuloplasty ring 100 also comprises a suturable material 128, shown partially cut away in FIG. 1A, and not shown in FIGS. 1B and 1C for clarity. The suturable material 128 is disposed about the tubular member 112 to facilitate surgical implantation of the annuloplasty ring 100 in a body structure, such as about a heart valve annulus. In certain embodiments, the suturable material 128 comprises a suitable biocompatible material such. as Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or the like. In other embodiments, the suturable material 128 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue. The suturable material 128 may be disposed about the entire circumference of the tubular member 112, or selected portions thereof. For example, in certain embodiments, the suturable material 128 is disposed so as to enclose substantially the entire tubular member 112 except at the narrowed insert end 116 that slides into the receptacle end 118 of the tubular member 112.
  • As shown in FIGS. 1A and 1B, in certain embodiments, the annuloplasty ring 100 also comprises a ratchet member 120 secured to the receptacle end 114 of the tubular member 112. The ratchet member 120 comprises a pawl 122 configured to engage transverse slots 124 (shown in FIG. 1B) on the insert end 116 of the tubular member 112. The pawl 122 of the ratchet member 120 engages the slots 124 in such a way as to allow contraction of the circumference of the annuloplasty ring 100 and prevent or reduce circumferential expansion of the annuloplasty ring 100. Thus, the ratchet reduces unwanted circumferential expansion of the annuloplasty ring 100 after implantation due, for example, to dynamic forces on the annuloplasty ring 100 from the heart tissue during systolic contraction of the heart.
  • In certain embodiments, the tubular member 112 comprises a rigid material such as stainless steel, titanium, or the like, or a flexible material such as silicon rubber, Dacron®, or the like. In certain such embodiments, after implantation into a patient's body, the circumference of the annuloplasty ring 100 is adjusted in vivo by inserting a catheter (not shown) into the body and pulling a wire (not shown) attached to the tubular member 112 through the catheter to manually slide the insert end 116 of the tubular member 112 into the receptacle end 114 of the tubular member 112. As the insert end 116 slides into the receptacle end 114, the pawl 122 of the ratchet member 120 engages the slots 124 on the insert end 116 to hold the insert end 116 in the receptacle end 114. Thus, for example, as the size of a heart valve annulus reduces after implantation of the annuloplasty ring 100, the size of the annuloplasty ring 100 can also be reduced to provide an appropriate amount of reinforcement to the heart valve.
  • In certain other embodiments, the tubular member 112 comprises a shape memory material that is responsive to changes in temperature and/or exposure to a magnetic field. As discussed above, the shape memory material may include shape memory polymers (e.g., polylactic acid (PLA), polyglycolic acid (PGA)) and/or shape memory alloys (e.g., nickel-titanium) including ferromagnetic shape memory alloys (e.g., Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, Co—Ni—Al). In certain such embodiments, the annuloplasty ring 100 is adjusted in vivo by applying an energy source such as radio frequency energy, X-ray energy, microwave energy, ultrasonic energy such as high intensity focused ultrasound (HIFU) energy, light energy, electric field energy, magnetic field energy, combinations of the foregoing, or the like. Preferably, the energy source is applied in a non-invasive manner from outside the body. For example, as discussed above, a magnetic field and/or RF pulses can be applied to the annuloplasty ring 100 within a patient's body with an apparatus external to the patient's body such as is commonly used for magnetic resonance imaging (MRI). However, in other embodiments, the energy source may be applied surgically such as by inserting a catheter into the body and applying the energy through the catheter.
  • In certain embodiments, the tubular body member 112 comprises a shape memory material that responds to the application of temperature that differs from a nominal ambient temperature, such as the nominal body temperature of 37 degrees Celsius for humans. The tubular member 112 is configured to respond by starting to contract upon heating the tubular member 112 above the As temperature of the shape memory material. In certain such embodiments, the annuloplasty ring 100 has an initial diameter or transverse dimension 123 of approximately 30 mm, and contracts or shrinks to a transverse dimension 123 of approximately 23 mm to approximately 28 mm, or any increment between those values. This produces a contraction percentage in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter.
  • The activation temperatures (e.g., temperatures ranging from the As temperature to the Af temperature) at which the tubular member 112 contracts to a reduced circumference may be selected and built into the annuloplasty ring 100 such that collateral damage is reduced or eliminated in tissue adjacent the annuloplasty ring 100 during the activation process. Exemplary Af temperatures for the shape memory material of the tubular member 112 at which substantially maximum contraction occurs are in a range between approximately 38 degrees Celsius and approximately 1310 degrees Celsius. In certain embodiments, the Af temperature is in a range between approximately 39 degrees Celsius and approximately 75 degrees Celsius. For some embodiments that include shape memory polymers for the tubular member 112, activation temperatures at which the glass transition of the material or substantially maximum contraction occur range between approximately 38 degrees Celsius and approximately 60 degrees Celsius. In other such embodiments, the activation temperature is in a range between approximately 40 degrees Celsius and approximately 59 degrees Celsius.
  • In certain embodiments, the tubular member 112 is shape set in the austenite phase to a remembered configuration during the manufacturing of the tubular member 112 such that the remembered configuration is that of a relatively small circumferential value with the insert end 116 fully inserted into the receptacle end 114. After cooling the tubular member 112 below the Mf temperature, the tubular member 112 is manually deformed to a larger circumferential value with the insert end 116 only partially inserted into the receptacle end 114 to achieve a desired starting nominal circumference for the annuloplasty ring 100. In certain such embodiments, the tubular member 112 is sufficiently malleable in the martensite phase to allow a user such as a physician to adjust the circumferential value by hand to achieve a desired fit with the heart valve annulus. In certain embodiments, the starting nominal circumference for the annuloplasty ring 100 is configured to improve leaflet coaptation and reduce regurgitation in a heart valve.
  • After implantation, the annuloplasty ring 100 is preferably activated non-invasively by the application of energy to the patient's body to heat the tubular member 112. In certain embodiments, an MRI device is used as discussed above to heat the tubular member 112, which then causes the shape memory material of the tubular member 112 to transform to the austenite phase and remember its contracted configuration. Thus, the circumference of the annuloplasty ring 100 is reduced in vivo without the need for surgical intervention. Standard techniques for focusing the magnetic field from the MRI device onto the annuloplasty ring 100 may be used. For example, a conductive coil can be wrapped around the patient in an area corresponding to the annuloplasty ring 100. In other embodiments, the shape memory material is activated by exposing it other sources of energy, as discussed above.
  • The circumference reduction process, either non-invasively or through a catheter, can be carried out all at once or incrementally in small steps at different times in order to achieve the adjustment necessary to produce the desired clinical result. If heating energy is applied such that the temperature of the tubular member 112 does not reach the Af temperature for substantially maximum transition contraction, partial shape memory transformation and contraction may occur. FIG. 2 graphically illustrates the relationship between the temperature of the tubular member 112 and the diameter or transverse dimension 123 of the annuloplasty ring 100 according to certain embodiments. At body temperature of approximately 37 degrees Celsius, the diameter of the tubular member 112 has a first diameter do. The shape memory material is then increased to a first raised temperature T1. In response, the diameter of the tubular member 112 reduces to a second diameter dn. The diameter of the tubular member 112 can then be reduced to a third diameter dnm by raising the temperature to a second temperature T2.
  • As graphically illustrated in FIG. 2, in certain embodiments, the change in diameter from d0 to dnm is substantially continuous as the temperature is increased from body temperature to T2. For example, in certain embodiments a magnetic field of about 2.5 Tesla to about 3.0 Tesla is used to raise the temperature of the tubular member 112 above the Af temperature to complete the austenite phase and return the tubular member 112 to the remembered configuration with the insert end 116 fully inserted into the receptacle end 114. However, a lower magnetic field (e.g., 0.5 Tesla) can initially be applied and increased (e.g., in 0.5 Tesla increments) until the desired level of heating and desired contraction of the annuloplasty ring 100 is achieved. In other embodiments, the tubular member 112 comprises a plurality of shape memory materials with different activation temperatures and the diameter of the tubular member 112 is reduced in steps as the temperature increases.
  • Whether the shape change is continuous or stepped, the diameter or transverse dimension 123 of the ring 100 can be assessed or monitored during the contraction process to determine the amount of contraction by use of MRI imaging, ultrasound imaging, computed tomography (CT), X-ray or the like. If magnetic energy is being used to activate contraction of the ring 100, for example, MRI imaging techniques can be used that produce a field strength that is lower than that required for activation of the annuloplasty ring 100.
  • In certain embodiments, the tubular member 112 comprises an energy absorption enhancement material 126. As shown in FIGS. 1A and 1C, the energy absorption enhancement material 126 may be disposed within an inner chamber of the tubular member 112. As shown in FIG. 1C (and not shown in FIG. 1A for clarity), the energy absorption enhancement material 126 may also be coated on the outside of the tubular member 112 to enhance energy absorption by the tubular member 112. For embodiments that use energy absorption enhancement material 126 for enhanced absorption, it may be desirable for the energy absorption enhancement material 126, a carrier material (not shown) surrounding the energy absorption enhancement material 126, if there is one, or both to be thermally conductive. Thus, thermal energy from the energy absorption enhancement material 126 is efficiently transferred to the shape memory material of the annuloplasty ring 100, such as the tubular member 112.
  • As discussed above, the energy absorption enhancement material 126 may include a material or compound that selectively absorbs a desired heating energy and efficiently converts the non-invasive heating energy to heat which is then transferred by thermal conduction to the tubular member 112. The energy absorption enhancement material 126 allows the tubular member 112 to be actuated and adjusted by the non-invasive application of lower levels of energy and also allows for the use of non-conducting materials, such as shape memory polymers, for the tubular member 112. For some embodiments, magnetic flux ranging between about 2.5 Tesla and about 3.0 Tesla may be used for activation. By allowing the use of lower energy levels, the energy absorption enhancement material 126 also reduces thermal damage to nearby tissue. Suitable energy absorption enhancement materials 126 are discussed above.
  • In certain embodiments, a circumferential contraction cycle can be reversed to induce an expansion of the annuloplasty ring 100. Some shape memory alloys, such as NiTi or the like, respond to the application of a temperature below the nominal ambient temperature. After a circumferential contraction cycle has been performed, the tubular member 112 is cooled below the Ms temperature to start expanding the annuloplasty ring 100. The tubular member 112 can also be cooled below the Mf temperature to finish the transformation to the martensite phase and reverse the contraction cycle. As discussed above, certain polymers also exhibit a two-way shape memory effect and can be used to both expand and contract the annuloplasty ring 100 through heating and cooling processes. Cooling can be achieved, for example, by inserting a cool liquid onto or into the annuloplasty ring 100 through a catheter, or by cycling a cool liquid or gas through a catheter placed near the annuloplasty ring 100. Exemplary temperatures for a NiTi embodiment for cooling and reversing a contraction cycle range between approximately 20 degrees Celsius and approximately 30 degrees Celsius.
  • In certain embodiments, external stresses are applied to the tubular member 112 during cooling to expand the annuloplasty ring 100. In certain such embodiments, one or more biasing elements (not shown) are operatively coupled to the tubular member 112 so as to exert a circumferentially expanding force thereon. For example, in certain embodiments a biasing element such as a spring (not shown) is disposed in the receptacle end 114 of the tubular member 112 so as to push the insert end 16 at least partially out of the receptacle end 114 during cooling. In such embodiments, the tubular member 112 does not include the ratchet member 120 such that the insert end 116 can slide freely into or out of the receptacle end 114.
  • In certain embodiments, the tubular member comprises ferromagnetic shape memory material, as discussed above. In such embodiments, the diameter of the tubular member 112 can be changed by exposing the tubular member 112 to a magnetic field. Advantageously, nearby healthy tissue is not exposed to high temperatures that could damage the tissue. Further, since the shape memory material does not need to be heated, the size of the tubular member 112 can be adjusted more quickly and more uniformly than by heat activation.
  • FIGS. 3A-3C illustrate an embodiment of an adjustable annuloplasty ring 300 that is similar to the annuloplasty ring 100 discussed above, but having a D-shaped configuration instead of a circular configuration. The annuloplasty ring 300 comprises a tubular body member 311 having a receptacle end 312 and an insert end 314 sized and configured to slide freely in the hollow receptacle end 312 in an axial direction which allows the annuloplasty ring 300 to constrict upon activation to a lesser circumference or transverse dimension as indicated by arrows 316. The annuloplasty ring 300 has a major transverse dimension indicated by arrow 318 that is reduced upon activation of the annuloplasty ring 300. The major transverse dimension indicated by arrow 318 can be the same as or similar to the transverse dimension indicated by arrow 123 discussed above. In certain embodiments, the features, dimensions and materials of the annuloplasty ring 300 are the same as or similar to the features, dimensions and materials of annuloplasty ring 100 discussed above. The D-shaped configuration of ring 32 allows a proper fit of the ring 32 with the morphology of some particular heart valves.
  • FIGS. 4A-4C show an embodiment of an annuloplasty ring 400 that includes a continuous tubular member 410 surrounded by a suturable material 128. The tubular member 410 has a substantially circular transverse cross section, as shown in FIG. 4C, and has an absorption enhancing material 126 disposed within an inner chamber of the tubular member 410. In certain embodiments, the absorption enhancing material 126 is also disposed on the outer surface of the tubular member 410. The tubular member 410 may be made from a shape memory material such as a shape memory polymer or a shape memory alloy including a ferromagnetic shape memory alloy, as discussed above.
  • For embodiments of the annuloplasty ring 400 with a tubular member 410 made from a continuous piece of shape memory alloy (e.g., NiTi alloy) or shape memory polymer, the annuloplasty ring 400 can be activated by the surgical and/or non-invasive application of heating energy by the methods discussed above with regard to other embodiments. For embodiments of the annuloplasty ring 400 with a tubular member 410 made from a continuous piece of ferromagnetic shape memory alloy, the annuloplasty ring 400 can be activated by the non-invasive application of a suitable magnetic field. The annuloplasty ring 400 has a nominal inner diameter or transverse dimension indicated by arrow 412 in FIG. 4A that is set during manufacture of the ring 400. In certain embodiments, the annuloplasty ring 400 is sufficiently malleable when it is implanted into a patient's body that it can be adjusted by hand to be fitted to a particular heart valve annulus.
  • In certain embodiments, upon activating the tubular member 410 by the application of energy, the tubular member 410 remembers and assumes a configuration wherein the transverse dimension is less than the nominal transverse dimension 412. A contraction in a range between approximately 6 percent to approximately 23 percent may be desirable in some embodiments which have continuous hoops of shape memory tubular members 410. In certain embodiments, the tubular member 410 comprises a shape memory NiTi alloy having an inner transverse dimension in a range between approximately 25 mm and approximately 38 mm. In certain such embodiments, the tubular member 410 can contract or shrink in a range between approximately 6 percent and approximately 23 percent, where the percentage of contraction is defined as a ratio of the difference between the starting diameter and finish diameter divided by the starting diameter. In certain embodiments, the annuloplasty ring 400 has a nominal inner transverse dimension 412 of approximately 30 mm and an inner transverse dimension in a range between approximately 23 mm and approximately 128 mm in a fully contracted state.
  • As discussed above in relation to FIG. 2, in certain embodiments, the inner transverse dimension 412 of certain embodiments can be altered as a function of the temperature of the tubular member 410. As also discussed above, in certain such embodiments, the progress of the size change can be measured or monitored in real-time conventional imaging techniques. Energy from conventional imaging devices can also be used to activate the shape memory material and change the inner transverse dimension 412 of the tubular member 410. In certain embodiments, the features, dimensions and materials of the annuloplasty ring 400 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above. For example, in certain embodiments, the tubular member 410 comprises a shape memory material that exhibits a two-way shape memory effect when heated and cooled. Thus, the annuloplasty ring 400, in certain such embodiments, can be contracted and expanded.
  • FIG. 5 illustrates a top view of an annuloplasty ring 500 having a D-shaped configuration according to certain embodiments. The annuloplasty ring 500 includes a continuous tubular member 510 comprising a shape memory material that has a nominal inner transverse dimension indicated by arrow 512 that may contract or shrink upon the activation of the shape memory material by surgically or non-invasive applying energy thereto, as discussed above. The tubular member 510 may comprise a homogeneous shape memory material, such as a shape memory polymer or a shape memory alloy including, for example, a ferromagnetic shape memory alloy.
  • Alternatively, the tubular member 510 may comprise two or more sections or zones of shape memory material having different temperature response curves. The shape memory response zones may be configured in order to achieve a desired configuration of the annuloplasty ring 500 as a whole when in a contracted state, either fully contracted or partially contracted. For example, the tubular member 510 may have a first zone or section 514 that includes the arched portion of the tubular member that terminates at or near the corners 516 and a second zone or section 518 that includes the substantially straight portion of the tubular member 510 disposed directly between the corners 516.
  • The annuloplasty ring 500 is shown in a contracted state in FIG. 5 as indicated by the dashed lines 520, 522, which represent contracted states of certain embodiments wherein both the first section 514 and second section 518 of the tubular member 510 have contracted axially. A suturable material (not shown), such as the suturable material 128 shown in FIG. 1, may be disposed about the tubular member 510 and the tubular member 510 may comprise or be coated with an energy absorption enhancement material 126, as discussed above. In certain embodiments, the features, dimensions and materials of the annuloplasty ring 500 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 100 discussed above.
  • FIG. 6A is a schematic diagram of a top view of a substantially D-shaped wire 600 comprising a shape memory material according to certain embodiments of the invention. The term “wire” is a broad term having its normal and customary meaning and includes, for example, mesh, flat, round, rod-shaped, or band-shaped members. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. The wire 600 comprises a substantially linear portion 608, two corner portions 610, and a substantially semi-circular portion 612.
  • For purposes of discussion, the wire 600 is shown relative to a first reference point 614, a second reference point 616 and a third reference point 618. The radius of the substantially semi-circular portion 612 is defined with respect to the first reference point 614 and the corner portions 610 are respectively defined with respect to the second reference point 616 and the third reference point 618. Also for purposes of discussion, FIG. 6A shows a first transverse dimension A, a second transverse dimension B.
  • In certain embodiments, the first transverse dimension A is in a range between approximately 20.0 mm and approximately 40.0 mm, the second transverse dimension B is in a range between approximately 10.0 mm and approximately 25.0 mm. In certain such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.45 mm and approximately 0.55 mm, the radius of each corner portion 610 is in a range between approximately 5.8 mm and 7.2 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 11.5 mm and approximately 14.0 mm. In certain other such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.1 mm and 7.4 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 11.7 mm and approximately 14.3 mm.
  • In certain other embodiments, the first transverse dimension A is in a range between approximately 26.1 mm and approximately 31.9 mm, the second transverse dimension B is in a range between approximately 20.3 mm and approximately 24.9 mm. In certain such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.4 mm and approximately 0.6 mm, the radius of each corner portion 610 is in a range between approximately 6.7 mm and 8.3 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 13.3 mm and approximately 16.2 mm. In certain other such embodiments, the wire 600 comprises a rod having a diameter in a range between approximately 0.90 mm and approximately 1.10 mm, the radius of each corner portion 610 is in a range between approximately 6.9 mm and 8.5 mm, and the radius of the substantially semi-circular portion 612 is in a range between approximately 13.5 mm and approximately 16.5 mm.
  • In certain embodiments, the wire 600 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above. In certain such embodiments, the first transverse dimension A of the wire 600 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase. In certain such embodiments, the austenite start temperature As is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, the austenite finish temperature Af is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, the martensite start temperature Ms is less than approximately 30 degrees Celsius, and the martensite finish temperature Mf is greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius. Other embodiments can include other start and finish temperatures for martensite, rhombohedral and austenite phases as described herein.
  • FIGS. 6B-6E are schematic diagrams of side views of the shape memory wire 600 of FIG. 6A according to certain embodiments. In addition to expanding and/or contracting the first transverse dimension A and/or the second transverse dimension B when transitioning to the austenite phase, in certain embodiments the shape memory wire 600 is configured to change shape in a third dimension perpendicular to the first transverse dimension A and the second transverse dimension B. For example, in certain embodiments, the shape memory wire 600 is substantially planar or flat in the third dimension, as shown in FIG. 6B, when implanted into a patient's body. Then, after implantation, the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and flexes or bows in the third dimension such that it is no longer planar, as shown in FIG. 6C. Such bowing may be symmetrical as shown in FIG. 6C or asymmetrical as shown in FIG. 6D to accommodate the natural shape of the annulus.
  • In certain embodiments, the shape memory wire 600 is configured to bow in the third dimension a distance in a range between approximately 2 millimeters and approximately 10 millimeters. In certain embodiments, the shape memory wire 600 is implanted so as to bow towards the atrium when implanted around a cardiac valve annulus to accommodate the natural shape of the annulus. In other embodiments, the shape memory wire 600 is configured to bow towards the ventricle when implanted around a cardiac valve to accommodate the natural shape of the annulus.
  • In certain embodiments, the shape memory wire 600 is bowed in the third dimension, as shown in FIG. 6C, when implanted into the patient's body. Then, after implantation, the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and further flexes or bows in the third dimension, as shown in FIG. 6E. In certain other embodiments, the shape memory wire 600 is bowed in the third dimension, as shown in FIG. 6C, when implanted into the patient's body. Then, after implantation, the shape memory wire 600 is activated such that it expands or contracts in the first transverse dimension A and/or the second transverse dimension B and changes shape in the third dimension so as to become substantially flat, as shown in FIG. 6B. An artisan will recognize from the disclosure herein that other annuloplasty rings disclosed herein can also be configured to bow or change shape in a third dimension so as to accommodate or further reinforce a valve annulus.
  • FIG. 7A is a perspective view illustrating portions of an annuloplasty ring 700 comprising the wire 600 shown in FIG. 6A according to certain embodiments of the invention. The wire 600 is covered by a flexible material 712 such as silicone rubber and a suturable material 714 such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material. In other embodiments, the suturable material 714 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue. For illustrative purposes, portions of the flexible material 712 and the suturable material 714 are not shown in FIG. 7A to show the wire 600. However, in certain embodiments, the flexible material 712 and the suturable material 714 are continuous and cover substantially the entire wire 600. Although not shown, in certain embodiments, the wire 600 is coated with an energy absorption enhancement material, as discussed above.
  • FIG. 7B is an enlarged perspective view of a portion of the annuloplasty ring 700 shown in FIG. 7A. For illustrative purposes, portions of the flexible material 712 are not shown to expose the wire 600 and portions of the suturable material 714 are shown peeled back to expose the flexible material 712. In certain embodiments, the diameter of the flexible material 712 is in a range between approximately 0.10 inches and approximately 0.15 inches. FIG. 7B shows the wire 600 substantially centered within the circumference of the flexible material 712. However, in certain embodiments, the wire 600 is offset within the circumference of the flexible material 712 to allow more space for sutures.
  • FIG. 8 is a schematic diagram of a substantially C-shaped wire 800 comprising a shape memory material according to certain embodiments of the invention. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. The wire 800 comprises two corner portions 810, and a substantially semi-circular portion 812.
  • For purposes of discussion, the wire 800 is shown relative to a first reference point 814, a second reference point 816 and a third reference point 818. The radius of the substantially semi-circular portion 812 is defined with respect to the first reference point 814 and the corner portions 810 are respectively defined with respect to the second reference point 816 and the third reference point 818. Also for purposes of discussion, FIG. 8 shows a first transverse dimension A and a second transverse dimension B. In certain embodiments, the wire 800 comprises a rod having a diameter and dimensions A and B as discussed above in relation to FIG. 6A.
  • In certain embodiments, the wire 800 comprises a NiTi alloy configured to transition to its austenite phase when heated so as to transform to a memorized shape, as discussed above. In certain such embodiments, the first transverse dimension A of the wire 800 is configured to be reduced by approximately 10% to 25% when transitioning to the austenite phase. In certain such embodiments, the austenite start temperature As is in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, the austenite finish temperature Af is in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, the martensite start temperature Ms is less than approximately 30 degrees Celsius, and the martensite finish temperature Mf is greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
  • FIG. 9A is a perspective view illustrating portions of an annuloplasty ring 900 comprising the wire 800 shown in FIG. 8 according to certain embodiments of the invention. The wire 800 is covered by a flexible material 912 such as silicone rubber and a suturable material 914 such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material. In other embodiments, the suturable material 914 comprises a biological material such as bovine or equine pericardium, homograft, patient graft, or cell-seeded tissue. For illustrative purposes, portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 9A to show the wire 800. However, in certain embodiments, the flexible material 912 and the suturable material 914 cover substantially the entire wire 800. Although not shown, in certain embodiments, the wire 800 is coated with an energy absorption enhancement material, as discussed above.
  • FIG. 9B is an enlarged perspective view of a portion of the annuloplasty ring 900 shown in FIG. 9A. For illustrative purposes, portions of the flexible material 912 are not shown to expose the wire 800 and portions of the suturable material 914 are shown peeled back to expose the flexible material 912. In certain embodiments, the diameter of the flexible material 912 is in a range between approximately 0.10 inches and approximately 0.15 inches. FIG. 9B shows the wire 800 substantially centered within the circumference of the flexible material 912. However, in certain embodiments, the wire 800 is offset within the circumference of the flexible material 912 to allow more space for sutures.
  • FIG. 10A is a perspective view illustrating portions of an annuloplasty ring 1000 configured to contract and expand according to certain embodiments of the invention. FIG. 10B is a top cross-sectional view of the annuloplasty ring 1000. As discussed above, after the annuloplasty ring 1000 has been contracted, it may become necessary to expand the annuloplasty ring 1000. For example, the annuloplasty ring 1000 may be implanted in a child with an enlarged heart. When the size of the heart begins to recover to its natural size, the annuloplasty ring 1000 can be contracted. Then, as the child gets older and the heart begins to grow, the annuloplasty ring 1000 can be enlarged as needed.
  • The annuloplasty ring 1000 comprises a first shape memory wire 1010 for contracting the annuloplasty ring 1000 and a second shape memory wire 1012 for expanding the annuloplasty ring 1000. The first and second shape memory wires, 1010, 1012 are covered by the flexible material 912 and the suturable material 914 shown in FIGS. 9A-9B. For illustrative purposes, portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 10A to show the shape memory wires 1010, 1012. However, as schematically illustrated in FIG. 10B, in certain embodiments, the flexible material 912 and the suturable material 914 substantially cover the first and second shape memory wires 1010, 1012. As discussed below, the flexible material 912 operatively couples the first shape memory wire 1010 and the second shape memory wire 1012 such that a shape change in one will mechanically effect the shape of the other. The first and second shape memory wires 1010, 1012 each comprise a shape memory material, such as the shape memory materials discussed above. However, the first and second shape memory wires 1010, 1012 are activated at different temperatures.
  • In certain embodiments, the annuloplasty ring 1000 is heated to a first temperature that causes the first shape memory wire 1010 to transition to its austenite phase and contract to its memorized shape. At the first temperature, the second shape memory wire 1012 is in its martensite phase and is substantially flexible as compared the contracted first shape memory wire 1010. Thus, when the first shape memory wire 1010 transitions to its austenite phase, it exerts a sufficient force on the second shape memory wire 1012 through the flexible material 912 to deform the second shape memory wire 1012 and cause the annuloplasty ring 1000 to contract.
  • The annuloplasty ring 1000 can be expanded by heating the annuloplasty ring to a second temperature that causes the second shape memory wire 1012 to transition to its austenite phase and expand to its memorized shape. In certain embodiments, the second temperature is higher than the first temperature. Thus, at the second temperature, both the first and second shape memory wires 1010, 1012 are in their respective austenite phases. In certain such embodiments, the diameter of the second shape memory wire 1012 is sufficiently larger than the diameter of the first shape memory wire 1010 such that the second memory shape wire 1012 exerts a greater force to maintain its memorized shape in the austenite phase than the first shape memory wire 1010. Thus, the first shape memory wire 1010 is mechanically deformed by the force of the second memory shape wire 1012 and the annuloplasty ring 1000 expands.
  • In certain embodiments, the first memory shape wire 1010 is configured to contract by approximately 10% to 25% when transitioning to its austenite phase. In certain such embodiments, the first memory shape wire 1010 has an austenite start temperature As in a range between approximately 33 degrees Celsius and approximately 43 degrees Celsius, an austenite finish temperature Af in a range between approximately 45 degrees Celsius and approximately 55 degrees Celsius, a martensite start temperature Ms less than approximately 30 degrees Celsius, and a martensite finish temperature Mf greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af of the first memory shape wire 1010 is in a range between approximately 48.75 degrees Celsius and approximately 51.25 degrees Celsius.
  • In certain embodiments, the second memory shape wire 1012 is configured to expand by approximately 10% to 25% when transitioning to its austenite phase. In certain such embodiments, the second memory shape wire 1010 has an austenite start temperature As in a range between approximately 60 degrees Celsius and approximately 70 degrees Celsius, an austenite finish temperature Af in a range between approximately 65 degrees Celsius and approximately 75 degrees Celsius, a martensite start temperature Ms less than approximately 30 degrees Celsius, and a martensite finish temperature Mf greater than approximately 20 degrees Celsius. In other embodiments, the austenite finish temperature Af of the first memory shape wire 1010 is in a range between approximately 68.75 degrees Celsius and approximately 71.25 degrees Celsius.
  • FIG. 11A is a perspective view illustrating portions of an annuloplasty ring 1100 according to certain embodiments comprising the first shape memory wire 1010 for contraction, the second shape memory wire 1012 for expansion, the flexible material 912 and the suturable material 914 shown in FIGS. 10A-10B. For illustrative purposes, portions of the flexible material 912 and the suturable material 914 are not shown in FIG. 11A to show the shape memory wires 1010, 1012. However, in certain embodiments, the flexible material 912 and the suturable material 914 substantially cover the first and second shape memory wires 1010, 1012. FIG. 11B is an enlarged perspective view of a portion of the annuloplasty ring 1100 shown in FIG. 1A. For illustrative purposes, portions of the flexible material 912 are not shown to expose the first and second shape memory wires 1010, 1012 and portions of the suturable material 914 are shown peeled back to expose the flexible material 912.
  • The first shape memory wire 1010 comprises a first coating 1120 and the second shape memory wire 1012 comprises a second coating 1122. In certain embodiments, the first coating 1120 and the second coating 1122 each comprise silicone tubing configured to provide suture attachment to a heart valve annulus. In certain other embodiments, the first coating 1120 and the second coating 1122 each comprise an energy absorption material, such as the energy absorption materials discussed above. In certain such embodiments, the first coating 1120 heats when exposed to a first form of energy and the second coating 1122 heats when exposed to a second form of energy. For example, the first coating 1120 may heat when exposed to MRI energy and the second coating 1122 may heat when exposed to HIFU energy. As another example, the first coating 1120 may heat when exposed to RF energy at a first frequency and the second coating 1122 may heat when exposed to RF energy at a second frequency. Thus, the first shape memory wire 1010 and the second shape memory wire 1012 can be activated independently such that one transitions to its austenite phase while the other remains in its martensite phase, resulting in contraction or expansion of the annuloplasty ring 1100.
  • FIG. 12 is a perspective view of a shape memory wire 800, such as the wire 800 shown in FIG. 8, wrapped in an electrically conductive coil 1210 according to certain embodiments of the invention. The coil 1210 is wrapped around a portion of the wire 800 where it is desired to focus energy and heat the wire 800. In certain embodiments, the coil 1210 is wrapped around approximately 5% to approximately 15% of the wire 800. In other embodiments, the coil 1210 is wrapped around approximately 15% to approximately 70% of the wire 800. In other embodiments, the coil 1210 is wrapped around substantially the entire wire 800. Although not shown, in certain embodiments, the wire 800 also comprises a coating comprising an energy absorption material, such as the energy absorption materials discussed above. The coating may or may not be covered by the coil 1210.
  • As discussed above, an electrical current can be non-invasively induced in the coil 1210 using electromagnetic energy. For example, in certain embodiments, a handheld or portable device (not shown) comprising an electrically conductive coil generates an electromagnetic field that non-invasively penetrates the patient's body and induces a current in the coil 1210. The electrical current causes the coil 1210 to heat. The coil 1210, the wire 800 and the coating (if any) are thermally conductive so as to transfer the heat or thermal energy from the coil 1210 to the wire 800. Thus, thermal energy can be directed to the wire 800, or portions thereof, while reducing thermal damage to surrounding tissue.
  • FIGS. 13A and 13B show an embodiment of an annuloplasty ring 1310 having a nominal inner diameter or transverse dimension indicated by arrow 1312 and a nominal outer diameter or transverse dimension indicated by arrows 1314. The ring 1310 includes a tubular member 1316 having a substantially round transverse cross section with an internal shape memory member 1318 disposed within an inner chamber 1319 of the tubular member 1316. The internal shape memory member 1318 is a ribbon or wire bent into a series of interconnected segments 1320. Upon heating of the tubular member 1316 and the internal shape memory member 1318, the inner transverse dimension 1312 becomes smaller due to axial shortening of the tubular member 1316 and an inward radial force applied to an inner chamber surface 1322 of the tubular member 1316 by the internal shape memory member 1318. The internal shape memory member 1318 is expanded upon heating such that the ends of segments 1320 push against the inner chamber surface 1322 and outer chamber surface 1324, as shown by arrow 1326 in FIG. 13B, and facilitate radial contraction of the inner transverse dimension 1312. Thus, activation of the internal shape memory member 1318 changes the relative distance between the against the inner chamber surface 1322 and outer chamber surface 1324.
  • Although not shown in FIGS. 13A or 13B, The inner shape memory member 1318 may also have a heating energy absorption enhancement material, such as one or more of the energy absorption enhancement materials discussed above, disposed about it within the inner chamber 1319. The energy absorption material may also be coated on an outer surface and/or an inner surface of the tubular member 1316. The inner transverse dimension 1312 of the ring 1310 in FIG. 13B is less than the inner transverse dimension 1312 of the ring 1310 shown in FIG. 13A. However, according to certain embodiments, the outer transverse dimension 1314 is substantially constant in both FIGS. 13A and 13B.
  • For some indications, it may be desirable for an adjustable annuloplasty ring to have some compliance in order to allow for expansion and contraction of the ring in concert with the expansion and contraction of the heart during the beating cycle or with the hydrodynamics of the pulsatile flow through the valve during the cycle. As such, it may be desirable for an entire annuloplasty ring, or a section or sections thereof, to have some axial flexibility to allow for some limited and controlled expansion and contraction under clinical conditions. FIGS. 14 and 15 illustrate embodiments of adjustable annuloplasty rings that allow some expansion and contraction in a deployed state.
  • FIG. 14 shows an annuloplasty ring 1400 that is constructed in such a way that it allows mechanical expansion and compression of the ring 1400 under clinical conditions. The ring 1400 includes a coil 1412 made of a shape memory material, such as one or more of the shape memory materials discussed above. The shape memory material or other portion of the ring 1400 may be coated with an energy absorption material, such as the energy absorption materials discussed above. The coil 1412 may have a typical helical structure of a normal spring wire coil, or alternatively, may have another structure such as a ribbon coil. In certain embodiments, the coil 1412 is surrounded by a suturable material 128, such as Dacron® or the other suturable materials discussed herein. The coiled structure or configuration of the coil 1412 allows the ring 1400 to expand and contract slightly when under physiological pressures and forces from heart dynamics or hydrodynamics of blood flow through a host heart valve.
  • For embodiments where the coil 1412 is made of NiTi alloy or other shape memory material, the ring 1400 is responsive to temperature changes which may be induced by the application of heating energy on the coil 1412. In certain embodiments, if the temperature is raised, the coil 1412 will contract axially or circumferentially such that an inner transverse dimension of the ring 1400 decreases, as shown by the dashed lines in FIG. 14. In FIG. 14, reference 1412′ represents the coil 1412 in its contracted state and reference 128′ represents the suturable material 128 in its contracted state around the contracted coil 1412′. In addition, or in other embodiments, the coil 1412 expands axially or circumferentially such that the inner transverse dimension of the ring 1400 increases. Thus, in certain embodiments, the ring 1400 can be expanded and contracted by applying invasive or non-invasive energy thereto.
  • FIG. 15 illustrates another embodiment of an adjustable annuloplasty ring 1500 that has dynamic compliance with dimensions, features and materials that may be the same as or similar to those of ring 1400. However, the ring 1500 has a zig-zag ribbon member 1510 in place of the coil 1412 in the embodiment of FIG. 14. In certain embodiments, if the temperature is raised, the ribbon member 1510 will contract axially or circumferentially such that an inner transverse dimension of the ring 1500 decreases, as shown by the dashed lines in FIG. 15. In FIG. 15, reference 1510′ represents the ribbon member 1510 in its contracted state and reference 128′ represents the suturable material 128 in its contracted state around the contracted ribbon member 1510′. In addition, or in other embodiments, the ribbon member 1510 expands axially or circumferentially such that the inner transverse dimension of the ring 1500 increases. Thus, in certain embodiments, the ring 1500 can be expanded and contracted by applying invasive or non-invasive energy thereto.
  • The embodiments of FIGS. 14 and 15 may have a substantially circular configuration as shown in the figures, or may have D-shaped or C-shaped configurations as shown with regard to other embodiments discussed above. In certain embodiments, the features, dimensions and materials of rings 1400 and 1500 are the same as or similar to the features, dimensions and materials of the annuloplasty ring 400 discussed above.
  • FIGS. 16A and 16B illustrate an annuloplasty ring 1600 according to certain embodiments that has a substantially circular shape or configuration when in the non-activated state shown in FIG. 16A. The ring 1600 comprises shape memory material or materials which are separated into a first temperature response zone 1602, a second temperature response zone 1604, a third temperature response zone 1606 and a fourth temperature response zone 1608. The zones are axially separated by boundaries 1610. Although the ring 1600 is shown with four zones 1602, 1604, 1606, 1608, an artisan will recognize from the disclosure herein that other embodiments may include two or more zones of the same or differing lengths. For example, one embodiment of an annuloplasty ring 1600 includes approximately three to approximately eight temperature response zones.
  • In certain embodiments, the shape memory materials of the various temperature response zones 1602, 1604, 1606, 1608 are selected to have temperature responses and reaction characteristics such that a desired shape and configuration can be achieved in vivo by the application of invasive or non-invasive energy, as discussed above. In addition to general contraction and expansion changes, more subtle changes in shape and configuration for improvement or optimization of valve function or hemodynamics may be achieved with such embodiments.
  • According to certain embodiments, the first zone 1602 and second zone 1604 of the ring 1600 are made from a shape memory material having a first shape memory temperature response. The third zone 1606 and fourth zone 1608 are made from a shape memory material having a second shape memory temperature response. In certain embodiments, the four zones comprise the same shape memory material, such as NiTi alloy or other shape memory material as discussed above, processed to produce the varied temperature response in the respective zones. In other embodiments, two or more of the zones may comprise different shape memory materials. Certain embodiments include a combination of shape memory alloys and shape memory polymers in order to achieve the desired results.
  • According to certain embodiments, FIG. 16B shows the ring 1600 after heat activation such that it comprises expanded zones 1606′, 1608′ corresponding to the zones 1606, 1608 shown in FIG. 16A. As schematically shown in FIG. 16A, activation has expanded the zones 1606′, 1608′ so as to increase the axial lengths of the segments of the ring 1600 corresponding to those zones. In addition, or in other embodiments, the zones 1606 and 1608 are configured to contract by a similar percentage instead of expand. In other embodiments, the zones 1602, 1604, 1606, 1608 are configured to each have a different shape memory temperature response such that each segment corresponding to each zone 1602, 1604, 1606, 1608 could be activated sequentially.
  • FIG. 16B schematically illustrates that the zones 1606′, 1608′ have expanded axially (i.e., from their initial configuration as shown by the zones 1606, 1608 in FIG. 16A). In certain embodiments, the zones 1602, 1604 are configured to be thermally activated to remember a shape memory dimension or size upon reaching a temperature in a range between approximately 51 degrees Celsius and approximately 60 degrees Celsius. In certain such embodiments, the zones 1606 and 1608 are configured to respond at temperatures in a range between approximately 41 degrees Celsius and approximately 48 degrees Celsius. Thus, for example, by applying invasive or non-invasive energy, as discussed above, to the ring 1600 until the ring 1600 reaches a temperature of approximately 41 degrees Celsius to approximately 48 degrees Celsius, the zones 1606, 1608 will respond by expanding or contracting by virtue of the shape memory mechanism, and the zones 1602, 1604 will not.
  • In certain other embodiments, the zones 1602, 1604 are configured to expand or contract by virtue of the shape memory mechanism at a temperature in a range between approximately 50 degrees Celsius and approximately 60 degrees Celsius. In certain such embodiments, the zones 1606, 1608 are configured to respond at a temperature in a range between approximately 39 degrees Celsius and approximately 45 degrees Celsius.
  • In certain embodiments, the materials, dimensions and features of the annuloplasty ring 1600 and the corresponding zones 1602, 1604, 1606, 1608 have the same or similar features, dimensions or materials as those of the other ring embodiments discussed above. In certain embodiments, the features of the annuloplasty ring 1600 are added to the embodiments discussed above.
  • FIGS. 17A and 17B illustrate an annuloplasty ring 1700 according to certain embodiments that is similar to the annuloplasty ring 1600 discussed above, but having a “D-shaped” configuration. The ring 1700 comprises shape memory material or materials which are separated into a first temperature response zone 1714, a second temperature response zone 1716, a third temperature response zone 1718 and a fourth temperature response zone 1720. The segments defined by the zones 1714, 1716, 1718, 1720 are separated by boundaries 1722. Other than the D-shaped configuration, the ring 1700 according to certain embodiments has the same or similar features, dimensions and materials as the features, dimension and materials of the ring 1600 discussed above.
  • According to certain embodiments, FIG. 17B shows the ring 1700 after heat activation such that it comprises expanded zones 1718′, 1720′ corresponding to the zones 1718, 1720 shown in FIG. 17A. As schematically shown in FIG. 17B, activation has expanded the zones 1718′, 1720′ by virtue of the shape memory mechanism. The zones 1718, 1720 could also be selectively shrunk or contracted axially by virtue of the same shape memory mechanism for an embodiment having a remembered shape smaller than the nominal shape shown in FIG. 17A. The transverse cross sections of the rings 1600 and 1700 are substantially round, but can also have any other suitable transverse cross sectional configuration, such as oval, square, rectangular or the like.
  • In certain situations, it is advantageous to reshape a heart valve annulus in one dimension while leaving another dimension substantially unchanged or reshaped in a different direction. For example, FIG. 18 is a sectional view of a mitral valve 1810 having an anterior (aortic) leaflet 1812, a posterior leaflet 1814 and an annulus 1816. The anterior leaflet 1812 and the posterior leaflet 1814 meet at a first commissure 1818 and a second commissure 1820. When healthy, the annulus 1816 encircles the leaflets 1812, 1814 and maintains their spacing to provide closure of a gap 1822 during left ventricular contraction. When the heart is not healthy, the leaflets 1812, 1814 do not achieve sufficient coaptation to close the gap 1822, resulting in regurgitation. In certain embodiments, the annulus 1816 is reinforced so as to push the anterior leaflet 1812 and the posterior leaflet 1814 closer together without substantially pushing the first commissure 1818 and the second commissure 1820 toward one another.
  • FIG. 18 schematically illustrates an exemplary annuloplasty ring 1826 comprising shape memory material configured to reinforce the annulus 1816 according to certain embodiments of the invention. For illustrative purposes, the annuloplasty ring 1826 is shown in an activated state wherein it has transformed to a memorized configuration upon application of invasive or non-invasive energy, as described herein. While the annuloplasty ring 1826 is substantially C-shaped, an artisan will recognize from the disclosure herein that other shapes are possible including, for example, a continuous circular, oval or D-shaped ring.
  • In certain embodiments, the annuloplasty ring 1826 comprises a first marker 1830 and a second marker 1832 that are aligned with the first commissure 1818 and the second commissure 1820, respectively, when the annuloplasty ring 1826 is implanted around the mitral valve 1810. In certain embodiments, the first marker 1830 and the second marker 1832 comprise materials that can be imaged in-vivo using standard imaging techniques. For example, in certain embodiments, the markers 1830 comprise radiopaque markers or other imaging materials, as is known in the art. Thus, the markers 1830, 1832 can be used for subsequent procedures for alignment with the annuloplasty ring 1826 and/or the commissures 1818, 1820. For example, the markers 1830, 1832 can be used to align a percutaneous energy source, such as a heated balloon inserted through a catheter, with the annuloplasty ring 1826.
  • When the shape memory material is activated, the annuloplasty ring 1826 contracts in the direction of the arrow 1824 to push the anterior leaflet 1812 toward the posterior leaflet 1814. Such anterior/posterior contraction improves the coaptation of the leaflets 1812, 1814 such that the gap 1824 between the leaflets 1812, 1814 sufficiently closes during left ventricular contraction. In certain embodiments, the annuloplasty ring 1826 also expands in the direction of arrows 1834. Thus, the first commissure 1818 and the second commissure 1820 are pulled away from each other, which draws the leaflets 1812, 1814 closer together and further improves their coaptation. However, in certain other embodiments, the annuloplasty ring does not expand in the direction of the arrows 1834. In certain such embodiments, the distance between the lateral portions of the annuloplasty ring 1826 between the anterior portion and the posterior portion (e.g., the lateral portions approximately correspond to the locations of the markers 1830, 1832 in the embodiment shown in FIG. 18) remains substantially the same after the shape memory material is activated.
  • FIG. 19 is a schematic diagram of a substantially C-shaped wire comprising a shape memory material configured to contract in a first direction and expand in a second direction according to certain embodiments of the invention. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. FIG. 19 schematically illustrates the wire 800 in its activated configuration or memorized shape. For illustrative purposes, the wire 800 is shown relative to dashed lines representing its deformed shape or configuration when implanted into a body before activation.
  • When the shape memory material is activated, the wire 800 is configured to respond by contracting in a first direction as indicated by arrow 1824. In certain embodiments, the wire 800 also expands in a second direction as indicated by arrows 1834. Thus, the wire 800 is usable by the annuloplasty ring 1826 shown in FIG. 18 to improve the coaptation of the leaflets 1812, 1814 by contracting the annulus 1816 in the anterior/posterior direction. In certain embodiments, the anterior/posterior contraction is in a range between approximately 10% and approximately 20%. In certain embodiments, only a first portion 1910 and a second portion 1912 of the wire 800 comprise the shape memory material. When the shape memory material is activated, the first portion 1910 and the second portion 1912 of the wire 800 are configured to respond by transforming to their memorized configurations and reshaping the wire 800 as shown.
  • FIGS. 20A and 20B are schematic diagrams of a body member 2000 according to certain embodiments usable by an annuloplasty ring, such as the annuloplasty ring 1826 shown in FIG. 18. Although not shown, in certain embodiments, the body member 2000 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • The body member 2000 comprises a wire 2010 and a shape memory tube 2012. As used herein, the terms “tube,” “tubular member” and “tubular structure” are broad terms having at least their ordinary and customary meaning and include, for example, hollow elongated structures that may in cross-section be cylindrical, elliptical, polygonal, or any other shape. Further, the hollow portion of the elongated structure may be filled with one or more materials that may be the same as and/or different than the material of the elongated structure. In certain embodiments, the wire 2010 comprises a metal or metal alloy such as stainless steel, titanium, platinum, combinations of the foregoing, or the like. In certain embodiments, the shape memory tube 2012 comprises shape memory materials formed in a tubular structure through which the wire 2010 is inserted. In certain other embodiments, the shape memory tube 2012 comprises a shape memory material coated over the wire 2010. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. Although not shown, in certain embodiments, the body member 2000 comprises an energy absorption enhancement material, as discussed above.
  • FIG. 20A schematically illustrates the body member 2000 in a first configuration or shape and FIG. 20B schematically illustrates the body member 2000 in a second configuration or shape after the shape memory tube has been activated. For illustrative purposes, dashed lines in FIG. 20B also show the first configuration of the body member 2000. When the shape memory material is activated, the shape memory tube 2012 is configured to respond by contracting in a first direction as indicated by arrow 1824. In certain embodiments, the shape memory tube 2012 is also configured to expand in a second direction as indicated by arrows 1834. The transformation of the shape memory tube 2012 exerts a force on the wire 2010 so as to change its shape. Thus, the body member 2000 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818, 1820 further apart and push the leaflets 1812, 1814 closer together to improve coaptation.
  • FIGS. 21A and 21B are schematic diagrams of a body member 2100 according to certain embodiments usable by an annuloplasty ring, such as the annuloplasty ring 1826 shown in FIG. 18. Although not shown, in certain embodiments, the body member 2100 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • The body member 2100 comprises a wire 2010, such as the wire 2010 shown in FIGS. 20A and 20B and a shape memory tube 2112. As schematically illustrated in FIGS. 21A and 21B, the shape memory tube 2112 is sized and configured to cover a certain percentage of the wire 2010. However, an artisan will recognize from the disclosure herein that in other embodiments the shape memory tube 2112 may cover other percentages of the wire 2010. Indeed, FIGS. 22A and 22B schematically illustrate another embodiment of a body member 2200 comprising a shape memory tube 2112 covering a substantial portion of a wire 2010. The amount of coverage depends on such factors as the particular application, the desired shape change, the shape memory materials used, the amount of force to be exerted by the shape memory tube 2112 when changing shape, combinations of the foregoing, and the like. For example, in certain embodiments where, as in FIGS. 22A and 22B, the shape memory tube 2112 covers a substantial portion of a wire 2010, portions of the shape memory tube 2112 are selectively heated to reshape the wire 2010 at a particular location. In certain such embodiments, HIFU energy is directed towards, for example, the left side of the shape memory tube 2112, the right side of the shape memory tube 2112, the bottom side of the shape memory tube 2112, or a combination of the foregoing to activate only a portion of the shape memory tube 2112. Thus, the body member 2200 can be reshaped one or more portions at a time to allow selective adjustments.
  • In certain embodiments, the shape memory tube 2112 comprises a first shape memory material 2114 and a second shape memory material 2116 formed in a tubular structure through which the wire 2010 is inserted. In certain such embodiments, the first shape memory material 2114 and the second shape memory material 2116 are each configured as a semi-circular portion of the tubular structure. For example, FIG. 23 is a transverse cross-sectional view of the body member 2100. As schematically illustrated in FIG. 23, the first shape memory material 2114 and the second shape memory material 2116 are joined at a first boundary 2310 and a second boundary 2312. In certain embodiments, silicone tubing (not shown) holds the first shape memory material 2114 and the second shape memory material 2116 together. In certain other embodiments, the first shape memory material 2114 and the second shape memory material 2116 each comprise a shape memory coating covering opposite sides of the wire 2010. Suitable shape memory materials include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. Although not shown, in certain embodiments the body member 2100 comprises an energy absorption enhancement material, as discussed above.
  • FIG. 21A schematically illustrates the body member 2100 in a first configuration or shape before the first shape memory material 2114 and the second shape memory material 2116 are activated. In certain embodiments, the first shape memory material 2114 and the second shape memory material 2116 are configured to be activated or return to their respective memorized shapes at different temperatures. Thus, the first shape memory material 2114 and the second shape memory material 2116 can be activated at different times to selectively expand and/or contract the body member 2100. For example, in certain embodiments, the second shape memory material 2116 is configured to be activated at a lower temperature than the first shape memory material 2114.
  • FIG. 21B schematically illustrates the body member 2100 in a second configuration or shape after the second shape memory material 2116 has been activated. For illustrative purposes, dashed lines in FIG. 21B also show the first configuration of the body member 2100. When the second shape memory material 2116 is activated, it responds by bending the body member 2100 in a first direction as indicated by arrow 1824. In certain embodiments, activation also expands the body member 2100 in a second direction as indicated by arrows 1834. Thus, the body member 2100 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818, 1820 further apart and push the leaflets 1812, 1814 closer together to improve coaptation.
  • In certain embodiments, the first shape memory material 2114 can then be activated to bend the body member 2100 opposite to the first direction as indicated by arrow 2118. In certain such embodiments, the body member 2100 is reshaped to the first configuration as shown in FIG. 21A (or the dashed lines in FIG. 21B). Thus, for example, if the size of the patient's heart begins to grow again (e.g., due to age or illness), the body member 2100 can be enlarged to accommodate the growth. In certain other embodiments, activation of the first shape memory material 2114 further contracts the body member 2100 in the direction of the arrow 1824. In certain embodiments, the first shape memory material 2114 has an austenite start temperature As in a range between approximately 42 degrees Celsius and approximately 50 degrees Celsius and the second shape memory material 2116 has an austenite start temperature As in a range between approximately 38 degrees Celsius and 41 degrees Celsius.
  • FIG. 24 is a perspective view of a body member 2400 usable by an annuloplasty ring according to certain embodiments comprising a first shape memory band 2410 and a second shape memory band 2412. Suitable shape memory materials for the bands 2410, 2412 include shape memory polymers or shape memory alloys including, for example, ferromagnetic shape memory alloys, as discussed above. Although not shown, in certain embodiments the body member 2100 comprises an energy absorption enhancement material, as discussed above. Although not shown, in certain embodiments, the body member 2100 is covered by a flexible material such as silicone rubber and a suturable material such as woven polyester cloth, Dacron®, woven velour, polyurethane, polytetrafluoroethylene (PTFE), heparin-coated fabric, or other biocompatible material, as discussed above.
  • The first shape memory band 2410 is configured to loop back on itself to form a substantially C-shaped configuration. However, an artisan will recognize from the disclosure herein that the first shape memory band 2410 can be configured to loop back on itself in other configurations including, for example, circular, D-shaped, or other curvilinear configurations. When activated, the first shape memory band 2410 expands or contracts such that overlapping portions of the band 2410 slide with respect to one another, changing the overall shape of the body member 2400. The second shape memory band 2412 is disposed along a surface of the first shape memory band 2410 such that the second shape memory band 2412 is physically deformed when the first shape memory band 2410 is activated, and the first shape memory band 2410 is physically deformed when the second shape memory band 2412 is activated.
  • As shown in FIG. 24, in certain embodiments at least a portion of the second shape memory band 2412 is disposed between overlapping portions of the first shape memory band 2410. An artisan will recognize from the disclosure herein, however, that the second shape memory band 2412 may be disposed adjacent to an outer surface or an inner surface of the first shape memory band 2410 rather than between overlapping portions of the first shape memory band 2410. When the second shape memory band 2412 is activated, it expands or contracts so as to slide with respect to the first shape memory band 2410. In certain embodiments, the first shape memory band 2410 and the second shape memory band 2412 are held in relative position to one another by the flexible material and/or suturable material discussed above.
  • While the first shape memory band 2410 and the second shape memory band 2412 shown in FIG. 24 are substantially flat, an artisan will recognize from the disclosure herein that other shapes are possible including, for example, rod-shaped wire. However, in certain embodiments the first shape memory band 2410 and the second shape memory band 2412 advantageously comprise substantially flat surfaces configured to guide one another during expansion and/or contraction. Thus, the surface area of overlapping portions of the first shape memory band 2410 and/or the second shape memory band 2412 guide the movement of the body member 2400 in a single plane and reduce misalignment (e.g., twisting or moving in a vertical plane) during shape changes. The surface area of overlapping portions also advantageously increases support to a heart valve by reducing misalignment during beating of the heart.
  • An artisan will recognize from the disclosure herein that certain embodiments of the body member 2400 may not comprise either the first shape memory band 2410 or the second shape memory band 2412. For example, in certain embodiments the body member 2400 does not include the second shape memory band 2412 and is configured to expand and/or contract by only activating the first shape memory band 2410. Further, an artisan will recognize from the disclosure herein that either the first band 2410 or the second band 2412 may not comprise a shape memory material. For example, the first band 2410 may titanium, platinum, stainless steel, combinations of the foregoing, or the like and may be used with or without the second band 2412 to support a coronary valve annulus.
  • As schematically illustrated in FIGS. 25A-25C, in certain embodiments the body member 2400 is configured to change shape at least twice by activating both the first shape memory band 2410 and the second shape memory band 2412. FIG. 25A schematically illustrates the body member 2400 in a first configuration or shape before the first shape memory band 2410 or the second shape memory band 2412 are activated. In certain embodiments, the first shape memory band 2410 and the second shape memory band 2412 are configured to be activated or return to their respective memorized shapes at different temperatures. Thus, the first shape memory band 2410 and the second shape memory band 2412 can be activated at different times to selectively expand and/or contract the body member 2400. For example (and for purposes of discussing FIGS. 25A-25C), in certain embodiments, the first shape memory band 2410 is configured to be activated at a lower temperature than the second shape memory band 2412. However, an artisan will recognize from the disclosure herein that in other embodiments the second shape memory band 2412 may be configured to be activated at a lower temperature than the first shape memory band 2410.
  • FIG. 25B schematically illustrates the body member 2400 in a second configuration or shape after the first shape memory band 2410 has been activated. When the first shape memory band 2410 is activated, it responds by bending the body member 2400 in a first direction as indicated by arrow 1824. In certain embodiments, the activation also expands the body member 2400 in a second direction as indicated by arrows 1834. Thus, the body member 2400 is usable by the annuloplasty ring 1826 shown in FIG. 18 to pull the commissures 1818, 1820 further apart and push the leaflets 1812, 1814 closer together to improve coaptation.
  • In certain embodiments, the second shape memory band 2412 can then be activated to further contract the body member 2400 in the direction of the arrow 1824 and, in certain embodiments, further expand the body member 2400 in the direction of arrows 1834. In certain such embodiments, activating the second shape memory band 2412 reshapes the body member 2400 to a third configuration as shown in FIG. 25C. Thus, for example, as the patient's heart progressively heals and reduces in size, the body member 2400 can be re-sized to provide continued support and improved leaflet coaptation. In certain other embodiments, activation of the second shape memory band 2412 bends the body member 2400 opposite to the first direction as indicated by arrow 2118. In certain such embodiments, activating the second shape memory band 2412 reshapes the body member 2400 to the first configuration as shown in FIG. 25A. Thus, for example, if the size of the patient's heart begins to grow again (e.g., due to age or illness), the body member 2400 can be re-sized to accommodate the growth.
  • In certain annuloplasty ring embodiments, flexible materials and/or suturable materials used to cover shape memory materials also thermally insulate the shape memory materials so as to increase the time required to activate the shape memory materials through application of thermal energy. Thus, surrounding tissue is exposed to the thermal energy for longer periods of time, which may result in damage to the surrounding tissue. Therefore, in certain embodiments of the invention, thermally conductive materials are configured to penetrate the flexible materials and/or suturable materials so as to deliver thermal energy to the shape memory materials such that the time required to activate the shape memory materials is decreased.
  • For example, FIG. 26 is a perspective view illustrating an annuloplasty ring 2600 comprising one or more thermal conductors 2610, 2612, 2614 according to certain embodiments of the invention. The annuloplasty ring 2600 further comprises a shape memory wire 800 covered by a flexible material 912 and a suturable material 914, such as the wire 800, the flexible material 912 and the suturable material 914 shown in FIG. 9A. As shown in FIG. 26, in certain embodiments, the shape memory wire 800 is offset from the center of the flexible material 912 to allow more room for sutures to pass through the flexible material 912 and suturable material 914 to attach the annuloplasty ring 2600 to a cardiac valve. In certain embodiments, the flexible material 912 and/or the suturable material 914 are thermally insulative. In certain such embodiments, the flexible material 912 comprises a thermally insulative material. Although the annuloplasty ring 2600 is shown in FIG. 26 as substantially C-shaped, an artisan will recognize from the disclosure herein that the one or more thermal conductors 2610, 2612, 2614 can also be used with other configurations including, for example, circular, D-shaped, or other curvilinear configurations.
  • In certain embodiments, the thermal conductors 2610, 2612, 2614 comprise a thin (e.g., having a thickness in a range between approximately 0.002 inches and approximately 0.015 inches) wire wrapped around the outside of the suturable material 914 and penetrating the suturable material 914 and the flexible material 912 at one or more locations 2618 so as to transfer externally applied heat energy to the shape memory wire 800. For example, FIGS. 27A-27C are transverse cross-sectional views of the annuloplasty ring 2600 schematically illustrating exemplary embodiments for conducting thermal energy to the shape memory wire 800. In the exemplary embodiment shown in FIG. 27A, the thermal conductor 2614 wraps around the suturable material 914 one or more times, penetrates the suturable material 914 and the flexible material 912, passes around the shape memory wire 800, and exits the flexible material 912 and the suturable material 914. In certain embodiments, the thermal conductor 2614 physically contacts the shape memory wire 800. However, in other embodiments, the thermal conductor 2614 does not physically contact the shape memory wire 800 but passes sufficiently close to the shape memory wire 800 so as to decrease the time required to activate the shape memory wire 800. Thus, the potential for thermal damage to surrounding tissue is reduced.
  • In the exemplary embodiment shown in FIG. 27B, the thermal conductor 2614 wraps around the suturable material 914 one or more times, penetrates the suturable material 914 and the flexible material 912, passes around the shape memory wire 800 two or more times, and exits the flexible material 912 and the suturable material 914. By passing around the shape memory wire 800 two or more times, the thermal conductor 2614 concentrates more energy in the area of the shape memory wire 800 as compared to the exemplary embodiment shown in FIG. 27A. Again, the thermal conductor 2614 may or may not physically contact. the shape memory wire 800.
  • In the exemplary embodiment shown in FIG. 27C, the thermal conductor 2614 wraps around the suturable material 914 one or more times and passes through the suturable material 914 and the flexible material 912 two or more times. Thus, portions of the thermal conductor 2614 are disposed proximate the shape memory wire 800 so as to transfer heat energy thereto. Again, the thermal conductor 2614 may or may not physically contact the shape memory wire 800. An artisan will recognize from the disclosure herein that one or more of the exemplary embodiments shown in FIGS. 27A-27C can be combined and that the thermal conductor 2614 can be configured to penetrate the suturable material 914 and the flexible material 912 in other ways in accordance with the invention so as to transfer heat to the shape memory wire 800.
  • Referring again to FIG. 26, in certain embodiments the locations of the thermal conductors 2610, 2612, 2614 are selected based at least in part on areas where energy will be applied to activate the shape memory wire 800. For example, in certain embodiments heat energy is applied percutaneously through a balloon catheter and the thermal conductors 2610, 2612, 2614 are disposed on the surface of the suturable material 914 in locations likely to make contact with the inflated balloon.
  • In addition, or in other embodiments, the thermal conductors 2610, 2612, 2614 are located so as to mark desired positions on the annuloplasty ring 2600. For example, the thermal conductors 2610, 2612, 2614 may be disposed at locations on the annuloplasty ring 2600 corresponding to commissures of heart valve leaflets, as discussed above with respect to FIG. 18. As another example, the thermal conductors 2610, 2612, 2614 can be used to align a percutaneous energy source, such as a heated balloon inserted through a catheter, with the annuloplasty ring 2600. In certain such embodiments the thermal conductors 2610, 2612, 2614 comprise radiopaque materials such as gold, copper or other imaging materials, as is known in the art.
  • FIG. 28 is a schematic diagram of an annuloplasty ring 2800 according to certain embodiments of the invention comprising one or more thermal conductors 2810, 2812, 2814, 2816, 2818, such as the thermal conductors 2610, 2612, 2614 shown in FIG. 26. As schematically illustrated in FIG. 28, the annuloplasty ring 2800 further comprises a shape memory wire 800 covered by a flexible material 912 and a suturable material 914, such as the wire 800, the flexible material 912 and the suturable material 914 shown in FIG. 9A.
  • In certain embodiments, the shape memory wire 800 is not sufficiently thermally conductive so as to quickly transfer heat applied in the areas of the thermal conductors 2810, 2812, 2814, 2816, 2818. Thus, in certain such embodiments, the annuloplasty ring 2800 comprises a thermal conductor 2820 that runs along the length of the shape memory wire 800 so as to transfer heat to points of the shape memory wire 800 extending beyond or between the thermal conductors 2810, 2812, 2814, 2816, 2818. In certain embodiments, each of the thermal conductors 2810, 2812, 2814, 2816, 2818, comprise a separate thermally conductive wire configured to transfer heat to the thermal conductive wire 2820. However, in certain other embodiments, at least two of the thermal conductors 2810, 2812, 2814, 2816, 2818 and the thermal conductor 2820 comprise one continuous thermally conductive wire.
  • Thus, thermal energy can be quickly transferred to the annuloplasty ring 2600 or the annuloplasty ring 2800 to reduce the amount of energy required to activate the shape memory wire 800 and to reduce thermal damage to the patient's surrounding tissue.
  • While certain embodiments of the inventions have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of the inventions. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms; furthermore, various omissions, substitutions and changes in the form of the methods and systems described herein may be made without departing from the spirit of the inventions. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the inventions.

Claims (35)

1. An adjustable annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said second size is less than said first size; and
a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said second size is less than said third size.
2. The adjustable annuloplasty ring of claim 1, wherein said first shape memory member is configured to change shape in response to being heated to a first temperature, and wherein said second shape memory member is configured to change shape in response to being heated to a second temperature.
3. The adjustable annuloplasty ring of claim 2, wherein said first temperature is lower than said second temperature.
4. The adjustable annuloplasty ring of claim 2, wherein said second temperature is lower than said first temperature.
5. The adjustable annuloplasty ring of claim 2, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid.
6. The adjustable annuloplasty ring of claim 1, wherein at least one of said first shape memory member and said second shape memory member is configured to change shape in response to a magnetic field.
7. The adjustable annuloplasty ring of claim 6, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al.
8. The adjustable annuloplasty ring of claim 1, wherein said ring dimension is a septolateral dimension.
9. An adjustable annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said second size is less than said first size; and
a second shape memory member configured to transform said annuloplasty ring from said second size to a third size of the ring dimension, wherein said third size is less than said second size.
10. The adjustable annuloplasty ring of claim 9, wherein said first shape memory member is configured to change shape in response to being heated to a first temperature, and wherein said second shape memory member is configured to change shape in response to being heated to a second temperature.
11. The adjustable annuloplasty ring of claim 10, wherein said first temperature is lower than said second temperature.
12. The adjustable annuloplasty ring of claim 10, wherein said second temperature is lower than said first temperature.
13. The adjustable annuloplasty ring of claim 10, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid.
14. The adjustable annuloplasty ring of claim 9, wherein at least one of said first shape memory member and said second shape memory member is configured to change shape in response to a magnetic field.
15. The adjustable annuloplasty ring of claim 14, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al.
16. The adjustable annuloplasty ring of claim 9, wherein said ring dimension is a septolateral dimension.
17. An adjustable annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size; and
a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said third size is less than said second size.
18. The adjustable annuloplasty ring of claim 17, wherein said first shape memory member is configured to change shape in response to being heated to a first temperature, and wherein said second shape memory member is configured to change shape in response to being heated to a second temperature.
19. The adjustable annuloplasty ring of claim 18, wherein said first temperature is lower than said second temperature.
20. The adjustable annuloplasty ring of claim 18, wherein said second temperature is lower than said first temperature.
21. The adjustable annuloplasty ring of claim 18, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid.
22. The adjustable annuloplasty ring of claim 17, wherein at least one of said first shape memory member and said second shape memory member is configured to change shape in response to a magnetic field.
23. The adjustable annuloplasty ring of claim 22, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al.
24. The adjustable annuloplasty ring of claim 17, wherein said ring dimension is a septolateral dimension.
25. An adjustable annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said first size is less than said second size; and
a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said second size is less than said third size.
26. The adjustable annuloplasty ring of claim 25, wherein said first shape memory member is configured to change shape in response to being heated to a first temperature, and wherein said second shape memory member is configured to change shape in response to being heated to a second temperature.
27. The adjustable annuloplasty ring of claim 26, wherein said first temperature is lower than said second temperature.
28. The adjustable annuloplasty ring of claim 26, wherein said second temperature is lower than said first temperature.
29. The adjustable annuloplasty ring of claim 26, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of a metal, a metal alloy, a nickel titanium alloy, a shape memory polymer, polylactic acid, and polyglycolic acid.
30. The adjustable annuloplasty ring of claim 25, wherein at least one of said first shape memory member and said second shape memory member is configured to change shape in response to a magnetic field.
31. The adjustable annuloplasty ring of claim 30, wherein at least one of said first shape memory member and said second shape memory member comprises at least one of Fe—C, Fe—Pd, Fe—Mn—Si, Co—Mn, Fe—Co—Ni—Ti, Ni—Mn—Ga, Ni2MnGa, and Co—Ni—Al.
32. The adjustable annuloplasty ring of claim 25, wherein said ring dimension is a septolateral dimension.
33. A method for treating a cardiac valve, said method comprising:
providing an annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension, wherein said second size is less than said first size; and
a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension, wherein said second size is less than said third size; and
implanting said annuloplasty ring on or near a cardiac valve annulus.
34. An adjustable annuloplasty ring comprising:
a first shape memory member configured to transform said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension; and
a second shape memory member configured to transform said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension.
35. An annuloplasty ring comprising:
first means for transforming said annuloplasty ring from a first configuration having a first size of a ring dimension to a second configuration having a second size of the ring dimension; and
second means for transforming said annuloplasty ring from said second configuration to a third configuration having a third size of the ring dimension.
US11/123,891 2004-06-29 2005-05-06 Selectively adjustable cardiac valve implants Abandoned US20050288778A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/123,891 US20050288778A1 (en) 2004-06-29 2005-05-06 Selectively adjustable cardiac valve implants
JP2007519262A JP2008504878A (en) 2004-06-29 2005-06-16 Selectable adjustable heart valve implant (implant)
PCT/US2005/021324 WO2006012038A2 (en) 2004-06-29 2005-06-16 Selectively adjustable cardiac valve implants
EP05784934A EP1761213A4 (en) 2004-06-29 2005-06-16 Selectively adjustable cardiac valve implants
US13/079,429 US20110257740A1 (en) 2004-06-29 2011-04-04 Selectively adjustable cardiac valve implants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58443204P 2004-06-29 2004-06-29
US11/123,891 US20050288778A1 (en) 2004-06-29 2005-05-06 Selectively adjustable cardiac valve implants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/079,429 Continuation US20110257740A1 (en) 2004-06-29 2011-04-04 Selectively adjustable cardiac valve implants

Publications (1)

Publication Number Publication Date
US20050288778A1 true US20050288778A1 (en) 2005-12-29

Family

ID=35507053

Family Applications (11)

Application Number Title Priority Date Filing Date
US11/124,409 Expired - Fee Related US7396364B2 (en) 2004-06-29 2005-05-06 Cardiac valve implant with energy absorbing material
US11/123,851 Expired - Fee Related US7361190B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with coupling mechanism
US11/124,415 Abandoned US20050288783A1 (en) 2004-06-29 2005-05-06 Methods for treating cardiac valves using magnetic fields
US11/124,364 Expired - Fee Related US7713298B2 (en) 2004-06-29 2005-05-06 Methods for treating cardiac valves with adjustable implants
US11/123,852 Abandoned US20050288777A1 (en) 2004-06-29 2005-05-06 Thermal conductor for adjustable cardiac valve implant
US11/124,408 Expired - Fee Related US7510577B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with ferromagnetic material
US11/124,405 Expired - Fee Related US7377941B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with selective dimensional adjustment
US11/123,891 Abandoned US20050288778A1 (en) 2004-06-29 2005-05-06 Selectively adjustable cardiac valve implants
US12/032,476 Expired - Fee Related US7722668B2 (en) 2004-06-29 2008-02-15 Cardiac valve implant with energy absorbing material
US12/049,240 Abandoned US20080200981A1 (en) 2004-06-29 2008-03-14 Adjustable cardiac valve implant with coupling mechanism
US13/079,429 Abandoned US20110257740A1 (en) 2004-06-29 2011-04-04 Selectively adjustable cardiac valve implants

Family Applications Before (7)

Application Number Title Priority Date Filing Date
US11/124,409 Expired - Fee Related US7396364B2 (en) 2004-06-29 2005-05-06 Cardiac valve implant with energy absorbing material
US11/123,851 Expired - Fee Related US7361190B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with coupling mechanism
US11/124,415 Abandoned US20050288783A1 (en) 2004-06-29 2005-05-06 Methods for treating cardiac valves using magnetic fields
US11/124,364 Expired - Fee Related US7713298B2 (en) 2004-06-29 2005-05-06 Methods for treating cardiac valves with adjustable implants
US11/123,852 Abandoned US20050288777A1 (en) 2004-06-29 2005-05-06 Thermal conductor for adjustable cardiac valve implant
US11/124,408 Expired - Fee Related US7510577B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with ferromagnetic material
US11/124,405 Expired - Fee Related US7377941B2 (en) 2004-06-29 2005-05-06 Adjustable cardiac valve implant with selective dimensional adjustment

Family Applications After (3)

Application Number Title Priority Date Filing Date
US12/032,476 Expired - Fee Related US7722668B2 (en) 2004-06-29 2008-02-15 Cardiac valve implant with energy absorbing material
US12/049,240 Abandoned US20080200981A1 (en) 2004-06-29 2008-03-14 Adjustable cardiac valve implant with coupling mechanism
US13/079,429 Abandoned US20110257740A1 (en) 2004-06-29 2011-04-04 Selectively adjustable cardiac valve implants

Country Status (4)

Country Link
US (11) US7396364B2 (en)
EP (4) EP1761207A4 (en)
JP (4) JP2008504876A (en)
WO (4) WO2006012013A2 (en)

Cited By (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050288782A1 (en) * 2004-06-29 2005-12-29 Shahram Moaddeb Cardiac valve implant with energy absorbing material
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20070055368A1 (en) * 2005-09-07 2007-03-08 Richard Rhee Slotted annuloplasty ring
US20070100439A1 (en) * 2005-10-31 2007-05-03 Medtronic Vascular, Inc. Chordae tendinae restraining ring
US20080097593A1 (en) * 2001-11-13 2008-04-24 Bolling Steven F Mitral Annuloplasty Ring Having Upward Bows
WO2008068756A2 (en) 2006-12-05 2008-06-12 Valtech Cardio, Ltd. Segmented ring placement
US20090157176A1 (en) * 2007-02-09 2009-06-18 Alain Carpentier Annuloplasty rings for correcting degenerative valvular diseases
US20090287303A1 (en) * 2008-05-13 2009-11-19 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring
US7842085B2 (en) 2005-03-23 2010-11-30 Vaso Adzich Annuloplasty ring and holder combination
US20110022169A1 (en) * 2007-01-26 2011-01-27 Ryan Timothy R Annuloplasty Device for Tricuspid Valve Repair
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US20130116780A1 (en) * 2011-11-04 2013-05-09 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US8518107B2 (en) 2010-08-04 2013-08-27 Valcare, Inc. Percutaneous transcatheter repair of heart valves
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US20140013602A1 (en) * 2008-12-31 2014-01-16 Medtronic, Inc. Semi-Rigid Annuloplasty Ring and Band
US8685083B2 (en) 2005-06-27 2014-04-01 Edwards Lifesciences Corporation Apparatus, system, and method for treatment of posterior leaflet prolapse
US8932350B2 (en) 2010-11-30 2015-01-13 Edwards Lifesciences Corporation Reduced dehiscence annuloplasty ring
US8940044B2 (en) 2011-06-23 2015-01-27 Valtech Cardio, Ltd. Closure element for use with an annuloplasty structure
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9119719B2 (en) 2009-05-07 2015-09-01 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9180008B2 (en) 2012-02-29 2015-11-10 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9192472B2 (en) 2008-06-16 2015-11-24 Valtec Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US9402721B2 (en) 2011-06-01 2016-08-02 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US9414921B2 (en) 2009-10-29 2016-08-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US9474606B2 (en) 2009-05-04 2016-10-25 Valtech Cardio, Ltd. Over-wire implant contraction methods
US9526613B2 (en) 2005-03-17 2016-12-27 Valtech Cardio Ltd. Mitral valve treatment techniques
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US9622861B2 (en) 2009-12-02 2017-04-18 Valtech Cardio, Ltd. Tool for actuating an adjusting mechanism
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9713530B2 (en) 2008-12-22 2017-07-25 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US9724192B2 (en) 2011-11-08 2017-08-08 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US9839519B2 (en) 2012-02-29 2017-12-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
US9883943B2 (en) 2006-12-05 2018-02-06 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US9968454B2 (en) 2009-10-29 2018-05-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of artificial chordae
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10195030B2 (en) 2014-10-14 2019-02-05 Valtech Cardio, Ltd. Leaflet-restraining techniques
US10226342B2 (en) 2016-07-08 2019-03-12 Valtech Cardio, Ltd. Adjustable annuloplasty device with alternating peaks and troughs
US10231831B2 (en) 2009-12-08 2019-03-19 Cardiovalve Ltd. Folding ring implant for heart valve
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10350068B2 (en) 2009-02-17 2019-07-16 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US10376266B2 (en) 2012-10-23 2019-08-13 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
US10470882B2 (en) 2008-12-22 2019-11-12 Valtech Cardio, Ltd. Closure element for use with annuloplasty structure
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US10682232B2 (en) 2013-03-15 2020-06-16 Edwards Lifesciences Corporation Translation catheters, systems, and methods of use thereof
US10695046B2 (en) 2005-07-05 2020-06-30 Edwards Lifesciences Corporation Tissue anchor and anchoring system
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
US10765514B2 (en) 2015-04-30 2020-09-08 Valtech Cardio, Ltd. Annuloplasty technologies
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US10813751B2 (en) 2013-05-22 2020-10-27 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US10828160B2 (en) 2015-12-30 2020-11-10 Edwards Lifesciences Corporation System and method for reducing tricuspid regurgitation
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US10918374B2 (en) 2013-02-26 2021-02-16 Edwards Lifesciences Corporation Devices and methods for percutaneous tricuspid valve repair
US10918373B2 (en) 2013-08-31 2021-02-16 Edwards Lifesciences Corporation Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10925610B2 (en) 2015-03-05 2021-02-23 Edwards Lifesciences Corporation Devices for treating paravalvular leakage and methods use thereof
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US11058417B2 (en) 2013-06-28 2021-07-13 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11103349B2 (en) 2016-08-15 2021-08-31 Valcare, Inc. Devices and methods for the treatment of heart valve insufficiencies
US11123191B2 (en) 2018-07-12 2021-09-21 Valtech Cardio Ltd. Annuloplasty systems and locking tools therefor
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
US11395648B2 (en) 2012-09-29 2022-07-26 Edwards Lifesciences Corporation Plication lock delivery system and method of use thereof
US11534300B2 (en) 2018-12-03 2022-12-27 Valcare, Inc. Stabilizing and adjusting tool for controlling a minimally invasive mitral / tricuspid valve repair system
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
CN115671379A (en) * 2022-10-27 2023-02-03 牛瑞瑞 Medical implant and preparation method and application thereof
US11576779B2 (en) 2017-03-17 2023-02-14 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
US11654018B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US11660191B2 (en) 2008-03-10 2023-05-30 Edwards Lifesciences Corporation Method to reduce mitral regurgitation
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US11666442B2 (en) 2018-01-26 2023-06-06 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
US11779458B2 (en) 2016-08-10 2023-10-10 Cardiovalve Ltd. Prosthetic valve with leaflet connectors
US11779463B2 (en) 2018-01-24 2023-10-10 Edwards Lifesciences Innovation (Israel) Ltd. Contraction of an annuloplasty structure
US11793628B2 (en) 2019-07-15 2023-10-24 Valcare, Inc. Transcatheter bio-prosthesis member and support structure
US11801135B2 (en) 2015-02-05 2023-10-31 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US11819411B2 (en) 2019-10-29 2023-11-21 Edwards Lifesciences Innovation (Israel) Ltd. Annuloplasty and tissue anchor technologies
US11844691B2 (en) 2013-01-24 2023-12-19 Cardiovalve Ltd. Partially-covered prosthetic valves

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6736845B2 (en) * 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
MXPA05002284A (en) 2002-08-29 2006-02-10 Mitralsolutions Inc Implantable devices for controlling the internal circumference of an anatomic orifice or lumen.
US8758372B2 (en) 2002-08-29 2014-06-24 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
CA2526347C (en) * 2003-05-20 2010-07-06 The Cleveland Clinic Foundation Apparatus and methods for repair of a cardiac valve
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
US20080183285A1 (en) * 2004-06-29 2008-07-31 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US8012202B2 (en) 2004-07-27 2011-09-06 Alameddine Abdallah K Mitral valve ring for treatment of mitral valve regurgitation
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US7776061B2 (en) * 2004-09-28 2010-08-17 Garner Dean L Fluid adjustable band
KR100511618B1 (en) * 2005-01-17 2005-08-31 이경범 Multi-layer coating of drug release controllable coronary stent and method for manufacturing the same
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
ITTO20050074A1 (en) * 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
JP2008537898A (en) * 2005-02-11 2008-10-02 ミカーディア コーポレーション Dynamically adjustable gastric implant and method for treating obesity using the same
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
CN102247225B (en) * 2005-02-28 2015-07-22 梅德坦提亚国际有限公司 Device for improving the function of heart valve and kit
EP2767260B1 (en) 2005-03-25 2019-07-03 St. Jude Medical, Cardiology Division, Inc. Apparatus for controlling the internal circumference of an anatomic orifice or lumen
US8864823B2 (en) * 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
WO2006107901A1 (en) * 2005-04-04 2006-10-12 Micardia Corporation Dynamic reinforcement of the lower esophageal sphincter
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US7927371B2 (en) * 2005-07-15 2011-04-19 The Cleveland Clinic Foundation Apparatus and method for reducing cardiac valve regurgitation
DE602006009113D1 (en) * 2005-07-15 2009-10-22 Cleveland Clinic Foundation Device for remodeling a heart valve ring
CA2872116C (en) 2005-09-07 2017-02-28 Medtentia International Ltd Oy A device for improving the function of a heart valve
US20070067027A1 (en) * 2005-09-14 2007-03-22 Micardia Corporation Left atrial balloon catheter
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
JP2007155149A (en) * 2005-11-30 2007-06-21 Toyoda Gosei Co Ltd Blade driving device of swing resistor
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US7536228B2 (en) 2006-03-24 2009-05-19 Micardia Corporation Activation device for dynamic ring manipulation
KR101231357B1 (en) * 2006-04-06 2013-02-07 엘지전자 주식회사 Channel status information feedback method and data transmission method for multiple antenna system
US8135476B2 (en) * 2006-04-27 2012-03-13 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US8145323B2 (en) * 2006-04-27 2012-03-27 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US8200343B2 (en) * 2006-04-27 2012-06-12 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US8457763B2 (en) * 2006-04-27 2013-06-04 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US20070255367A1 (en) * 2006-04-27 2007-11-01 Medtronic, Inc. Implantable Medical Electrical Stimulation Lead Fixation Method and Apparatus
US8204569B2 (en) * 2006-04-27 2012-06-19 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
EP1854429A1 (en) * 2006-05-12 2007-11-14 Micardia Corporation Intraoperative and post-operative adjustment of an annuloplasty ring
ES2310092B1 (en) * 2006-06-02 2009-09-30 Ignacio Rada Martinez TELE-ADJUSTABLE PROTEST RING FOR MITRAL AND TRICUSPIDE VALVE REPAIR
US20070299456A1 (en) * 2006-06-06 2007-12-27 Teague James A Light responsive medical retrieval devices
US8430926B2 (en) * 2006-08-11 2013-04-30 Japd Consulting Inc. Annuloplasty with enhanced anchoring to the annulus based on tissue healing
US7879087B2 (en) 2006-10-06 2011-02-01 Edwards Lifesciences Corporation Mitral and tricuspid annuloplasty rings
US20080228272A1 (en) * 2006-12-04 2008-09-18 Micardia Corporation Dynamically adjustable suture and chordae tendinae
ES2277794B2 (en) * 2006-12-13 2008-05-16 Universidad Politecnica De Madrid ACTIVE ANULOPLASTIC SYSTEM FOR THE PROGRESSIVE TREATMENT OF VALVULAR INSUFFICIENCIES AND OTHER CARDIOVASCULAR PATHOLOGIES.
EP2111189B1 (en) 2007-01-03 2017-04-05 St. Jude Medical, Cardiology Division, Inc. Implantable devices for controlling the size and shape of an anatomical structure or lumen
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US9192471B2 (en) * 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20100121433A1 (en) * 2007-01-08 2010-05-13 Millipede Llc, A Corporation Of Michigan Reconfiguring heart features
WO2008091614A1 (en) * 2007-01-23 2008-07-31 Cvdevices, Llc Systems and methods for valve annulus remodeling
US8649798B2 (en) * 2007-01-25 2014-02-11 At&T Intellectual Property I, L.P. Methods and devices for attracting groups based upon mobile communications device location
EP3488822B1 (en) * 2007-01-26 2020-10-21 Medtronic, Inc. Annuloplasty device for tricuspid valve repair
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8529620B2 (en) 2007-05-01 2013-09-10 Ottavio Alfieri Inwardly-bowed tricuspid annuloplasty ring
US7695511B2 (en) * 2007-05-22 2010-04-13 Drake Daniel H Method and system for treatment of regurgitating heart valves
US7931685B2 (en) * 2007-05-22 2011-04-26 Drake Daniel H Method and system for treatment of regurgitating heart valves
US9956067B2 (en) 2007-07-06 2018-05-01 Claude Tihon Partial cuff
US10219808B2 (en) 2007-07-06 2019-03-05 Claude Tihon Partial cuff
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
EP2185105A4 (en) * 2007-08-10 2011-03-09 Micardia Corp Adjustable annuloplasty ring and activation system
JP2009087928A (en) * 2007-09-13 2009-04-23 Semiconductor Energy Lab Co Ltd Semiconductor device and manufacturing method therefor
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
US9848981B2 (en) * 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9295553B2 (en) * 2008-04-09 2016-03-29 Georgia Tech Research Corporation Annuloplasty rings and methods for heart valve repair
US11083579B2 (en) 2008-04-16 2021-08-10 Heart Repair Technologies, Inc. Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy
US20100121437A1 (en) * 2008-04-16 2010-05-13 Cardiovascular Technologies, Llc Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy
US20100121435A1 (en) * 2008-04-16 2010-05-13 Cardiovascular Technologies, Llc Percutaneous transvalvular intrannular band for mitral valve repair
US11013599B2 (en) 2008-04-16 2021-05-25 Heart Repair Technologies, Inc. Percutaneous transvalvular intraannular band for mitral valve repair
US10456259B2 (en) 2008-04-16 2019-10-29 Heart Repair Technologies, Inc. Transvalvular intraannular band for mitral valve repair
US8262725B2 (en) * 2008-04-16 2012-09-11 Cardiovascular Technologies, Llc Transvalvular intraannular band for valve repair
US20100131057A1 (en) 2008-04-16 2010-05-27 Cardiovascular Technologies, Llc Transvalvular intraannular band for aortic valve repair
US20090275961A1 (en) * 2008-05-01 2009-11-05 Harris Jason L Gastric volume reduction using anterior to posterior wall junctions
ATE554731T1 (en) 2008-05-16 2012-05-15 Sorin Biomedica Cardio Srl ATRAAUMATIC PROSTHETIC HEART VALVE PROSTHESIS
US8337390B2 (en) * 2008-07-30 2012-12-25 Cube S.R.L. Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart
US20100092238A1 (en) * 2008-10-13 2010-04-15 Gm Global Technology Operations, Inc. Active material elements having reinforced structural connectors
US8567188B2 (en) * 2008-10-13 2013-10-29 GM Global Technology Operations LLC Accelerating cooling in active material actuators using heat sinks
US8808368B2 (en) 2008-12-22 2014-08-19 Valtech Cardio, Ltd. Implantation of repair chords in the heart
US8147542B2 (en) 2008-12-22 2012-04-03 Valtech Cardio, Ltd. Adjustable repair chords and spool mechanism therefor
US8926697B2 (en) 2011-06-23 2015-01-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
EP2201911B1 (en) 2008-12-23 2015-09-30 Sorin Group Italia S.r.l. Expandable prosthetic valve having anchoring appendages
US8998982B2 (en) * 2009-01-12 2015-04-07 Valve Medical Ltd. Method and apparatus for fine adjustment of a percutaneous valve structure
US8808371B2 (en) 2009-01-22 2014-08-19 St. Jude Medical, Cardiology Division, Inc. Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring
EP2628465A1 (en) 2009-04-27 2013-08-21 Sorin Group Italia S.r.l. Prosthetic vascular conduit
US8523881B2 (en) 2010-07-26 2013-09-03 Valtech Cardio, Ltd. Multiple anchor delivery tool
WO2011011443A2 (en) 2009-07-20 2011-01-27 Micardia Corporation Adjustable annuloplasty ring with subcutaneous activation port
EP2470131B1 (en) 2009-08-24 2014-11-12 New Phase Ltd Phase-change materials
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
AU2010306762C1 (en) * 2009-10-14 2016-04-21 Heart Repair Technologies, Inc. Percutaneous transvalvular intraannular band for mitral valve repair
US8277502B2 (en) 2009-10-29 2012-10-02 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US8690939B2 (en) 2009-10-29 2014-04-08 Valtech Cardio, Ltd. Method for guide-wire based advancement of a rotation assembly
AU2010328106A1 (en) 2009-12-08 2012-07-05 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
US8323272B2 (en) * 2010-02-17 2012-12-04 Medshape Solutions, Inc. Apparatus and methods for programming a shape-memory medical device implant
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.
US8790394B2 (en) 2010-05-24 2014-07-29 Valtech Cardio, Ltd. Adjustable artificial chordeae tendineae with suture loops
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
EP2575685B1 (en) 2010-06-07 2019-02-13 Valtech Cardio, Ltd. Apparatus for guide-wire based advancement of a rotation assembly
US8550979B2 (en) 2010-06-15 2013-10-08 Coloplast A/S Method of treating incontinence
CN103153231A (en) * 2010-08-02 2013-06-12 鲁杰罗·德保利斯 Annuloplasty band for a simplified approach to mitral valvuloplasty for degenerative diseases
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
US20120089172A1 (en) * 2010-10-11 2012-04-12 Allergan, Inc. Re-shaping intragastric implants
EP2468215A1 (en) 2010-12-22 2012-06-27 Centre Hospitaller Universitaire Vaudois (CHUV) Annuloplasty ring
WO2012097366A1 (en) * 2011-01-14 2012-07-19 Massachusetts Institute Of Technology System and method for manipulation of devices using magnetic fields
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
EP2486894B1 (en) 2011-02-14 2021-06-09 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
EP2486893B1 (en) 2011-02-14 2017-07-05 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
EP2554139A1 (en) 2011-08-05 2013-02-06 Centre Hospitalier Universitaire Vaudois Actuating device for a surgical implant
US9480559B2 (en) 2011-08-11 2016-11-01 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
EP2609893B1 (en) 2011-12-29 2014-09-03 Sorin Group Italia S.r.l. A kit for implanting prosthetic vascular conduits
AU2013227235B2 (en) * 2012-02-28 2017-10-19 Mvalve Technologies Ltd. Single-ring cardiac valve support
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
WO2014021905A1 (en) 2012-07-30 2014-02-06 Tendyne Holdings, Inc. Improved delivery systems and methods for transcatheter prosthetic valves
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
EP2967945B1 (en) 2013-03-15 2020-10-28 California Institute of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
JP6461122B2 (en) 2013-06-25 2019-01-30 テンダイン ホールディングス,インコーポレイテッド Thrombus management and structural compliance features of prosthetic heart valves
JP6465883B2 (en) 2013-08-01 2019-02-06 テンダイン ホールディングス,インコーポレイテッド Epicardial anchor device and method
CN105491978A (en) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
US10166098B2 (en) 2013-10-25 2019-01-01 Middle Peak Medical, Inc. Systems and methods for transcatheter treatment of valve regurgitation
CN105682611B (en) 2013-10-28 2018-06-01 坦迪尼控股股份有限公司 Prosthetic heart valve and the system and method for conveying prosthetic heart valve
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
CN103735337B (en) * 2013-12-31 2016-08-17 金仕生物科技(常熟)有限公司 Artificial heart valve forming ring
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
AU2015229708B2 (en) 2014-03-10 2019-08-15 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
GB2526265B (en) 2014-05-13 2016-08-17 Cook Medical Technologies Llc Medical device having magnetically expandable frame
WO2015195823A1 (en) 2014-06-18 2015-12-23 Middle Peak Medical, Inc. Mitral valve implants for the treatment of valvular regurgitation
CA2958065C (en) 2014-06-24 2023-10-31 Middle Peak Medical, Inc. Systems and methods for anchoring an implant
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US10105225B2 (en) 2014-10-22 2018-10-23 Medtronic, Inc. Devices, systems and methods for tissue approximation, including approximating mitral valve leaflets
CA2968648C (en) 2014-11-25 2021-05-18 New Phase Ltd. Phase-change nanoparticle for treating cancerous cells
CN107405195B (en) 2015-01-07 2020-09-08 坦迪尼控股股份有限公司 Artificial mitral valve and apparatus and method for delivering artificial mitral valve
CA2975294A1 (en) 2015-02-05 2016-08-11 Tendyne Holdings, Inc. Expandable epicardial pads and devices and methods for delivery of same
CN111110401B (en) 2015-02-13 2022-03-29 波士顿科学国际有限公司 Valve replacement using a rotating anchor
US9773772B2 (en) 2015-04-09 2017-09-26 Samsung Electronics Co., Ltd. Semiconductor device and method of fabricating the same
EP3283010B1 (en) 2015-04-16 2020-06-17 Tendyne Holdings, Inc. Apparatus for delivery and repositioning of transcatheter prosthetic valves
EP3087952A1 (en) 2015-04-29 2016-11-02 Kephalios S.A.S. An annuloplasty system and a method for monitoring the effectiveness of an annuloplasty treatment
EP3632378A1 (en) 2015-05-01 2020-04-08 JenaValve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
DE102015107242B4 (en) * 2015-05-08 2022-11-03 Highlife Sas System for implanting an implant around a peripheral tissue structure in a heart and method for placing and delivering an implant on a guidewire of such a system
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
US9592121B1 (en) 2015-11-06 2017-03-14 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
EP3377000B1 (en) 2015-11-17 2023-02-01 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
EP3383322B1 (en) 2015-12-03 2020-02-12 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
CA3006010C (en) 2015-12-28 2023-09-26 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
WO2017125170A1 (en) * 2016-01-22 2017-07-27 Medtentia International Ltd Oy Annuloplasty implant
WO2017143075A1 (en) 2016-02-16 2017-08-24 Children's Medical Center Corporation Autonomously growing implantable device
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2017218375A1 (en) 2016-06-13 2017-12-21 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
US11090157B2 (en) 2016-06-30 2021-08-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
EP3484411A1 (en) 2016-07-12 2019-05-22 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
US10722359B2 (en) 2016-08-26 2020-07-28 Edwards Lifesciences Corporation Heart valve docking devices and systems
CR20190069A (en) 2016-08-26 2019-05-14 Edwards Lifesciences Corp Heart valve docking coils and systems
US11707611B2 (en) * 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
AU2017382273A1 (en) 2016-12-22 2019-08-08 Heart Repair Technologies, Inc. Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus
CN110392557A (en) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 Heart valve simulation
US11033375B2 (en) * 2017-01-29 2021-06-15 Innomedex Llc Devices and methods for sphincter reinforcement
EP3579789A4 (en) 2017-02-10 2020-09-30 Millipede, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US10478303B2 (en) 2017-03-13 2019-11-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
US10653524B2 (en) 2017-03-13 2020-05-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
WO2018169878A1 (en) 2017-03-13 2018-09-20 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
EP3651695B1 (en) 2017-07-13 2023-04-19 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus for delivery of same
USD890333S1 (en) 2017-08-21 2020-07-14 Edwards Lifesciences Corporation Heart valve docking coil
AU2018323900A1 (en) 2017-08-28 2020-02-27 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
CN108125733B (en) * 2018-02-11 2019-03-22 牡丹江医学院附属红旗医院 A kind of heart valve tricuspid annulus
EP3796873B1 (en) 2018-05-23 2022-04-27 Corcym S.r.l. A cardiac valve prosthesis
US20200188111A1 (en) * 2018-12-13 2020-06-18 Medtronic Vascular, Inc. Heart valve repair
WO2020252200A1 (en) * 2019-06-11 2020-12-17 Valcare, Inc. Annuloplasty ring with posterior leaflet for minimally invasive treatment
WO2021092625A1 (en) * 2019-11-07 2021-05-14 Primo Medical Group, Inc. Systems, apparatus and methods to repair operation of a heart valve
EP3831343B1 (en) 2019-12-05 2024-01-31 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning
US11464634B2 (en) 2020-12-16 2022-10-11 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors
CN113215366B (en) * 2021-04-29 2022-02-22 燕山大学 Variable-diameter induction heating device for ratchet wheel and heating method thereof
US11759321B2 (en) 2021-06-25 2023-09-19 Polares Medical Inc. Device, system, and method for transcatheter treatment of valvular regurgitation
KR102612046B1 (en) * 2021-12-24 2023-12-07 전북대학교산학협력단 Shape memory wire braided re- expansion stent

Citations (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233690A (en) * 1978-05-19 1980-11-18 Carbomedics, Inc. Prosthetic device couplings
US4489446A (en) * 1982-07-14 1984-12-25 Reed Charles C Heart valve prosthesis
US4507115A (en) * 1981-04-01 1985-03-26 Olympus Optical Co., Ltd. Medical capsule device
US4556050A (en) * 1984-05-02 1985-12-03 Hodgson Darel E Artificial sphincter including a shape memory member
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US4917698A (en) * 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US5064431A (en) * 1991-01-16 1991-11-12 St. Jude Medical Incorporated Annuloplasty ring
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5290300A (en) * 1989-07-31 1994-03-01 Baxter International Inc. Flexible suture guide and holder
US5350413A (en) * 1990-06-21 1994-09-27 The University Of Ottawa Transcutaneous energy transfer device
US5415623A (en) * 1991-09-06 1995-05-16 Nicole A. Cherubini Polymeric orthotic devices
US5509888A (en) * 1994-07-26 1996-04-23 Conceptek Corporation Controller valve device and method
US5843178A (en) * 1996-06-20 1998-12-01 St. Jude Medical, Inc. Suture guard for annuloplasty ring
US5850837A (en) * 1996-03-21 1998-12-22 Furukawa Electric Co., Ltd. Device for correcting an ingrown nail
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US6045497A (en) * 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US20020095187A1 (en) * 2000-11-03 2002-07-18 Thompson David L. Mems switching circuit and method for an implantable medical device
US20020133223A1 (en) * 2001-03-09 2002-09-19 Vito Raymond P. Intravascular device and method for axially stretching blood vessels
US6454698B1 (en) * 1999-08-12 2002-09-24 Obtech Medical Ag Anal incontinence treatment with energy transfer device
US20020151961A1 (en) * 2000-01-31 2002-10-17 Lashinski Randall T. Medical system and method for remodeling an extravascular tissue structure
US20020183838A1 (en) * 2001-03-29 2002-12-05 Liddicoat John R. Method and apparatus for improving mitral valve function
US20020183837A1 (en) * 2001-03-05 2002-12-05 Streeter Richard B. Apparatus and method for reducing mitral regurgitation
US20030040793A1 (en) * 2001-08-24 2003-02-27 Salvador Marquez Self-molding annuloplasty ring and method of use
US6565603B2 (en) * 1998-06-16 2003-05-20 Cardiac Concepts, Inc. Mitral valve annuloplasty ring
US6569198B1 (en) * 2000-03-31 2003-05-27 Richard A. Wilson Mitral or tricuspid valve annuloplasty prosthetic device
US20030135267A1 (en) * 2002-01-11 2003-07-17 Solem Jan Otto Delayed memory device
US20030191528A1 (en) * 2000-06-02 2003-10-09 Quijano Rodolfo C. Expandable medical implant and percutaneous delivery
US20030233142A1 (en) * 2002-06-13 2003-12-18 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6718985B2 (en) * 2001-04-24 2004-04-13 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty using local plications
US20040093017A1 (en) * 2002-11-06 2004-05-13 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
US20040102841A1 (en) * 2000-01-31 2004-05-27 Langberg Jonathan J. Percutaneous mitral annuloplasty with cardiac rhythm management
US20040106949A1 (en) * 1999-07-26 2004-06-03 Beth Israel Deaconess Medical Center Suture system
US20040138744A1 (en) * 2000-01-31 2004-07-15 Randall Lashinski Transluminal mitral annuloplasty with active anchoring
US20040153147A1 (en) * 2003-02-03 2004-08-05 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040181242A1 (en) * 2003-03-12 2004-09-16 Stack Richard S. Articulated suturing system
US20040243230A1 (en) * 2003-05-20 2004-12-02 The Cleveland Clinic Foundation Apparatus and methods for repair of a cardiac valve
US20040260393A1 (en) * 2000-09-20 2004-12-23 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20050055087A1 (en) * 2003-09-04 2005-03-10 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US20050060030A1 (en) * 2000-01-31 2005-03-17 Lashinski Randall T. Remotely activated mitral annuloplasty system and methods
US20050080483A1 (en) * 2001-12-28 2005-04-14 Solem Jan Otto Delayed memory device
US20050119733A1 (en) * 2003-11-19 2005-06-02 Synecor, Llc Highly convertable endolumenal prostheses and methods of manufacture
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
US7285087B2 (en) * 2004-07-15 2007-10-23 Micardia Corporation Shape memory devices and methods for reshaping heart anatomy
US7297150B2 (en) * 2002-08-29 2007-11-20 Mitralsolutions, Inc. Implantable devices for controlling the internal circumference of an anatomic orifice or lumen

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868956A (en) 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4341227A (en) 1979-01-11 1982-07-27 Bsd Corporation System for irradiating living tissue or simulations thereof
US4574782A (en) 1981-11-16 1986-03-11 Corning Glass Works Radio frequency-induced hyperthermia for tumor therapy
DE3230858C2 (en) 1982-08-19 1985-01-24 Ahmadi, Ali, Dr. med., 7809 Denzlingen Ring prosthesis
US4502752A (en) * 1982-11-08 1985-03-05 General Scanning, Inc. Resonant actuator for optical scanning
US5010897A (en) * 1989-04-26 1991-04-30 Leveen Harry H Apparatus for deep heating of cancer
US5099576A (en) * 1989-08-29 1992-03-31 Sanden Corporation Heat exchanger and method for manufacturing the heat exchanger
EP0632708A4 (en) 1990-01-29 1996-03-13 Hypertherm Corp Local application tumor treatment apparatus.
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5006106A (en) 1990-10-09 1991-04-09 Angelchik Jean P Apparatus and method for laparoscopic implantation of anti-reflux prosthesis
US5171252A (en) 1991-02-05 1992-12-15 Friedland Thomas W Surgical fastening clip formed of a shape memory alloy, a method of making such a clip and a method of using such a clip
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
EP0624080B1 (en) * 1992-01-27 2001-12-12 Medtronic, Inc. Annuloplasty and suture rings
US5993389A (en) * 1995-05-22 1999-11-30 Ths International, Inc. Devices for providing acoustic hemostasis
US5401241A (en) * 1992-05-07 1995-03-28 Inamed Development Co. Duodenal intubation catheter
US5593435A (en) 1994-07-29 1997-01-14 Baxter International Inc. Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth
US6217610B1 (en) * 1994-07-29 2001-04-17 Edwards Lifesciences Corporation Expandable annuloplasty ring
DE19508805C2 (en) * 1995-03-06 2000-03-30 Lutz Freitag Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions
NL1000225C1 (en) 1995-04-26 1996-05-28 Petrus Antonius Ir Besselink Deformable artificial body part with a metal frame that can be bent repeatedly without plastic deformation.
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US5711299A (en) * 1996-01-26 1998-01-27 Manwaring; Kim H. Surgical guidance method and system for approaching a target within a body
US6039759A (en) 1996-02-20 2000-03-21 Baxter International Inc. Mechanical prosthetic valve with coupled leaflets
AUPN978296A0 (en) 1996-05-10 1996-05-30 Gray, Bruce N Targeted hysteresis hyperthermia as a method for treating cancer
US6093883A (en) 1997-07-15 2000-07-25 Focus Surgery, Inc. Ultrasound intensity determining method and apparatus
US5843187A (en) * 1997-08-06 1998-12-01 Bayers; Jon H. Insertable intraocular lens
US6231516B1 (en) * 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
CA2316945A1 (en) 1998-02-23 1999-08-26 Mnemoscience Gmbh Shape memory polymers
HU222543B1 (en) 1998-02-23 2003-08-28 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6361559B1 (en) * 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
US6210347B1 (en) * 1998-08-13 2001-04-03 Peter Forsell Remote control food intake restriction device
US6425867B1 (en) 1998-09-18 2002-07-30 University Of Washington Noise-free real time ultrasonic imaging of a treatment site undergoing high intensity focused ultrasound therapy
IT1305062B1 (en) * 1998-12-23 2001-04-10 Leonardo Cammilli SINGLE INTRODUCTION CATHETER FOR MULTISITE STIMULATION OF THE FOUR CARDIAC CHAMBERS FOR TREATMENT OF PATHOLOGIES SUCH AS
US6077298A (en) * 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
AUPP899899A0 (en) 1999-03-03 1999-03-25 Paragon Medical Limited Magnetic material
JP4657456B2 (en) * 1999-04-09 2011-03-23 イバルブ・インコーポレーテッド Method and apparatus for heart valve repair
US6183512B1 (en) * 1999-04-16 2001-02-06 Edwards Lifesciences Corporation Flexible annuloplasty system
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
GB9910251D0 (en) * 1999-05-05 1999-06-30 Ciba Geigy Ag Process for the preparation of pigment compositions
IT1307268B1 (en) * 1999-09-30 2001-10-30 Sorin Biomedica Cardio Spa DEVICE FOR HEART VALVE REPAIR OR REPLACEMENT.
US20030069570A1 (en) * 1999-10-02 2003-04-10 Witzel Thomas H. Methods for repairing mitral valve annulus percutaneously
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US6797002B2 (en) * 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US6406493B1 (en) * 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US8956407B2 (en) * 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6913608B2 (en) * 2000-10-23 2005-07-05 Viacor, Inc. Automated annular plication for mitral valve repair
US6740094B2 (en) 2000-11-06 2004-05-25 The Regents Of The University Of California Shape memory polymer actuator and catheter
US6974476B2 (en) * 2003-05-05 2005-12-13 Rex Medical, L.P. Percutaneous aortic valve
WO2002062408A2 (en) * 2001-02-05 2002-08-15 Viacor, Inc. Method and apparatus for improving mitral valve function
US6786904B2 (en) 2002-01-10 2004-09-07 Triton Biosystems, Inc. Method and device to treat vulnerable plaque
US20020133225A1 (en) * 2001-03-13 2002-09-19 Gordon Lucas S. Methods and apparatuses for delivering a medical agent to a medical implant
US20060069429A1 (en) 2001-04-24 2006-03-30 Spence Paul A Tissue fastening systems and methods utilizing magnetic guidance
US6676702B2 (en) 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US7125421B2 (en) * 2001-08-31 2006-10-24 Mitral Interventions, Inc. Method and apparatus for valve repair
US6893460B2 (en) 2001-10-11 2005-05-17 Percutaneous Valve Technologies Inc. Implantable prosthetic valve
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US6949122B2 (en) * 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
WO2003039350A2 (en) * 2001-11-09 2003-05-15 Cardio-Optics, Inc. Direct, real-time imaging guidance of cardiac catheterization
JP4230915B2 (en) * 2001-12-21 2009-02-25 シムチャ ミロ Annuloplasty ring transplantation system
US6764510B2 (en) * 2002-01-09 2004-07-20 Myocor, Inc. Devices and methods for heart valve treatment
US6870705B2 (en) * 2002-01-17 2005-03-22 Hitachi Global Storage Technologies Netherlands, B.V. Magnetic head having short pole yoke length and method for fabrication thereof
US6993394B2 (en) 2002-01-18 2006-01-31 Calfacion Corporation System method and apparatus for localized heating of tissue
US6846985B2 (en) * 2002-01-22 2005-01-25 Nanoset, Llc Magnetically shielded assembly
US20030199974A1 (en) * 2002-04-18 2003-10-23 Coalescent Surgical, Inc. Annuloplasty apparatus and methods
EP1519683A4 (en) * 2002-05-30 2008-03-19 Univ Washington Solid hydrogel coupling for ultrasound imaging and therapy
US7101395B2 (en) * 2002-06-12 2006-09-05 Mitral Interventions, Inc. Method and apparatus for tissue connection
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
JP4420593B2 (en) * 2002-07-29 2010-02-24 Hoya株式会社 Bipolar high-frequency treatment instrument for endoscope
US7188627B2 (en) 2002-09-06 2007-03-13 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
US7441559B2 (en) 2002-09-06 2008-10-28 Koninklijke Philips Electronics N.V. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US6875231B2 (en) * 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
US20040055610A1 (en) * 2002-09-25 2004-03-25 Peter Forsell Detection of implanted wireless energy receiving device
US7172622B2 (en) 2002-10-30 2007-02-06 Boston Scientific Scimed, Inc. Medical devices including a magnetically activatable body or portion for treatment
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US20040098116A1 (en) 2002-11-15 2004-05-20 Callas Peter L. Valve annulus constriction apparatus and method
US7789891B2 (en) * 2003-09-23 2010-09-07 Boston Scientific Scimed, Inc. External activation of vaso-occlusive implants
US20050080482A1 (en) * 2003-10-14 2005-04-14 Craig Bonsignore Graft coupling apparatus and methods of using same
EP1684842B1 (en) * 2003-10-27 2013-03-06 Petrus Antonius Besselink Self-activating endoluminal device
US7740656B2 (en) * 2003-11-17 2010-06-22 Medtronic, Inc. Implantable heart valve prosthetic devices having intrinsically conductive polymers
US8828078B2 (en) * 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7591834B2 (en) * 2004-03-26 2009-09-22 Lawrence Livermore National Security, Llc Shape memory system with integrated actuation using embedded particles
EP2422751A3 (en) * 2004-05-05 2013-01-02 Direct Flow Medical, Inc. Unstented heart valve with formed in place support structure
EP1750607A2 (en) * 2004-06-02 2007-02-14 Medtronic, Inc. Loop ablation apparatus and method
US20080015688A1 (en) * 2004-06-29 2008-01-17 Micardia Corporation Adjustable multi-segment cardiac valve implant with selective dimensional adjustment
US20070135913A1 (en) * 2004-06-29 2007-06-14 Micardia Corporation Adjustable annuloplasty ring activation system
US7396364B2 (en) * 2004-06-29 2008-07-08 Micardia Corporation Cardiac valve implant with energy absorbing material
EP1768611A4 (en) 2004-07-15 2009-11-18 Micardia Corp Implants and methods for reshaping heart valves
US8012202B2 (en) * 2004-07-27 2011-09-06 Alameddine Abdallah K Mitral valve ring for treatment of mitral valve regurgitation
US7647109B2 (en) * 2004-10-20 2010-01-12 Boston Scientific Scimed, Inc. Leadless cardiac stimulation systems
US7357815B2 (en) * 2005-04-21 2008-04-15 Micardia Corporation Dynamically adjustable implants and methods for reshaping tissue
DE602006009113D1 (en) * 2005-07-15 2009-10-22 Cleveland Clinic Foundation Device for remodeling a heart valve ring
US8721634B2 (en) * 2005-07-21 2014-05-13 Covidien Lp Apparatus and method for ensuring thermal treatment of a hollow anatomical structure
US20070055368A1 (en) 2005-09-07 2007-03-08 Richard Rhee Slotted annuloplasty ring
US20070067027A1 (en) * 2005-09-14 2007-03-22 Micardia Corporation Left atrial balloon catheter
ATE429194T1 (en) * 2005-11-16 2009-05-15 Micardia Corp MAGNETIC ATTACHMENT OF A CATHETER TO AN IMPLANT
US20070142907A1 (en) * 2005-12-16 2007-06-21 Micardia Corporation Adjustable prosthetic valve implant
US7536228B2 (en) * 2006-03-24 2009-05-19 Micardia Corporation Activation device for dynamic ring manipulation
US20090088838A1 (en) * 2006-05-12 2009-04-02 Shaolian Samuel M Adjustable annuloplasty ring and activation system
US20080004692A1 (en) * 2006-06-28 2008-01-03 Henson Michael R Dynamically adjustable vascular stent
US20090248148A1 (en) * 2008-03-25 2009-10-01 Ellipse Technologies, Inc. Systems and methods for adjusting an annuloplasty ring with an integrated magnetic drive

Patent Citations (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233690A (en) * 1978-05-19 1980-11-18 Carbomedics, Inc. Prosthetic device couplings
US4507115A (en) * 1981-04-01 1985-03-26 Olympus Optical Co., Ltd. Medical capsule device
US4489446A (en) * 1982-07-14 1984-12-25 Reed Charles C Heart valve prosthesis
US4665906A (en) * 1983-10-14 1987-05-19 Raychem Corporation Medical devices incorporating sim alloy elements
US4556050A (en) * 1984-05-02 1985-12-03 Hodgson Darel E Artificial sphincter including a shape memory member
US4805618A (en) * 1985-08-08 1989-02-21 Olympus Optical Co., Ltd. Oviduct closing apparatus
US5061277B1 (en) * 1986-08-06 2000-02-29 Baxter Travenol Lab Flexible cardiac valvular support prosthesis
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US4917698A (en) * 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US5104407B1 (en) * 1989-02-13 1999-09-21 Baxter Int Selectively flexible annuloplasty ring
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5290300A (en) * 1989-07-31 1994-03-01 Baxter International Inc. Flexible suture guide and holder
US5350413A (en) * 1990-06-21 1994-09-27 The University Of Ottawa Transcutaneous energy transfer device
US5350413B1 (en) * 1990-06-21 1999-09-07 Heart Inst Research Corp Transcutaneous energy transfer device
US5064431A (en) * 1991-01-16 1991-11-12 St. Jude Medical Incorporated Annuloplasty ring
US5415623A (en) * 1991-09-06 1995-05-16 Nicole A. Cherubini Polymeric orthotic devices
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5509888A (en) * 1994-07-26 1996-04-23 Conceptek Corporation Controller valve device and method
US5850837A (en) * 1996-03-21 1998-12-22 Furukawa Electric Co., Ltd. Device for correcting an ingrown nail
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US5843178A (en) * 1996-06-20 1998-12-01 St. Jude Medical, Inc. Suture guard for annuloplasty ring
US6045497A (en) * 1997-01-02 2000-04-04 Myocor, Inc. Heart wall tension reduction apparatus and method
US6273908B1 (en) * 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US6565603B2 (en) * 1998-06-16 2003-05-20 Cardiac Concepts, Inc. Mitral valve annuloplasty ring
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20040106949A1 (en) * 1999-07-26 2004-06-03 Beth Israel Deaconess Medical Center Suture system
US6454698B1 (en) * 1999-08-12 2002-09-24 Obtech Medical Ag Anal incontinence treatment with energy transfer device
US20020151961A1 (en) * 2000-01-31 2002-10-17 Lashinski Randall T. Medical system and method for remodeling an extravascular tissue structure
US20040102841A1 (en) * 2000-01-31 2004-05-27 Langberg Jonathan J. Percutaneous mitral annuloplasty with cardiac rhythm management
US20050060030A1 (en) * 2000-01-31 2005-03-17 Lashinski Randall T. Remotely activated mitral annuloplasty system and methods
US20040138744A1 (en) * 2000-01-31 2004-07-15 Randall Lashinski Transluminal mitral annuloplasty with active anchoring
US6569198B1 (en) * 2000-03-31 2003-05-27 Richard A. Wilson Mitral or tricuspid valve annuloplasty prosthetic device
US6805711B2 (en) * 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US20030191528A1 (en) * 2000-06-02 2003-10-09 Quijano Rodolfo C. Expandable medical implant and percutaneous delivery
US20040260393A1 (en) * 2000-09-20 2004-12-23 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US20020095187A1 (en) * 2000-11-03 2002-07-18 Thompson David L. Mems switching circuit and method for an implantable medical device
US20020183837A1 (en) * 2001-03-05 2002-12-05 Streeter Richard B. Apparatus and method for reducing mitral regurgitation
US20020133223A1 (en) * 2001-03-09 2002-09-19 Vito Raymond P. Intravascular device and method for axially stretching blood vessels
US20020183838A1 (en) * 2001-03-29 2002-12-05 Liddicoat John R. Method and apparatus for improving mitral valve function
US6718985B2 (en) * 2001-04-24 2004-04-13 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty using local plications
US6726716B2 (en) * 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US20030040793A1 (en) * 2001-08-24 2003-02-27 Salvador Marquez Self-molding annuloplasty ring and method of use
US20050080483A1 (en) * 2001-12-28 2005-04-14 Solem Jan Otto Delayed memory device
US20030135267A1 (en) * 2002-01-11 2003-07-17 Solem Jan Otto Delayed memory device
US20030233142A1 (en) * 2002-06-13 2003-12-18 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US7297150B2 (en) * 2002-08-29 2007-11-20 Mitralsolutions, Inc. Implantable devices for controlling the internal circumference of an anatomic orifice or lumen
US20070299543A1 (en) * 2002-08-29 2007-12-27 Mitralsolutions, Inc. Implantable devices for controlling the internal circumference of an anatomic orifice or lumen
US20040093017A1 (en) * 2002-11-06 2004-05-13 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
US20040153147A1 (en) * 2003-02-03 2004-08-05 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040181242A1 (en) * 2003-03-12 2004-09-16 Stack Richard S. Articulated suturing system
US20040243230A1 (en) * 2003-05-20 2004-12-02 The Cleveland Clinic Foundation Apparatus and methods for repair of a cardiac valve
US20050055087A1 (en) * 2003-09-04 2005-03-10 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US20050119733A1 (en) * 2003-11-19 2005-06-02 Synecor, Llc Highly convertable endolumenal prostheses and methods of manufacture
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
US7285087B2 (en) * 2004-07-15 2007-10-23 Micardia Corporation Shape memory devices and methods for reshaping heart anatomy

Cited By (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US10188518B2 (en) 2001-08-28 2019-01-29 Edwards Lifesciences Corporation Annuloplasty ring with variable cross-section
US9414922B2 (en) 2001-08-28 2016-08-16 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US8236050B2 (en) 2001-11-13 2012-08-07 Edwards Lifesciences Corporation Mitral annuloplasty ring having upward bows
US20080097593A1 (en) * 2001-11-13 2008-04-24 Bolling Steven F Mitral Annuloplasty Ring Having Upward Bows
US7396364B2 (en) 2004-06-29 2008-07-08 Micardia Corporation Cardiac valve implant with energy absorbing material
US7510577B2 (en) 2004-06-29 2009-03-31 Micardia Corporation Adjustable cardiac valve implant with ferromagnetic material
US7377941B2 (en) 2004-06-29 2008-05-27 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US7713298B2 (en) 2004-06-29 2010-05-11 Micardia Corporation Methods for treating cardiac valves with adjustable implants
US7722668B2 (en) 2004-06-29 2010-05-25 Micardia Corporation Cardiac valve implant with energy absorbing material
US20050288782A1 (en) * 2004-06-29 2005-12-29 Shahram Moaddeb Cardiac valve implant with energy absorbing material
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US11497605B2 (en) 2005-03-17 2022-11-15 Valtech Cardio Ltd. Mitral valve treatment techniques
US10561498B2 (en) 2005-03-17 2020-02-18 Valtech Cardio, Ltd. Mitral valve treatment techniques
US9526613B2 (en) 2005-03-17 2016-12-27 Valtech Cardio Ltd. Mitral valve treatment techniques
US8216304B2 (en) 2005-03-23 2012-07-10 Edwards Lifesciences Corporation Annuloplasty ring and holder combination
US7842085B2 (en) 2005-03-23 2010-11-30 Vaso Adzich Annuloplasty ring and holder combination
US8685083B2 (en) 2005-06-27 2014-04-01 Edwards Lifesciences Corporation Apparatus, system, and method for treatment of posterior leaflet prolapse
US10695046B2 (en) 2005-07-05 2020-06-30 Edwards Lifesciences Corporation Tissue anchor and anchoring system
US20070055368A1 (en) * 2005-09-07 2007-03-08 Richard Rhee Slotted annuloplasty ring
WO2007030417A2 (en) * 2005-09-07 2007-03-15 Micardia Corporation Slotted annuloplasty ring
WO2007030417A3 (en) * 2005-09-07 2009-04-16 Micardia Corp Slotted annuloplasty ring
US20070100439A1 (en) * 2005-10-31 2007-05-03 Medtronic Vascular, Inc. Chordae tendinae restraining ring
US10010419B2 (en) 2005-12-15 2018-07-03 Georgia Tech Research Corporation Papillary muscle position control devices, systems, and methods
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US8591576B2 (en) 2006-05-15 2013-11-26 Edwards Lifesciences Ag Method for altering the geometry of the heart
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US10357366B2 (en) 2006-12-05 2019-07-23 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US7988725B2 (en) 2006-12-05 2011-08-02 Valtech Cardio, Ltd. Segmented ring placement
US11344414B2 (en) 2006-12-05 2022-05-31 Valtech Cardio Ltd. Implantation of repair devices in the heart
US9872769B2 (en) 2006-12-05 2018-01-23 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US9883943B2 (en) 2006-12-05 2018-02-06 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US9974653B2 (en) 2006-12-05 2018-05-22 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US10363137B2 (en) 2006-12-05 2019-07-30 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US20090259307A1 (en) * 2006-12-05 2009-10-15 Valtech Cardio, Ltd. Segmented ring placement
WO2008068756A2 (en) 2006-12-05 2008-06-12 Valtech Cardio, Ltd. Segmented ring placement
US9351830B2 (en) 2006-12-05 2016-05-31 Valtech Cardio, Ltd. Implant and anchor placement
US8926695B2 (en) 2006-12-05 2015-01-06 Valtech Cardio, Ltd. Segmented ring placement
US20110022169A1 (en) * 2007-01-26 2011-01-27 Ryan Timothy R Annuloplasty Device for Tricuspid Valve Repair
US10130473B2 (en) 2007-01-26 2018-11-20 Medtronic, Inc. Annuloplasty device for tricuspid valve repair
US9381084B2 (en) * 2007-01-26 2016-07-05 Medtronic, Inc. Annuloplasty device for tricuspid valve repair
US9801718B2 (en) 2007-01-26 2017-10-31 Medtronic, Inc. Annuloplasty device for tricuspid valve repair
US8764821B2 (en) 2007-02-09 2014-07-01 Edwards Lifesciences Corporation Degenerative vavlular disease specific annuloplasty ring sets
US7959673B2 (en) 2007-02-09 2011-06-14 Edwards Lifesciences Corporation Degenerative valvular disease specific annuloplasty rings
US9011529B2 (en) 2007-02-09 2015-04-21 Edwards Lifesciences Corporation Mitral annuloplasty rings with sewing cuff
US20090157176A1 (en) * 2007-02-09 2009-06-18 Alain Carpentier Annuloplasty rings for correcting degenerative valvular diseases
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US11576784B2 (en) 2007-09-07 2023-02-14 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US10842629B2 (en) 2007-09-07 2020-11-24 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US11660191B2 (en) 2008-03-10 2023-05-30 Edwards Lifesciences Corporation Method to reduce mitral regurgitation
US11903830B2 (en) 2008-05-13 2024-02-20 Edwards Lifesciences Corporation Physiologically harmonized repair of tricuspid valve
US9937041B2 (en) 2008-05-13 2018-04-10 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring
US20090287303A1 (en) * 2008-05-13 2009-11-19 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring
US9192472B2 (en) 2008-06-16 2015-11-24 Valtec Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
EP3628362A1 (en) 2008-06-16 2020-04-01 Valtech Cardio, Ltd. Annuloplasty devices and methods of delivery therefor
US11116634B2 (en) 2008-12-22 2021-09-14 Valtech Cardio Ltd. Annuloplasty implants
US10470882B2 (en) 2008-12-22 2019-11-12 Valtech Cardio, Ltd. Closure element for use with annuloplasty structure
US9713530B2 (en) 2008-12-22 2017-07-25 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US9011530B2 (en) 2008-12-22 2015-04-21 Valtech Cardio, Ltd. Partially-adjustable annuloplasty structure
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US9662209B2 (en) 2008-12-22 2017-05-30 Valtech Cardio, Ltd. Contractible annuloplasty structures
US10856986B2 (en) 2008-12-22 2020-12-08 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US9414919B2 (en) * 2008-12-31 2016-08-16 Medtronic, Inc. Semi-rigid annuloplasty ring and band
US20140013602A1 (en) * 2008-12-31 2014-01-16 Medtronic, Inc. Semi-Rigid Annuloplasty Ring and Band
US11202709B2 (en) 2009-02-17 2021-12-21 Valtech Cardio Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US10350068B2 (en) 2009-02-17 2019-07-16 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US9474606B2 (en) 2009-05-04 2016-10-25 Valtech Cardio, Ltd. Over-wire implant contraction methods
US10548729B2 (en) 2009-05-04 2020-02-04 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring and over-wire rotation tool
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
US11844665B2 (en) 2009-05-04 2023-12-19 Edwards Lifesciences Innovation (Israel) Ltd. Deployment techniques for annuloplasty structure
US11076958B2 (en) 2009-05-04 2021-08-03 Valtech Cardio, Ltd. Annuloplasty ring delivery catheters
US11766327B2 (en) 2009-05-04 2023-09-26 Edwards Lifesciences Innovation (Israel) Ltd. Implantation of repair chords in the heart
US11185412B2 (en) 2009-05-04 2021-11-30 Valtech Cardio Ltd. Deployment techniques for annuloplasty implants
US10856987B2 (en) 2009-05-07 2020-12-08 Valtech Cardio, Ltd. Multiple anchor delivery tool
US9119719B2 (en) 2009-05-07 2015-09-01 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US9592122B2 (en) 2009-05-07 2017-03-14 Valtech Cardio, Ltd Annuloplasty ring with intra-ring anchoring
US11723774B2 (en) 2009-05-07 2023-08-15 Edwards Lifesciences Innovation (Israel) Ltd. Multiple anchor delivery tool
US9937042B2 (en) 2009-05-07 2018-04-10 Valtech Cardio, Ltd. Multiple anchor delivery tool
US9968454B2 (en) 2009-10-29 2018-05-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of artificial chordae
US11617652B2 (en) 2009-10-29 2023-04-04 Edwards Lifesciences Innovation (Israel) Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US9414921B2 (en) 2009-10-29 2016-08-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
US10751184B2 (en) 2009-10-29 2020-08-25 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US11141271B2 (en) 2009-10-29 2021-10-12 Valtech Cardio Ltd. Tissue anchor for annuloplasty device
US11602434B2 (en) 2009-12-02 2023-03-14 Edwards Lifesciences Innovation (Israel) Ltd. Systems and methods for tissue adjustment
US10492909B2 (en) 2009-12-02 2019-12-03 Valtech Cardio, Ltd. Tool for actuating an adjusting mechanism
US9622861B2 (en) 2009-12-02 2017-04-18 Valtech Cardio, Ltd. Tool for actuating an adjusting mechanism
US10548726B2 (en) 2009-12-08 2020-02-04 Cardiovalve Ltd. Rotation-based anchoring of an implant
US11839541B2 (en) 2009-12-08 2023-12-12 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US11141268B2 (en) 2009-12-08 2021-10-12 Cardiovalve Ltd. Prosthetic heart valve with upper and lower skirts
US11351026B2 (en) 2009-12-08 2022-06-07 Cardiovalve Ltd. Rotation-based anchoring of an implant
US10660751B2 (en) 2009-12-08 2020-05-26 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US10231831B2 (en) 2009-12-08 2019-03-19 Cardiovalve Ltd. Folding ring implant for heart valve
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9433503B2 (en) 2010-08-04 2016-09-06 Valcare, Inc. Percutaneous transcatheter repair of heart valves
US8518107B2 (en) 2010-08-04 2013-08-27 Valcare, Inc. Percutaneous transcatheter repair of heart valves
US10182912B2 (en) 2010-08-24 2019-01-22 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US10940003B2 (en) 2010-08-24 2021-03-09 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US10543089B2 (en) 2010-11-30 2020-01-28 Edwards Lifesciences Corporation Annuloplasty ring with reduced dehiscence
US9474607B2 (en) 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US8932350B2 (en) 2010-11-30 2015-01-13 Edwards Lifesciences Corporation Reduced dehiscence annuloplasty ring
US11872132B2 (en) 2010-11-30 2024-01-16 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9402721B2 (en) 2011-06-01 2016-08-02 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US10779945B2 (en) 2011-06-01 2020-09-22 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US8940044B2 (en) 2011-06-23 2015-01-27 Valtech Cardio, Ltd. Closure element for use with an annuloplasty structure
US11197759B2 (en) 2011-11-04 2021-12-14 Valtech Cardio Ltd. Implant having multiple adjusting mechanisms
US8858623B2 (en) * 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US9775709B2 (en) 2011-11-04 2017-10-03 Valtech Cardio, Ltd. Implant having multiple adjustable mechanisms
US20130116780A1 (en) * 2011-11-04 2013-05-09 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US9265608B2 (en) 2011-11-04 2016-02-23 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US10363136B2 (en) 2011-11-04 2019-07-30 Valtech Cardio, Ltd. Implant having multiple adjustment mechanisms
US11857415B2 (en) 2011-11-08 2024-01-02 Edwards Lifesciences Innovation (Israel) Ltd. Controlled steering functionality for implant-delivery tool
US10568738B2 (en) 2011-11-08 2020-02-25 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9724192B2 (en) 2011-11-08 2017-08-08 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US11298230B2 (en) 2012-02-29 2022-04-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
US11571307B2 (en) 2012-02-29 2023-02-07 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9180008B2 (en) 2012-02-29 2015-11-10 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9814576B2 (en) 2012-02-29 2017-11-14 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9839519B2 (en) 2012-02-29 2017-12-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
US10722363B2 (en) 2012-02-29 2020-07-28 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US11395648B2 (en) 2012-09-29 2022-07-26 Edwards Lifesciences Corporation Plication lock delivery system and method of use thereof
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US10376266B2 (en) 2012-10-23 2019-08-13 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
US11344310B2 (en) 2012-10-23 2022-05-31 Valtech Cardio Ltd. Percutaneous tissue anchor techniques
US10893939B2 (en) 2012-10-23 2021-01-19 Valtech Cardio, Ltd. Controlled steering functionality for implant delivery tool
US11890190B2 (en) 2012-10-23 2024-02-06 Edwards Lifesciences Innovation (Israel) Ltd. Location indication system for implant-delivery tool
US11583400B2 (en) 2012-12-06 2023-02-21 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for guided advancement of a tool
US10610360B2 (en) 2012-12-06 2020-04-07 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US11844691B2 (en) 2013-01-24 2023-12-19 Cardiovalve Ltd. Partially-covered prosthetic valves
US11793505B2 (en) 2013-02-26 2023-10-24 Edwards Lifesciences Corporation Devices and methods for percutaneous tricuspid valve repair
US10918374B2 (en) 2013-02-26 2021-02-16 Edwards Lifesciences Corporation Devices and methods for percutaneous tricuspid valve repair
US10265171B2 (en) 2013-03-14 2019-04-23 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US11045319B2 (en) 2013-03-14 2021-06-29 Edwards Lifesciences Corporation Methods of forming heat set annuloplasty rings
US11534583B2 (en) 2013-03-14 2022-12-27 Valtech Cardio Ltd. Guidewire feeder
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
US10682232B2 (en) 2013-03-15 2020-06-16 Edwards Lifesciences Corporation Translation catheters, systems, and methods of use thereof
US11382749B2 (en) 2013-03-15 2022-07-12 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US11890194B2 (en) 2013-03-15 2024-02-06 Edwards Lifesciences Corporation Translation catheters, systems, and methods of use thereof
US10813751B2 (en) 2013-05-22 2020-10-27 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US11617647B2 (en) 2013-05-22 2023-04-04 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US11654018B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US11654017B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US11058417B2 (en) 2013-06-28 2021-07-13 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11191536B2 (en) 2013-06-28 2021-12-07 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11806009B2 (en) 2013-06-28 2023-11-07 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11224422B2 (en) 2013-06-28 2022-01-18 Valcare, Inc. Device, system, and method to secure an article to a tissue
US10918373B2 (en) 2013-08-31 2021-02-16 Edwards Lifesciences Corporation Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US11744573B2 (en) 2013-08-31 2023-09-05 Edwards Lifesciences Corporation Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US11065001B2 (en) 2013-10-23 2021-07-20 Valtech Cardio, Ltd. Anchor magazine
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
US11766263B2 (en) 2013-10-23 2023-09-26 Edwards Lifesciences Innovation (Israel) Ltd. Anchor magazine
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US10265170B2 (en) 2013-12-26 2019-04-23 Valtech Cardio, Ltd. Implantation of flexible implant
US10973637B2 (en) 2013-12-26 2021-04-13 Valtech Cardio, Ltd. Implantation of flexible implant
US11071628B2 (en) 2014-10-14 2021-07-27 Valtech Cardio, Ltd. Leaflet-restraining techniques
US10195030B2 (en) 2014-10-14 2019-02-05 Valtech Cardio, Ltd. Leaflet-restraining techniques
US11801135B2 (en) 2015-02-05 2023-10-31 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US10925610B2 (en) 2015-03-05 2021-02-23 Edwards Lifesciences Corporation Devices for treating paravalvular leakage and methods use thereof
US11020227B2 (en) 2015-04-30 2021-06-01 Valtech Cardio, Ltd. Annuloplasty technologies
US10765514B2 (en) 2015-04-30 2020-09-08 Valtech Cardio, Ltd. Annuloplasty technologies
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11471280B2 (en) 2015-06-09 2022-10-18 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11324593B2 (en) 2015-06-09 2022-05-10 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11660192B2 (en) 2015-12-30 2023-05-30 Edwards Lifesciences Corporation System and method for reshaping heart
US11890193B2 (en) 2015-12-30 2024-02-06 Edwards Lifesciences Corporation System and method for reducing tricuspid regurgitation
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
US10828160B2 (en) 2015-12-30 2020-11-10 Edwards Lifesciences Corporation System and method for reducing tricuspid regurgitation
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
US11540835B2 (en) 2016-05-26 2023-01-03 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
US10226342B2 (en) 2016-07-08 2019-03-12 Valtech Cardio, Ltd. Adjustable annuloplasty device with alternating peaks and troughs
US10959845B2 (en) 2016-07-08 2021-03-30 Valtech Cardio, Ltd. Adjustable annuloplasty device with alternating peaks and troughs
US11779458B2 (en) 2016-08-10 2023-10-10 Cardiovalve Ltd. Prosthetic valve with leaflet connectors
US11103349B2 (en) 2016-08-15 2021-08-31 Valcare, Inc. Devices and methods for the treatment of heart valve insufficiencies
US11576779B2 (en) 2017-03-17 2023-02-14 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
US11883611B2 (en) 2017-04-18 2024-01-30 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US11832784B2 (en) 2017-11-02 2023-12-05 Edwards Lifesciences Innovation (Israel) Ltd. Implant-cinching devices and systems
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
US11779463B2 (en) 2018-01-24 2023-10-10 Edwards Lifesciences Innovation (Israel) Ltd. Contraction of an annuloplasty structure
US11666442B2 (en) 2018-01-26 2023-06-06 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
US11701228B2 (en) 2018-03-20 2023-07-18 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11026791B2 (en) 2018-03-20 2021-06-08 Medtronic Vascular, Inc. Flexible canopy valve repair systems and methods of use
US11285003B2 (en) 2018-03-20 2022-03-29 Medtronic Vascular, Inc. Prolapse prevention device and methods of use thereof
US11123191B2 (en) 2018-07-12 2021-09-21 Valtech Cardio Ltd. Annuloplasty systems and locking tools therefor
US11890191B2 (en) 2018-07-12 2024-02-06 Edwards Lifesciences Innovation (Israel) Ltd. Fastener and techniques therefor
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US11534300B2 (en) 2018-12-03 2022-12-27 Valcare, Inc. Stabilizing and adjusting tool for controlling a minimally invasive mitral / tricuspid valve repair system
US11793628B2 (en) 2019-07-15 2023-10-24 Valcare, Inc. Transcatheter bio-prosthesis member and support structure
US11819411B2 (en) 2019-10-29 2023-11-21 Edwards Lifesciences Innovation (Israel) Ltd. Annuloplasty and tissue anchor technologies
CN115671379A (en) * 2022-10-27 2023-02-03 牛瑞瑞 Medical implant and preparation method and application thereof

Also Published As

Publication number Publication date
WO2006012038A2 (en) 2006-02-02
US7361190B2 (en) 2008-04-22
EP1765226A2 (en) 2007-03-28
JP2008504878A (en) 2008-02-21
EP1776067A4 (en) 2008-04-02
EP1761213A2 (en) 2007-03-14
WO2006012013A2 (en) 2006-02-02
US20110257740A1 (en) 2011-10-20
JP2008504875A (en) 2008-02-21
WO2006012011B1 (en) 2006-11-02
JP2008504876A (en) 2008-02-21
US7510577B2 (en) 2009-03-31
US20080215145A1 (en) 2008-09-04
JP2008504879A (en) 2008-02-21
WO2006012013A3 (en) 2006-12-28
US20050288779A1 (en) 2005-12-29
WO2006012011A2 (en) 2006-02-02
US7713298B2 (en) 2010-05-11
US20050288782A1 (en) 2005-12-29
US7722668B2 (en) 2010-05-25
WO2006012011A3 (en) 2006-03-09
US7377941B2 (en) 2008-05-27
WO2006012068A3 (en) 2007-02-22
US20080200981A1 (en) 2008-08-21
EP1761207A2 (en) 2007-03-14
US7396364B2 (en) 2008-07-08
US20050288781A1 (en) 2005-12-29
US20050288783A1 (en) 2005-12-29
US20050288777A1 (en) 2005-12-29
WO2006012068A2 (en) 2006-02-02
EP1776067A2 (en) 2007-04-25
EP1761213A4 (en) 2009-03-18
WO2006012038A3 (en) 2006-10-26
EP1761207A4 (en) 2008-04-09
US20050288780A1 (en) 2005-12-29
EP1765226A4 (en) 2009-01-21
US20050288776A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
US7713298B2 (en) Methods for treating cardiac valves with adjustable implants
US20070055368A1 (en) Slotted annuloplasty ring
EP1790318B1 (en) Magnetic engagement of catheter to implantable device
US7357815B2 (en) Dynamically adjustable implants and methods for reshaping tissue
US20110257741A1 (en) Implants and methods for reshaping heart valves
US20070135913A1 (en) Adjustable annuloplasty ring activation system
US20080183285A1 (en) Adjustable cardiac valve implant with selective dimensional adjustment
US20080015688A1 (en) Adjustable multi-segment cardiac valve implant with selective dimensional adjustment

Legal Events

Date Code Title Description
AS Assignment

Owner name: MICARDIA CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHAOULIAN, EMANUEL;MOADDEB, SHAHRAM;SHAOLIAN, SAMUEL M.;REEL/FRAME:016886/0197;SIGNING DATES FROM 20050714 TO 20050715

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION